{"id":103,"date":"2025-06-16T19:21:57","date_gmt":"2025-06-16T10:21:57","guid":{"rendered":"https:\/\/www.hosp.kagoshima-u.ac.jp\/pharm\/wpo\/?page_id=103"},"modified":"2025-06-26T19:32:29","modified_gmt":"2025-06-26T10:32:29","slug":"achievement","status":"publish","type":"page","link":"https:\/\/www.hosp.kagoshima-u.ac.jp\/pharm\/achievement\/","title":{"rendered":"\u696d\u7e3e"},"content":{"rendered":"

<\/path><\/svg><\/blocsicon> 2024\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u8ad6\u6587\uff08\u7dcf\u8aac\uff09<\/h3>\n\n\n\n
\u8ad6\u6587\u533a\u5206<\/th>\n\u8457\u8005\u533a\u5206<\/th>\n\u8457\u8005\u540d<\/th>\n\u8ad6\u6587\u540d<\/th>\n\u96d1\u8a8c\u540d\u7b49<\/th>\n\u5dfb\u6570\uff1a\u521d\u9801\uff0d\u7d42\u9801<\/th>\n\u767a\u884c\u5e74\uff08\u897f\u66a6\uff09\u6708\u65e5<\/th>\n<\/tr>\n
\u548c\u6587\u7dcf\u8aac<\/td>\n\u5358\u8457<\/td>\n\u83c5\u539f\u3000\u82f1\u8f1d<\/td>\n\u6211\u304c\u56fd\u306e\u6709\u5bb3\u4e8b\u8c61\u81ea\u767a\u5831\u544a\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u3092\u7528\u3044\u305f\u304c\u3093\u30fb\u7de9\u548c\u85ac\u7269\u7642\u6cd5\u306b\u95a2\u3059\u308b\u7814\u7a76\u5831\u544a<\/td>\n\u65e5\u672c\u7de9\u548c\u533b\u7642\u85ac\u5b66\u96d1\u8a8c<\/td>\n17: 69-85<\/td>\n2024\u5e74<\/td>\n<\/tr>\n<\/table>\n

\t<\/p>\n

\u539f\u8457\u8ad6\u6587<\/h3>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u8ad6\u6587\u533a\u5206<\/th>\n\u8457\u8005\u533a\u5206<\/th>\n\u8457\u8005\u540d<\/th>\n\u8ad6\u6587\u540d<\/th>\n\u96d1\u8a8c\u540d\u7b49<\/th>\n\u5dfb\u6570\uff1a\u521d\u9801\uff0d\u7d42\u9801<\/th>\n\u767a\u884c\u5e74\uff08\u897f\u66a6\uff09\u6708\u65e5<\/th>\n<\/tr>\n
\u6b27\u6587\u539f\u8457<\/td>\n\u5171\u8457<\/td>\nKawashiri T, Sugawara H, Makihara K, Ohno R, Miyamoto Y, Hidaka N, Uchida M, Takase H<\/td>\nMedical Economic Effect of Pharmaceutical Interventions by Board-Certified Pharmacists in Palliative Pharmacy for Patients with Cancer Using Medical Narcotics in Japan: A Multicenter, Retrospective Study<\/td>\nJ Nippon Med Sch<\/td>\n2024; 91: 59-65<\/td>\n2024\u5e742\u6708<\/td>\n<\/tr>\n
\u6b27\u6587\u539f\u8457<\/td>\n\u5171\u8457<\/td>\nKawamura H, Arimura S, Saida R, Murata N, Shigemi A, Kodama Y, Nakamura M, Obama Y, Fukuyama R, Hamada Y, Shinkawa N, Sunagawa T, Kamiya H, Nishi J.<\/td>\nEnhanced measures, including PCR-based screening and syndromic surveillance for nosocomial outbreaks of the COVID-19 Omicron variant, using descriptive epidemiology and whole-genome sequencing in a Japanese tertiary care hospital.<\/td>\nJ Infect Chemother.<\/td>\n30(2):104-110<\/td>\n2024\u5e742\u6708<\/td>\n<\/tr>\n
\u548c\u6587\u539f\u8457<\/td>\n\u5171\u8457<\/td>\n\u65e5\u9ad8\u670b\u3001\u65b0\u7530\u7f8e\u5948\u3001\u897f\u5ddd\u62d3\u6717\u3001\u5ca1\u672c\u5eb7\u88d5\u3001\u5bfa\u8597\u82f1\u4e4b\u3001\u6b66\u7530\u6cf0\u751f<\/td>\n\u795e\u7d4c\u82bd\u816b\u306b\u5bfe\u3059\u308b\u30b8\u30cc\u30c4\u30ad\u30b7\u30de\u30d6\u6301\u7d9a\u6295\u4e0e\u7d42\u4e86\u5f8c\u306e\u75bc\u75db\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u306b\u96e3\u6e0b\u3057\u305f\uff11\u75c7\u4f8b<\/td>\n\u65e5\u672c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u96d1\u8a8c<\/td>\n60(4):382-386<\/td>\n2024\u5e744\u6708<\/td>\n<\/tr>\n
\u548c\u6587\u539f\u8457<\/td>\n\u5171\u8457<\/td>\n\u6c38\u702c\u601c\u53f8, \u68ee\u6728\u90a6\u660e, \u718a\u4e95\u6b63\u8cb4, \u7e04\u7530\u4fee\u4e00, \u5343\u8449\u8cb4\u5fd7, \u6df1\u6c34\u77e5\u82f1, \u5fd7\u7530\u654f\u5b8f<\/td>\n\u85ac\u5264\u90e8\u9580\u306b\u6240\u5c5e\u3057\u3066\u3044\u308b\u85ac\u5264\u5e2b\u4ee5\u5916\u306e\u8005\u3078\u306e\u30bf\u30b9\u30af\u30b7\u30d5\u30c8\u306e\u696d\u52d9\u8ca0\u62c5\u8efd\u6e1b\u52b9\u679c\u3068\u5bfe\u4eba\u696d\u52d9\u3078\u306e\u5f71\u97ff\u306b\u95a2\u3059\u308b\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\u7d50\u679c<\/td>\n\u533b\u7642\u85ac\u5b66<\/td>\n50(4): 143-152<\/td>\n2024\u5e744\u6708<\/td>\n<\/tr>\n
\u6b27\u6587\u539f\u8457<\/td>\n\u5171\u8457<\/td>\nKanazawa N, Shigemi A, Amadatsu N, Arimura K, Shimono S, Oda K, Chuang VTG, Matsumoto K, Kawamura H, Terazono H.<\/td>\nA cohort study of the risk factors and the target AUC to avoid vancomycin-associated acute kidney injury in pediatric patients.<\/td>\nJ Infect Chemother.<\/td>\n30(4):323-328<\/td>\n2024\u5e744\u6708<\/td>\n<\/tr>\n
\u6b27\u6587\u539f\u8457<\/td>\n\u5171\u8457<\/td>\nHigashi K, Sonoda Y, Kaku N, Fujii F, Yamashita F, Lee S, Tocan V, Ebihara G, Matsuoka W, Tetsuhara K, Sonoda M, Chong PF, Mushimoto Y, Kojima-Ishii K, Ishimura M, Koga Y, Fukuta A, Tsuchihashi NA, Kikuchi Y, Karashima T, Sawada T, Hotta T, Yoshimitsu M, Terazono H, Tajiri T, Nakagawa T, Sakai Y, Nakamura K, Ohga S.<\/td>\nRapid and long-lasting efficacy of high-dose ambroxol therapy for neuronopathic Gaucher disease: A case report and literature review<\/td>\nMol Genet Genomic Med<\/td>\n12(4):e2427.<\/td>\n2024\u5e744\u6708<\/td>\n<\/tr>\n
\u6b27\u6587\u539f\u8457<\/td>\n\u5171\u8457<\/td>\nKawamura H, Imuta N, Ooka T, Shigemi A, Nakamura M, Mougi K, Obama Y, Fukuyama R, Arimura S, Murata N, Tominaga H, Sasaki H, Nagano S, Taniguchi N, Nishi J.<\/td>\nImpact of control measures including decolonization and hand hygiene for orthopaedic surgical site infection caused by MRSA at a Japanese tertiary-care hospital.<\/td>\nJ Hosp Infect.<\/td>\n146:151-159<\/td>\n2024\u5e744\u6708<\/td>\n<\/tr>\n
\u548c\u6587\u539f\u8457<\/td>\n\u5171\u8457<\/td>\n\u6751\u5c71\u7531\u9999\u91cc, \u6709\u99ac\u76f4\u4f38, \u91cd\u4e45\u53cb\u7d00, \u677e\u5143\u771f\u54c9, \u4e95\u4e0a\u548c\u5553, \u5bfa\u8597\u82f1\u4e4b, \u6b66\u7530\u6cf0\u751f<\/td>\n\u9662\u5916\u51e6\u65b9\u7b8b\u306b\u8868\u793a\u3059\u308b\u81e8\u5e8a\u691c\u67fb\u9805\u76ee\u306e\u691c\u8a0e\u3068\u4fdd\u967a\u85ac\u5c40\u306b\u304a\u3051\u308b\u81e8\u5e8a\u691c\u67fb\u5024\u306e\u5229\u7528\u72b6\u6cc1\u306e\u8abf\u67fb<\/td>\n\u533b\u7642\u85ac\u5b66<\/td>\n50(8): 411-420<\/td>\n2024\u5e748\u6708<\/td>\n<\/tr>\n
\u6b27\u6587\u539f\u8457<\/td>\n\u5171\u8457<\/td>\nShiro Beppu, Takuro Nishikawa, Dan Tomomasa, Atsushi Hijikata, Hiroshi Kasabata, Hideyuki Terazono, Kazuro Ikawa, Tatsuro Nakamura, Shogo Horikawa, Jun Nagahama, Aki Nakamura, Takanari Abematsu, Shunsuke Nakagawa, Kaoru Oketani, Hirokazu Kanegane, Yasuhiro Okamoto<\/td>\nPerspectives in newborn screening for SCID in Japan. Case report: newborn screening identified X-linked severe combined immunodeficiency with a novel IL2RG variant<\/td>\nFront Immunol.<\/td>\n20;15:1478411.<\/td>\n2024\u5e7411\u6708<\/td>\n<\/tr>\n
\u6b27\u6587\u539f\u8457<\/td>\n\u5171\u8457<\/td>\nMatsukane R, Nakamura S, Minami H, Tsubouchi K, Yoneshima Y, Hata K, Yasukochi S, Suetsugu K, Okamoto I, Hirota T.<\/td>\nKrebs von den Lungen-6 surveillance in immune checkpoint inhibitor-induced pneumonitis<\/td>\nJ Immunother Cancer<\/td>\n12(12):e010114.<\/td>\n2024\u5e7412\u6708<\/td>\n<\/tr>\n
\u6b27\u6587\u539f\u8457<\/td>\n\u5171\u8457<\/td>\nOda K, Matsumoto K, Shoji K, Shigemi A, Kawamura H, Takahashi Y, Katanoda T, Hashiguchi Y, Jono H, Saito H, Takesue Y, Kimura T.<\/td>\nValidation and development of population pharmacokinetic model of vancomycin using a real-world database from a nationwide free web application.<\/td>\nJ Infect Chemother.<\/td>\n30(12):1244-1251<\/td>\n2024\u5e7412\u6708<\/td>\n<\/tr>\n<\/table>\n

\t\t<\/p>\n

\u5831\u544a\u30fb\u8a18\u4e8b\u7b49<\/h3>\n\n\n\n
\u5831\u544a\u30fb\u8a18\u4e8b\u7b49<\/th>\n\u8457\u8005\u533a\u5206<\/th>\n\u8457\u8005\u540d\u30fb\u25cb\u7814\u7a76\u4ee3\u8868\u8005\u7b49\u30fb\u30fb\u30fb<\/th>\n\u8ad6\u6587\u540d\u30fb\u984c\u76ee\u30fb\u30fb\u30fb<\/th>\n\u96d1\u8a8c\u540d\u7b49<\/th>\n\u5dfb\u6570\uff1a\u521d\u9801\uff0d\u7d42\u9801\u7b49<\/th>\n\u767a\u884c\u6240\u7b49<\/th>\n\u767a\u884c\u5e74\uff08\u897f\u66a6\uff09\u6708\u65e5<\/th>\n<\/tr>\n
\u5b66\u8853\u96d1\u8a8c\u5916<\/td>\n<\/td>\n\u3007\u5f8c\u85e4\u3000\u512a<\/td>\n\u30ef\u30ab\u30bf\u30b9\u300c”\u82e5\u624b\u201d\u306e\u7686\u3055\u3093\uff01KIDS\u306e\u3053\u3068\u3001\u3082\u3063\u3068\u77e5\u3063\u3066\u307f\u307e\u305b\u3093\u304b\uff1f\u300d<\/td>\n\u65e5\u672c\u814e\u81d3\u75c5\u85ac\u7269\u7642\u6cd5\u5b66\u4f1a\u5b66\u4f1a\u8a8c<\/td>\n\u7b2c13\u5dfb\u7b2c3\u53f7396-398<\/td>\n\u4e00\u822c\u793e\u56e3\u6cd5\u4eba\u65e5\u672c\u814e\u81d3\u75c5\u85ac\u7269\u7642\u6cd5\u5b66\u4f1a<\/td>\n2024\u5e7412\u67081\u65e5<\/td>\n<\/tr>\n<\/table>\n

\t\t<\/p>\n

\u5b66\u4f1a\u767a\u8868<\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u5b66\u4f1a\u767a\u8868<\/th>\n\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09<\/th>\n\u6f14\u984c\u540d<\/th>\n\u767a\u8868\u5b66\u4f1a\u7b49<\/th>\n\u958b\u50ac\u90fd\u5e02<\/th>\n\u958b\u50ac\uff08\u897f\u66a6\uff09\u5e74\u6708\u65e5<\/th>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u25cb\u6709\u99ac \u592a\u967d, \u83c5\u539f \u82f1\u8f1d, \u6e80\u5c3e \u660e\u6075, \u798f\u53f8\u5c71 \u5178\u5b50, \u5bfa\u8597 \u82f1\u4e4b<\/td>\n\u30d5\u30a7\u30f3\u30bf\u30cb\u30eb\u6301\u7d9a\u9759\u6ce8\u6f38\u6e1b\u4e2d\u6b62\u306b\u3088\u308a\u96e2\u8131\u75c7\u72b6\u3092\u8a8d\u3081\u305f\u672b\u68a2\u8840\u5e79\u7d30\u80de\u79fb\u690d\u5f8c\u306e\u60a3\u5150\u306e1\u4f8b\u200b<\/td>\n\u7b2c17\u56de\u7de9\u548c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a<\/td>\n\u6771\u4eac<\/td>\n2024\u5e745\u670824\u65e5\uff5e26\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u3007\u8302\u898b \u831c\u91cc, \u5ddd\u6751 \u82f1\u6a39, \u5929\u9054 \u83dc\u7dd2,
\u6709\u6751 \u6602\u592a\u6717, \u91d1\u6fa4 \u76f4\u5b50, \u4e0b\u91ce \u5968\u5e73, \u897f \u9806\u4e00\u90ce, \u5bfa\u8597 \u82f1\u4e4b<\/td>\n		\u5916\u6765\u6297\u30a6\u30a4\u30eb\u30b9\u85ac\u52a0\u7642\u5f8c\u306b\u5165\u9662\u3092\u8981\u3057\u305f\u751f\u4f53\u814e\u79fb\u690d\u5f8cCOVID-19\u60a3\u80054\u75c7\u4f8b\u306e\u89e3\u6790<\/td>\n\u7b2c72\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a<\/td>\n\u795e\u6238\u5e02<\/td>\n2024\u5e746\u670827\uff5e29\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u3007\u8302\u898b \u831c\u91cc, \u5ddd\u6751 \u82f1\u6a39, \u5929\u9054 \u83dc\u7dd2,
\u6709\u6751 \u6602\u592a\u6717, \u91d1\u6fa4 \u76f4\u5b50, \u4e0b\u91ce \u5968\u5e73, \u897f \u9806\u4e00\u90ce, \u5bfa\u8597 \u82f1\u4e4b<\/td>\n		DASC\u6307\u6a19\u3092\u7528\u3044\u305fICU\u60a3\u8005\u9650\u5b9a\u306e\u30ab\u30eb\u30d0\u30da\u30cd\u30e0\u7cfb\u85ac\u8a31\u53ef\u5236\u5c0e\u5165\u304c\u9662\u5185\u306e\u6297\u83cc\u85ac\u4f7f\u7528\u306b\u4e0e\u3048\u305f\u5f71\u97ff\u3068\u85ac\u5264\u611f\u53d7\u6027\u3068\u306e\u95a2\u9023\u306b\u95a2\u3059\u308b\u691c\u8a0e<\/td>\n\u7b2c72\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a<\/td>\n\u795e\u6238\u5e02<\/td>\n2024\u5e746\u670827\uff5e29\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u25cb\u9ad9\u6ff1\u3000\u548c\u5f18, \u5c4b\u5730\u3000\u6176\u5b50, \u5bfa\u8597 \u82f1\u4e4b<\/td>\n\u6297HIV\u85ac\u306e\u9662\u5916\u51e6\u65b9\u7b8b\u5fdc\u9700\u306b\u95a2\u3059\u308b
\u4fdd\u967a\u85ac\u5c40\u306e\u5b9f\u614b\u8abf\u67fb\u7814\u7a76<\/td>\n		\u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e02024\/\u7b2c32\u56de\u30af\u30ea\u30cb\u30ab\u30eb\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/td>\n\u718a\u672c\u5e02<\/td>\n2024\u5e747\u67086\u65e5\uff5e7\u67087\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u3007\u5f8c\u85e4\u3000\u512a,\u5929\u9054 \u83dc\u7dd2,\u6709\u6751 \u6602\u592a\u6717,\u4e0b\u91ce \u5968\u5e73,\u6709\u99ac \u592a\u967d, \u91d1\u6fa4 \u76f4\u5b50, \u8302\u898b \u831c\u91cc, \u6075\u5cf6 \u5353\u6d77,\u5c71\u4e0b \u548c,\u5357 \u771f\u4eba\uff0c\u5409\u5dba \u967d\u4ec1,\u5bfa\u8597 \u82f1\u4e4b<\/td>\n\u8179\u819c\u900f\u6790\u60a3\u8005\u306e\u8702\u7aa9\u7e54\u708e\u306b\u5bfe\u3057\u30d0\u30f3\u30b3\u30de\u30a4\u30b7\u30f3\u7d4c\u9759\u8108\u7684\u6295\u4e0e\u3092\u884c\u3044\uff0c\uff34\uff24\uff2d\u304c\u594f\u529f\u3057\u305f1\u4f8b<\/td>\n\u7b2c18\u56de\u65e5\u672c\u814e\u81d3\u75c5\u85ac\u7269\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u5e74\u4f1a<\/td>\n\u672d\u5e4c\u5e02<\/td>\n2024\u5e749\u67087\u65e5\uff5e8\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u3007 \u4e2d\u6751 \u653f\u654f, \u5c0f\u6ff1 \u7950\u884c, \u53e4\u57ce \u525b, \u91ce\u908a \u7d17\u8036\u9999, \u6709\u6751 \u5c1a\u5b50, \u6751\u7530 \u5948\u7a42, \u8302\u898b \u831c\u91cc, \u6ce2\u91ce \u53f2\u5178, \u5ddd\u6751 \u82f1\u6a39, \u5927\u5c71 \u967d\u5b50, \u6a4b\u53e3 \u7167\u4eba, \u897f \u9806\u4e00\u90ce<\/td>\n\u9e7f\u5150\u5cf6\u770c\u306b\u304a\u3051\u308b\u85ac\u5264\u8010\u6027\u5bfe\u7b56\u30a2\u30af\u30b7\u30e7\u30f3\u30d7\u30e9\u30f3\u306b\u6e96\u3058\u305f\u85ac\u5264\u8010\u6027\u83cc\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u30b7\u30b9\u30c6\u30e0\u306e\u6d3b\u7528\u306b\u3064\u3044\u3066<\/td>\n\u7b2c56\u56de\u65e5\u672c\u533b\u7642\u691c\u67fb\u79d1\u5b66\u4f1a<\/td>\n\u6a2a\u6d5c\u5e02<\/td>\n2024\u5e7410\u67084\u65e5\uff5e6\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u25cb\u9ad9\u6ff1 \u548c\u5f18, \u5c4b\u5730 \u6176\u5b50, \u672b\u6b21 \u738b\u5353, \u5bfa\u8597 \u82f1\u4e4b<\/td>\n\u9e7f\u5150\u5cf6\u770c\u5185\u306b\u304a\u3051\u308b\u6297HIV\u85ac\u9662\u5916\u51e6\u65b9\u7b8b\u306e\u5fdc\u9700\u306b\u95a2\u3059\u308b\u8abf\u67fb<\/td>\n\u7b2c83\u56de\u4e5d\u5dde\u5c71\u53e3\u85ac\u5b66\u5927\u4f1a<\/td>\n\u9e7f\u5150\u5cf6\u5e02<\/td>\n2024\u5e7410\u670812\u65e5\uff5e13\u65e5<\/td>\n<\/tr>\n
\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/td>\n\u3007 \u91d1\u6fa4\u3000\u76f4\u5b50<\/td>\n\u5f53\u9662\u306b\u304a\u3051\u308b\u85ac\u5264\u60c5\u5831\u5171\u6709\u306e\u53d6\u308a\u7d44\u307f\u306b\u3064\u3044\u3066<\/td>\n\u7b2c83\u56de\u4e5d\u5dde\u5c71\u53e3\u85ac\u5b66\u5927\u4f1a<\/td>\n\u9e7f\u5150\u5cf6\u5e02<\/td>\n2024\u5e7410\u670812\u65e5\uff5e13\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u25cb\u5c4b\u5730 \u6176\u5b50, \u9ad8\u6ff1 \u548c\u5f18, \u5bfa\u8597 \u82f1\u4e4b<\/td>\n\u30a2\u30c9\u30d2\u30a2\u30e9\u30f3\u30b9\u4e0d\u826f\u306e HIV \u60a3\u8005\u306b\u5bfe\u3057\u6301\u52b9\u6027\u6ce8\u5c04\u5264\u3078\u306e\u5909\u66f4\u3092\u652f\u63f4\u3057\u305f\u4e00\u75c7\u4f8b<\/td>\n\u7b2c34\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a<\/td>\n\u5343\u8449\u5e02<\/td>\n2024\u5e7411\u67082\u65e5\uff5e4\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u3007 \u690d\u7530 \u8cb4\u53f2, \u4e2d\u5d8b \u4e00\u5f66, \u5409\u7530 \u8015\u4e00\u90ce, \u4e45\u6597 \u7ae0\u5e83,
\u6d6e\u6751 \u8061, \u5c0f\u5ddd \u62d3, \u9577\u5c3e \u7f8e\u7d00, \u8302\u898b \u831c\u91cc, \u4fdd\u5bcc \u5b97\u57ce,
\u7b20\u539f\u656c, \u4eca\u5317 \u83dc\u6d25\u5b50, \u639b\u5c4b \u5f18, \u91d1\u5b50 \u5e78\u5f18, \u4ec1\u6728 \u8aa0,
\u5bae\u5d0e \u6cf0\u53ef, \u5409\u5ca1 \u7766\u5c55, \u7af9\u672b \u82b3\u751f<\/td>\n		\u30ab\u30f3\u30b8\u30c0\u8840\u75c7\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30d9\u30c3\u30c8\u30b5\u30a4\u30c9\u3067\u306e\u4e88\u5f8c\u4e88\u6e2c\u6307\u6a19Modi\u4e18ed\u3000Pitt\u3000bacteremia\u3000Score\u306b\u3088\u308b\u6297\u771f\u83cc\u85ac \u306e\u9078\u629e<\/td>\n\u7b2c37\u56de\u65e5\u672c\u5916\u79d1\u611f\u67d3\u75c7\u5b66\u4f1a<\/td>\n\u6771\u4eac\u90fd\u53f0\u6771\u533a<\/td>\n2024\u5e7411\u67088\u65e5\uff5e11\u67089\u65e5<\/td>\n<\/tr>\n
\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/td>\n\u3007 \u8302\u898b \u831c\u91cc<\/td>\n\u30b7\u30f3\u30dd\u30b8\u30a6\u30e05\uff1b\u6297\u5fae\u751f\u7269\u85ac\u306e\u526f\u4f5c\u7528\u306b\u3064\u3044\u3066\u300e\u611f\u899a\u5668\u969c\u5bb3 \uff5e\u8074\u899a\u969c\u5bb3\u30fb\u8996\u899a\u969c\u5bb3\u3092\u4e2d\u5fc3\u306b\uff5e\u300f<\/td>\n\u3000\u3000\u7b2c72\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a
\u3000\u3000\u7b2c94\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a
\u5408\u540c\u5b66\u4f1a<\/td>\n		\u795e\u6238\u5e02<\/td>\n2024\u5e7411\u670814\u65e5\uff5e16\u65e5<\/td>\n<\/tr>\n
\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/td>\n\u3007 \u8302\u898b \u831c\u91cc\uff0c\u91d1\u6fa4 \u76f4\u5b50\uff0c\u9ad8\u6a4b \u83dc\u7dd2\uff0c\u6709\u6751 \u6602\u592a\u6717, \u4e0b\u91ce \u5968\u5e73, \u5ddd\u6751 \u82f1\u6a39<\/td>\n\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f35\uff1b
C. difficile\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\uff1a\u5404\u8077\u7a2e\u306e\u305d\u308c\u305e\u308c\u306e\u5f79\u5272
\u300e\u85ac\u5264\u5e2b\u306e\u7acb\u5834\u304b\u3089\u300f<\/td>\n		\u3000\u3000\u7b2c72\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a
\u3000\u3000\u7b2c94\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a
\u5408\u540c\u5b66\u4f1a<\/td>\n		\u795e\u6238\u5e02<\/td>\n2024\u5e7411\u670814\u65e5\uff5e16\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u3007\u6709\u6751\u6602\u592a\u6717\u3001\u8302\u898b\u831c\u91cc\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u5929\u9054\u83dc\u7dd2\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u4e0b\u91ce\u5968\u5e73\u3001\u897f\u9806\u4e00\u90ce\u3001\u5bfa\u8597\u82f1\u4e4b<\/td>\n\u5f53\u9662\u3067\u30cb\u30eb\u30de\u30c8\u30ec\u30d3\u30eb\/\u30ea\u30c8\u30ca\u30d3\u30eb\u3068\u30bf\u30af\u30ed\u30ea\u30e0\u30b9\u4f75\u7528\u5f8c\u306b\u5165\u9662\u52a0\u7642\u3092\u8981\u3057\u305fCOVID-19\u60a3\u80052\u75c7\u4f8b<\/td>\n\u7b2c72\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a<\/td>\n\u795e\u6238\u5e02<\/td>\n2024\u5e7411\u670814\u65e5\uff5e16\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u3007 \u4e0b\u91ce \u5968\u5e73, \u8302\u898b \u831c\u91cc, \u5ddd\u6751 \u82f1\u6a39, \u5929\u9054 \u83dc\u7dd2,
\u6709\u6751 \u6602\u592a\u6717, \u91d1\u6fa4 \u76f4\u5b50, \u897f \u9806\u4e00\u90ce, \u5bfa\u8597 \u82f1\u4e4b<\/td>\n		COVID-19\u6301\u7d9a\u611f\u67d3\u3092\u5448\u3057\u305f\u91cd\u75c7\u7b4b\u7121\u529b\u75c7\u60a3\u8005\u306b\u5bfe\u3057\u30a8\u30f3\u30b7\u30c8\u30ec\u30eb\u30d3\u30eb\u3068\u30ec\u30e0\u30c7\u30b7\u30d3\u30eb\u3092\u4f75\u7528\u3057\u52a0\u7642\u3057\u305f\u75c7\u4f8b\u306e\u7d4c\u9a13<\/td>\n\u7b2c72\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a<\/td>\n\u795e\u6238\u5e02<\/td>\n2024\u5e7411\u670814\u65e5\uff5e16\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u25cb\u8c37\u4e0a \u745e\u5b63, \u65b0\u7530 \u7f8e\u5948,\u9ad8\u6a4b \u6bc5\u884c, \u5c71\ufa11 \u667a\u4e45, \u6df1\u6c34 \u77e5\u82f1, \u83c5\u539f \u82f1\u8f1d, \u672b\u6b21 \u738b\u5353, \u5bfa\u8597 \u82f1\u4e4b<\/td>\n\u6297\u304c\u3093\u85ac\u6df7\u5408\u8abf\u88fd\u30ed\u30dc\u30c3\u30c8\u306e\u5c0e\u5165\u304c\u85ac\u5264\u5e2b\u306e
\u8abf\u88fd\u696d\u52d9\u306e\u52b9\u7387\u6027\u306b\u4e0e\u3048\u308b\u5f71\u97ff<\/td>\n		\u7b2c8\u56de\u9e7f\u5150\u5cf6\u770c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u5b66\u8853\u5927\u4f1a<\/td>\n\u9e7f\u5150\u5cf6\u5e02<\/td>\n2025\u5e742\u670816\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u3007\u5bae\u4e0b\u3000\u60a0\u751f\uff0c\u5c4b\u5730\u3000\u6176\u5b50\uff0c\u5929\u9054\u3000\u83dc\u7dd2\uff0c\u6e80\u5c3e\u3000\u660e\u6075\uff0c\u677e\u5143\u3000\u771f\u54c9\uff0c\u672b\u6b21\u3000\u738b\u5353\uff0c\u5bfa\u8597\u3000\u82f1\u4e4b<\/td>\n\u6551\u6025\u5916\u6765\u3078\u9069\u5207\u306a\u30a2\u30f3\u30c7\u30ad\u30b5\u30cd\u30c3\u30c8\u3000\u30a2\u30eb\u30d5\u30a1\u5b9a\u6570\u914d\u7f6e\u3078\u306e\u53d6\u308a\u7d44\u307f<\/td>\n\u7b2c8\u56de\u9e7f\u5150\u5cf6\u770c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u5b66\u8853\u5927\u4f1a<\/td>\n\u9e7f\u5150\u5cf6\u5e02<\/td>\n2025\u5e742\u670816\u65e5<\/td>\n<\/tr>\n
\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/td>\n\u3007\u672b\u6b21 \u738b\u5353\u3001\u5185\u7530 \u307e\u3084\u3053\u3001\u5bfa\u8597 \u82f1\u4e4b<\/td>\n\u591a\u8077\u7a2e\u9023\u643a\u3092\u57fa\u76e4\u3068\u3057\u305f\u533b\u7642\u85ac\u5b66\u7814\u7a76\u306e\u6d3b\u6027\u5316\uff1a\u533b\u7642\u306e\u8cea\u3068\u793e\u4f1a\u7684\u30d7\u30ec\u30bc\u30f3\u30b9\u306e\u5411\u4e0a<\/td>\n\u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c145\u56de\u5e74\u4f1a<\/td>\n\u798f\u5ca1\u5e02<\/td>\n2025\u5e743\u670827\u65e5\uff5e29\u65e5<\/td>\n<\/tr>\n
\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/td>\n\u25cb\u5bfa\u8597\u3000\u82f1\u4e4b<\/td>\n\u533b\u7642\u73fe\u5834\u3067\u306e\u30c0\u30a4\u30d0\u30fc\u30b7\u30c6\u30a3\u306e\u73fe\u72b6\u306b\u3064\u3044\u3066<\/td>\n\u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c145\u56de\u5e74\u4f1a<\/td>\n\u798f\u5ca1\u5e02<\/td>\n2025\u5e743\u670827\u65e5\uff5e29\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u25cb\u6709\u99ac \u592a\u967d, \u9ad9\u6ff1 \u548c\u5f18, \u5c0f\u516b\u91cd\u3000\u85ab\u5b50, \u6817\u539f \u5d07, \u672b\u6b21 \u738b\u5353, \u5bfa\u8597\u3000\u82f1\u4e4b<\/td>\n\u30e9\u30c3\u30c8\u521d\u4ee3\u5f8c\u6839\u795e\u7d4c\u7bc0\u7d30\u80de\u3092\u7528\u3044\u305f\u7d30\u80de\u5916\u96fb\u4f4d\u8a08\u6e2c\u306b\u3088\u308b\u30aa\u30ad\u30b5\u30ea\u30d7\u30e9\u30c1\u30f3\u6025\u6027\u6bd2\u6027\u306e\u8a55\u4fa1<\/td>\n\u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c145\u56de\u5e74\u4f1a<\/td>\n\u798f\u5ca1\u5e02<\/td>\n2025\u5e743\u670827\u65e5\uff5e29\u65e5<\/td>\n<\/tr>\n
\u56fd\u5185\u5b66\u4f1a<\/td>\n\u3007\u611b\u7532 \u96bc\u4eba, \u9ad9\u6ff1 \u548c\u5f18, \u672b\u6b21 \u738b\u5353, \u5bfa\u8597 \u82f1\u4e4b<\/td>\nSingle cell in silico\u89e3\u6790\u306b\u3088\u308b\u518d\u767a\u30b0\u30ea\u30aa\u30d6\u30e9\u30b9\u30c8\u30fc\u30de
\u7279\u7570\u7684\u7d30\u80de\u96c6\u56e3\u306e\u540c\u5b9a<\/td>\n		\u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c145\u56de\u5e74\u4f1a<\/td>\n\u798f\u5ca1\u5e02<\/td>\n2025\u5e743\u670827\u65e5\uff5e29\u65e5<\/td>\n<\/tr>\n<\/table>\n

\t\t<\/p>\n

\u8ad6\u6587\u7dcf\u8aac<\/h3>\n\n\n\n\n
\u305d\u306e\u4ed6\u306e\u767a\u8868\u7b49\u533a\u5206<\/th>\n\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09<\/th>\n\u6f14\u984c\u540d\u7b49<\/th>\n\u767a\u8868\u5b66\u4f1a\u7b49<\/th>\n\u958b\u50ac\u5730<\/th>\n\u958b\u50ac\u5e74\u6708\u65e5<\/th>\n<\/tr>\n
\u7814\u7a76\u4f1a\u767a\u8868<\/td>\n\u3007\u8302\u898b\u3000\u831c\u91cc<\/td>\n\u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308b\u30ab\u30eb\u30d0\u30da\u30cd\u30e0\u7cfb\u85ac\u306e\u6297\u83cc\u85ac\u9069\u6b63\u4f7f\u7528\u6d3b\u52d5<\/td>\n\u7b2c1\u56de\u5357\u4e5d\u5dde\u6297\u83cc\u5316\u5b66\u7642\u6cd5\u7814\u7a76\u4f1a\u200b<\/td>\n\u9e7f\u5150\u5cf6\u5e02<\/td>\n2024\u5e746\u670823\u65e5<\/td>\n<\/tr>\n
\u7814\u7a76\u4f1a\u767a\u8868<\/td>\n\u3007\u91d1\u6fa4\u3000\u76f4\u5b50<\/td>\n\u5c0f\u5150\u306b\u304a\u3051\u308b\u30d0\u30f3\u30b3\u30de\u30a4\u30b7\u30f3\u306eTDM\u3092\u7528\u3044\u305f\u5b89\u5168\u6027\u306e\u8a55\u4fa1\u3068\u6025\u6027\u814e\u969c\u5bb3\u767a\u73fe\u30ea\u30b9\u30af\u56e0\u5b50\u306b\u95a2\u3059\u308b\u691c\u8a0e<\/td>\n\u7b2c2\u56de\u5357\u4e5d\u5dde\u6297\u83cc\u5316\u5b66\u7642\u6cd5\u7814\u7a76\u4f1a\u200b<\/td>\n\u718a\u672c\u5e02<\/td>\n2025\u5e742\u670824\u65e5<\/td>\n<\/tr>\n<\/table><\/div>\n<\/div>\n

<\/path><\/svg><\/blocsicon> 2023\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u6b27\u6587<\/h3>\n
\n\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Keisuke Tabata, Masaya Aoki, Ryo Miyata, Tadashi Umehara, Aya Harada Takeda, Go Kamimura, Toshiyuki Nagata, Ryuya Okizono, Hideyuki Terazono, Yasuo Takeda, Takayuki Suetsugu, Kazuhiro Ueda, Masami Sato<\/td>\nSuccessful treatment with osimertinib based on therapeutic drug monitoring in a hemodialysis patient with non-small cell lung cancer: a case report<\/td>\nCase Reports in Oncology<\/td>\n16(1):705\u2013710.<\/td>\n<\/tr>\n
Jun Nagahama, Takuro Nishikawa, Tatsuro Nakamura, Shunsuke Nakagawa, Yuichi Kodama, Hideyuki Terazono, Manabu Wakamatsu, Hideki Muramatsu, Yasuhiro Yamashiro, Hitoshi Kanno, Yasuhiro Okamoto<\/td>\nSevere \u03b2-thalassemia (Hb Zunyi) mimicking congenital dyserythropoietic anemia<\/td>\nPediatric Blood & Cancer<\/td>\n70(12):e30706<\/td>\n<\/tr>\n
Naoko Kanazawa, Akari Shigemi, Nao Amadatsu, Kotaro Arimura, Shohei Shimono, Kazutaka Oda, Victor Tuan Giam Chuang, Kazuaki Matsumoto, Hideki Kawamura, Hideyuki Terazono<\/td>\nA cohort study of the risk factors and the target AUC to avoid vancomycin-associated acute kidney injury in pediatric patients<\/td>\nJ Infect Chemother<\/td>\nNov 7:S1341-321X(23)00270-2<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n

<\/path><\/svg><\/blocsicon> 2022\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u6b27\u6587<\/h3>\n
\n\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Keisuke Komatsuya, Tomohiro Iguchi, Michiko Fukuyama, Ikuo Kawashima, Kiyoshi Ogura, Norihito Kikuchi, Yasushi Shimoda, Yasuo Takeda, Motoyuki Shimonaka, Naomasa Yamamoto, Nobuo Sugiura, Nobuaki Maeda, Kohji Kasahara<\/td>\nPhosphacan acts as a repulsive cue in murine and rat cerebellar granule cells in a TAG-1\/GD3 rafts-dependent manner<\/td>\nJournal of Neurochemistry<\/td>\n163(5):375-390<\/td>\n<\/tr>\n
Umezaki Y, Matsumoto K, Ikawa K, Yokoyama Y, Enoki Y, Shigemi A, Watanabe E, Nakamura K, Ueno K, Terazono H, Morikawa N, Takeda Y<\/td>\nConcentration-Dependent Activity of Pazufloxacin against Pseudomonas aeruginosa: An In Vivo Pharmacokinetic\/Pharmacodynamic Study<\/td>\nAntibiotics<\/td>\n21;11(7):982<\/td>\n<\/tr>\n
Terazono H, Tsuchiya M, Maki Y, Yoshikawa N, Kawahara Y, Nishimura K, Shinohara K, Ogawa D, Mori R, Iwamoto Y, Itagaki F, Masuko H, Yonemura M, Uchida M<\/td>\nEvaluation of a Webinar for Pharmacists Learning Basic Clinical-Oncology during COVID-19 Pandemic in Japan.<\/td>\nBiological and Pharmaceutical Bulletin<\/td>\n45(7):856-862<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\t\t<\/p>\n

\u548c\u6587<\/h3>\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
\u68ee\u6728\u90a6\u660e\uff0c\u6c38\u702c\u601c\u53f8\uff0c\u5343\u8449\u8cb4\u5fd7\uff0c\u7e04\u7530\u4fee\u4e00\uff0c\u718a\u4e95\u6b63\u8cb4\uff0c\u6df1\u6c34\u77e5\u82f1\uff0c\u5fd7\u7530\u654f\u5b8f<\/td>\n \u85ac\u5264\u90e8\u9580\u306b\u6240\u5c5e\u3057\u3066\u3044\u308b\u85ac\u5264\u5e2b\u4ee5\u5916\u306e\u8005\u306e\u696d\u52d9\u5b9f\u614b\u306b\u95a2\u3059\u308b\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\u7d50\u679c <\/td>\n \u65e5\u672c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u96d1\u8a8c <\/td>\n Vol.58 No.7\u3000739-745 <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\t\t<\/p>\n

\u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n
\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09 <\/th>\n \u6f14\u984c\u540d <\/th>\n \u767a\u8868\u5b66\u4f1a\u7b49 <\/th>\n<\/tr>\n
\u25cb\u5bfa\u8597\u82f1\u4e4b\u3001\u5409\u5ddd\u76f4\u6a39\u3001\u5c0f\u5ddd\u5927\u4ecb\u3001\u68ee\u7406\u4fdd\u3001\u571f\u5c4b\u96c5\u7f8e\u3001\u7267\u967d\u4ecb\u3001\u677f\u57a3\u6587\u96c4\u3001\u6cb3\u539f\u967d\u4ecb\u3001\u897f\u6751\u4f73\u5b50\u3001\u7be0\u539f\u4f73\u7950\u3001\u5ca9\u672c\u7fa9\u5f18\u3001\u76ca\u5b50\u5bdb\u4e4b\u3001\u7c73\u6751\u96c5\u4eba\u3001\u5185\u7530\u307e\u3084\u3053 <\/td>\n \u81ea\u7531\u5358\u8a9e\u8a18\u8f09\u5f62\u5f0f\u30a2\u30f3\u30b1\u30fc\u30c8\u306b\u3088\u308bJASPO\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u30fb\u30d6\u30e9\u30c3\u30b7\u30e5\u30a2\u30c3\u30d7\u30bb\u30df\u30ca\u30fc2021\u30bb\u30df\u30ca\u30fc\u5185\u5bb9\u306b\u95a2\u3059\u308b\u89e3\u6790 <\/td>\n \u65e5\u672c\u81e8\u5e8a\u816b\u760d\u85ac\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a2023 <\/td>\n<\/tr>\n
\u25cb\u6709\u99ac\u592a\u967d\u3001\u5bfa\u8597\u82f1\u4e4b\u3001\u6817\u539f\u5d07\u3001\u5c0f\u516b\u91cd\u85b0\u5b50\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n Evaluation of acute toxicity of oxaliplatin and therapeutic candidates by extracellular potential measurement using rat primary dorsal root node cells <\/td>\n \u7b2c96\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u5e74\u4f1a\u30fb\u7b2c43\u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u4f50\u85e4\u6d38\u3001\u5bfa\u8597\u82f1\u4e4b\u3001\u5c4b\u5730\u6176\u5b50\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u5929\u9054\u83dc\u7dd2\u3001\u6709\u6751\u6602\u592a\u6717\u3001\u4e0b\u91ce\u5968\u5e73\u3001\u8302\u898b\u831c\u91cc\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u533b\u85ac\u54c1\u526f\u4f5c\u7528\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u3092\u7528\u3044\u305f\u30ec\u30e0\u30c7\u30b7\u30d3\u30eb\u306b\u3088\u308b\u526f\u4f5c\u7528\u767a\u73fe\u89e3\u6790 <\/td>\n \u65e5\u672c\u96c6\u4e2d\u6cbb\u7642\u533b\u5b66\u4f1a\u7b2c6\u56de\u4e5d\u5dde\u652f\u90e8\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5929\u9054\u83dc\u7dd2\u3001\u8302\u898b\u831c\u91cc\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u6709\u6751\u6602\u592a\u6717 \u3001\u5bfa\u8597\u82f1\u4e4b \u3001\u5150\u7389\u7950\u4e00\u3001\u897f\u9806\u4e00\u90ce\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30c1\u30a7\u30c3\u30af\u30ea\u30b9\u30c8\u306b\u57fa\u3065\u304f\u30d0\u30ea\u30b7\u30c1\u30cb\u30d6\u6295\u4e0e\u958b\u59cb\u524d\u306eB\u578b\u809d\u708e\u30a6\u30a4\u30eb\u30b9\u53ca\u3073\u7d50\u6838\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u691c\u67fb\u3068\u85ac\u5264\u5e2b\u304c\u9069\u6b63\u4f7f\u7528\u306b\u4ecb\u5165\u3057\u305f1\u4f8b <\/td>\n \u7b2c70\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u83c5\u539f\u82f1\u8f1d\u3001\u4e95\u4e0a\u548c\u5553\u3001\u5c4b\u5730\u6176\u5b50\u3001\u5bfa\u8597\u82f1\u4e4b\u3001\u7aaa\u8597\u7422\u90ce\u3001\u5927\u77f3\u5145\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u5782\u6c34\u5e02\u5728\u4f4f\u4e00\u822c\u5e02\u6c11\u306b\u304a\u3051\u308b\u670d\u85ac\u72b6\u6cc1\u8abf\u67fb <\/td>\n \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e02022 <\/td>\n<\/tr>\n
\u25cb\u4e45\u4fdd\u7530\u5915\u8cb4\u3001\u5bfa\u8597\u82f1\u4e4b\u3001\u77f3\u585a\u8cb4\u5468\u3001\u53e4\u7530\u8cb4\u5fd7\u3001\u677e\u5143\u771f\u54c9\u3001 \ufa11\u5143\u4ec1\u5fd7\u3001 \u5409\u4e95\u6d0b\u4e4b \u3001 \u51fa\u53e3\u660e\u7f8e\u3001\u4e2d\u6751\u96c5\u4e4b\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u7cbe\u795e\u79d1\u75c5\u68df\u306b\u304a\u3051\u308b\u3001\u6d88\u706f\u6642\u523b\u3068\u60a3\u8005\u306e\u7761\u7720\u30fb\u7761\u7720\u85ac\u4f7f\u7528\u306e\u95a2\u9023 <\/td>\n \u7b2c106\u56de\u9e7f\u5150\u5cf6\u7cbe\u795e\u795e\u7d4c\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u65b0\u7530\u7f8e\u5948\u3001\u9ad8\u6a4b\u6bc5\u884c\u3001\u5c71\ufa11\u667a\u4e45\u3001\u5bfa\u8597\u82f1\u4e4b\u3001\u897f\u5ddd\u62d3\u6717\u3001\u5ca1\u672c\u5eb7\u88d5\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u5c0f\u5150\u304c\u3093\u5316\u5b66\u7642\u6cd5\u306b\u304a\u3051\u308b\u6297\u304c\u3093\u85ac\u30ec\u30b8\u30e1\u30f3\u30aa\u30fc\u30c0\u30b7\u30b9\u30c6\u30e0\u306e\u5c0e\u5165\u306e\u53d6\u308a\u7d44\u307f <\/td>\n \u7b2c32\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u3007\u5929\u9054\u83dc\u7dd2\u3001\u8302\u898b\u831c\u91cc\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u6709\u6751\u6602\u592a\u6717\u3001\u4e0b\u91ce\u5968\u5e73\u3001\u624d\u7530\u9686\u4e00\u3001\u5150\u7389\u7950\u4e00\u3001\u5bfa\u8597\u82f1\u4e4b\u3001\u897f\u9806\u4e00\u90ce\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u916a\u9178\u83cc\uff08\u5bae\u5165\u83cc\uff09\u88fd\u5264\u6295\u4e0e\u4e2d\u306bClostridium butyricum \u83cc\u8840\u75c7\u3092\u4f75\u767a\u3057\u305f\u91cd\u75c7 COVID-19\u60a3\u8005\u306e1\u4f8b <\/td>\n \u7b2c70\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u3007\u6df1\u6c34\u77e5\u82f1\uff0c\u68ee\u6728\u90a6\u660e\uff0c\u6c38\u702c\u601c\u53f8\uff0c\u5343\u8449\u8cb4\u5fd7\uff0c\u7e04\u7530\u4fee\u4e00\uff0c\u718a\u4e95\u6b63\u8cb4\uff0c\u5fd7\u7530\u654f\u5b8f <\/td>\n \u85ac\u5264\u5e2b\u4ee5\u5916\u306e\u8005\u3084\u8abf\u5264\u6a5f\u5668\u306e\u5c0e\u5165\u306b\u3088\u308b\u85ac\u5264\u5e2b\u306e\u5bfe\u4eba\u696d\u52d9\u3078\u306e\u5bc4\u4e0e\u306b\u3064\u3044\u3066 <\/td>\n \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c143\u5e74\u4f1a <\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n

\t<\/path><\/svg><\/blocsicon> 2021\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u6b27\u6587<\/h3>\n
\n\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Nobuaki Egashira,Yu Goto,Ryota Takahashi,Hikari Iba,Shota Yamamoto,Takuya Watanabe,Kaori Kubota,Takehiro Kawashiri,Chise Tanigushi,Shutaro Katsurabayashi,Katsunori Iwasaki <\/td>\n Ibudilast suppresses oxaliplatin-induced mechanical allodynia and neurodegeneration in rats <\/td>\n Jounal of Pharmacological Science <\/td>\n Volume147,Issue1\uff1a114-117 <\/td>\n<\/tr>\n
Takahashi T, Terazono H, Suetsugu T, Sugawara H, Arima J, Nitta M, Tanabe T, Okutsu K, Ikeda R, Mizuno K, Inoue H, Takeda Y. <\/td>\n High-Trough Plasma Concentration of Afatinib Is Associated with Dose Reduction <\/td>\n Cancers <\/td>\n 8;13(14):3425. <\/td>\n<\/tr>\n
Masami Tsuchiya, Hideyuki Terazono, Yosuke Maki, Naoki Yoshikawa, Yosuke Kawahara, Keiko Nishimura, Keisuke Shinohara, Daisuke Ogawa, Riho Mori, Yoshihiro Iwamoto, Fumio Itagaki, Hiroyuki Masuko, Masahito Yonemura, Mayako Uchida <\/td>\n Evaluation of a web-based educational programme for pharmacists during the COVID-19 pandemic in Japan <\/td>\n Journal of Clinical Pharmacy and Therapeutics <\/td>\n doi.org\/10.1111\/jcpt.13526 <\/td>\n<\/tr>\n
Nobuaki Egashira, Yu Goto, Hikari Iba, Rikako Kawanaka, Ryota Takahashi, Chise Taniguchi, Takuya Watanabe, Kaori Kubota, Shutaro Katsurabayashi, Katsunori Iwasaki <\/td>\n Kamishoyosan potentiates pentobarbital-induced sleep in socially isolated, ovariectomized mice <\/td>\n Journal of Ethnopharmacology <\/td>\n Volume 281, 5 December 2021, 114585 <\/td>\n<\/tr>\n<\/table>\n

\t\t<\/p>\n

\u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n\n\n
\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09 <\/th>\n \u6f14\u984c\u540d <\/th>\n \u767a\u8868\u5b66\u4f1a\u7b49 <\/th>\n<\/tr>\n
\u25cb\u5bfa\u8597\u82f1\u4e4b\u3001\u9ad9\u6a4b\u6bc5\u884c\u3001\u672b\u6b21\u9686\u884c\u3001\u83c5\u539f\u82f1\u8f1d\u3001\u6709\u99ac\u7d14\u5b50\u3001\u65b0\u7530\u7f8e\u5948\u3001\u7530\u908a\u5fb9\u3001\u5965\u6d25\u679c\u512a\u3001\u6c34\u91ce\u572d\u5b50\u3001\u4e95\u4e0a\u535a\u96c5\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n TDM\u3092\u76ee\u6307\u3057\u305f\u5206\u5b50\u6a19\u7684\u85ac\u30a2\u30d5\u30a1\u30c1\u30cb\u30d6\u306e\u526f\u4f5c\u7528\u56de\u907f\u6fc3\u5ea6\u306e\u89e3\u6790 <\/td>\n \u7b2c5\u56de\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u4e5d\u5dde\uff65\u6c96\u7e04\u5730\u65b9\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5bfa\u8597\u82f1\u4e4b\u3001\u65e5\u9ad8\u670b\u3001\u9ad9\u6a4b\u6bc5\u884c\u3001\u5965\u6d25\u679c\u512a\u3001\u5409\u6e80\u8aa0\u3001\u77f3\u585a\u8ce2\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n Caucher\u75c5\u8a3a\u65ad\u306b\u5411\u3051\u305f\u30b0\u30eb\u30b3\u30b7\u30eb\u30b9\u30d5\u30a3\u30f3\u30b4\u30b7\u30f3\u8840\u4e2d\u6fc3\u5ea6\u6e2c\u5b9a <\/td>\n \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e02021\/\u7b2c29\u56de\u30af\u30ea\u30cb\u30ab\u30eb\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u91d1\u6fa4\u76f4\u5b50\u3001\u5bfa\u8597\u82f1\u4e4b\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30e1\u30c8\u30c8\u30ec\u30ad\u30b5\u30fc\u30c8\u5927\u91cf\u6295\u4e0e\u306b\u304a\u3051\u308b\u6392\u6cc4\u9045\u5ef6\u306e\u539f\u56e0\u89e3\u6790 <\/td>\n \u7b2c31\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n<\/table><\/div>\n<\/div>\n

<\/path><\/svg><\/blocsicon> 2020\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u6b27\u6587<\/h3>\n
\n\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Hamada Y, Ueda T, Miyazaki Y, Nakajima K, Fukunaga K, Miyazaki T, Nakada-Motokawa N, Nagao M, Kawamura H, Shigemi A, Ebihara F, Kimura T, Ikegame K, Uchino M, Ikeuchi H, Takesue Y. <\/td>\n Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan. <\/td>\n Mycoses <\/td>\n 63(8):779-786. <\/td>\n<\/tr>\n
Erika Watanabe, Kazuaki Matsumoto, Kazuro Ikawa, Yuta Yokoyama, Akari Shigemi, Yuki Enoki, Yasuhiro Umezaki, Koyo Nakamura, Keiichiro Ueno, Hideyuki Terazono, Norifumi Morikawa, Yasuo Takeda <\/td>\n Pharmacokinetic\/pharmacodynamic evaluation of teicoplanin against Staphylococcus aureus in a murine thigh infection model <\/td>\n Journal of Global Antimicrobial Resistance <\/td>\n 24:83-87 <\/td>\n<\/tr>\n
Yamada T, Fujii S, Shigemi A, Takesue Y. <\/td>\n A meta-analysis of the target trough concentration of gentamicin and amikacin for reducing the risk of nephrotoxicity <\/td>\n Journal of Infection and Chemotherapy <\/td>\n 27(2):256-261 <\/td>\n<\/tr>\n
Kayoko Matsubara, Kazuaki Matsumoto, Yuta Yokoyama, Erika Watanabe, Yuki Enoki, Akari Shigemi, Kazuro Ikawa, Hideyuki Terazono, Norifumi Morikawa, Tamao Ohshige, Yasuo Takeda <\/td>\n Dosing optimization of ampicillin-sulbactam based on cystatin C in elderly patients with pneumonia <\/td>\n Biological and Pharmaceutical Bulletin <\/td>\n in press <\/td>\n<\/tr>\n<\/table>\n

\t\t<\/p>\n

\u548c\u6587<\/h4>\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
\u6c60\u7530 \u6b63\u6a39, \u897f\u5ddd \u62d3\u6717, \u3042\u3079\u677e \u8cb4\u6210, \u5ddd\u6751 \u9806\u5e73, \u6a2a\u5c71 \u667a\u7f8e, \u5e73\u4e95 \u514b\u6a39, \u5bae\u539f \u6075\u5f25\u5b50, \u8302\u898b \u831c\u91cc, \u732a\u5ddd \u548c\u6717, \u5ca1\u672c \u5eb7\u88d5, \u53f3\u7530 \u660c\u5b8f, \u6cb3\u91ce \u5609\u6587 <\/td>\n \u81ea\u5bb6\u672b\u68a2\u8840\u5e79\u7d30\u80de\u79fb\u690d\u5f8c\u306b\u80ba\u52d5\u8108\u6027\u80ba\u9ad8\u8840\u5727\u3068\u79fb\u690d\u95a2\u9023\u8840\u6813\u6027\u5fae\u5c0f\u8840\u7ba1\u75c7\u3092\u767a\u75c7\u3057\u305f\u795e\u7d4c\u82bd\u816b\u60a3\u5150 <\/td>\n \u65e5\u672c\u9020\u8840\u7d30\u80de\u79fb\u690d\u5b66\u4f1a\u96d1\u8a8c <\/td>\n 9(2);60-64 <\/td>\n<\/tr>\n
\u4eca\u6751 \u653f\u4fe1, \u85e4\u4e95 \u88d5\u53f2, \u798f\u91cd \u53cb\u7406, \u5c71\u5d0e \u535a\u53f2, \u5165\u6c5f \u5229\u884c, \u91ce\u4e2d \u654f\u6cbb, \u4f0a\u6771 \u5f18\u6a39, \u5ba4 \u9ad8\u5e83, \u559c\u591a\u5ca1 \u6d0b\u6a39, \u8302\u898b \u831c\u91cc, \u5317\u539f \u9686\u5fd7 <\/td>\n \u4e5d\u5dde\u30fb\u5c71\u53e3\u5730\u533a\u306e\u533b\u7642\u6a5f\u95a2\u306b\u304a\u3051\u308bClostridioides(Clostridium)\u3000difficile\u611f\u67d3\u75c7\u306e\u8a3a\u7642\u306b\u95a2\u3059\u308b\u5b9f\u614b\u8abf\u67fb <\/td>\n \u4e5d\u5dde\u85ac\u5b66\u4f1a\u96d1\u8a8c <\/td>\n 74\uff1a49-52 <\/td>\n<\/tr>\n<\/table>\n

\u8457\u66f8<\/h4>\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u66f8\u540d\uff08\u5206\u62c5\u306e\u5834\u5408\u306f+\u6a19\u984c\u540d\uff09 <\/th>\n \u521d\u9801\uff0d\u7d42\u9801 <\/th>\n<\/tr>\n
\u7de8\u96c6\uff1a\u7af9\u672b \u82b3\u751f
\n \u5206\u62c5\uff1a\u8302\u898b\u3000\u831c\u91cc <\/td>\n		 AST\u864e\u306e\u5dfb\u3000\u65e5\u5e38\u306e\u7591\u554f\u306b\u7b54\u3048\u308b
\n \uff08IV \u6297\u83cc\u85ac\u6295\u4e0e\u8a2d\u8a08 4. 5 \u30ea\u30dd\u30bd\u30fc\u30de\u30eb\u30a2\u30e0\u30db\u30c6\u30ea\u30b7\u30f3B\u306e\u4e00\u822c\u75c5\u68df\u3067\u306e\u4f7f\u7528\u4e0a\u306e\u6ce8\u610f\u306b\u3064\u3044\u3066\uff09 <\/td>\n		 169-175 <\/td>\n<\/tr>\n<\/table>\n

\u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09 <\/th>\n \u6f14\u984c\u540d <\/th>\n \u767a\u8868\u5b66\u4f1a\u7b49 <\/th>\n<\/tr>\n
\u25cbYuki Kubota\uff0cHideyuki Terazono\uff0cYukari Murayama\uff0cHideki Sugawara\uff0cYasuo Takeda <\/td>\n Statistical analysis associated with insulin autoimmune syndrome based on the Japanese Adverse Drug Event Report database <\/td>\n 2020 Forbidden City International Pharmacists Forum <\/td>\n<\/tr>\n
\u25cbTomohisa Yamasaki\uff0c Hideyuki Terazono\uff0cHiroo Nakashima\uff0c Yasuo Takeda <\/td>\n Association analysis of concomitant drugs in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis based on the Japanese Adverse Drug Event Report database <\/td>\n 2020 Forbidden City International Pharmacists Forum <\/td>\n<\/tr>\n
\u25cb\u5c4b\u5730 \u6176\u5b50 <\/td>\n \u3075\u308b\u3055\u3068\u5b9f\u7fd2\u306a\u3089\u3067\u306f\u306e\u53d6\u308a\u7d44\u307f\u3068\u306f\u3000\u30fc\u85ac\u5b66\u90e8\u304c\u306a\u3044\u770c\u3067\u51fa\u6765\u308b\u3053\u3068\u30fc <\/td>\n \u7b2c5\u56de\u65e5\u672c\u85ac\u5b66\u6559\u80b2\u5b66\u4f1a\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5929\u9054 \u83dc\u7dd2\uff0c\u5ddd\u6751 \u82f1\u6a39\uff0c\u6709\u6751 \u6602\u592a\u6717\uff0c\u8302\u898b \u831c\u91cc\uff0c\u4e2d\u6751 \u96bc\u4eba\uff0c\u5150\u7389 \u7950\u4e00\uff0c\u897f \u9806\u4e00\u90ce\uff0c\u6b66\u7530 \u6cf0\u751f <\/td>\n \u6ce8\u5c04\u7528\u7b2c\u56db\u4e16\u4ee3\u30bb\u30d5\u30a1\u30ed\u30b9\u30dd\u30ea\u30f3\u7cfb\u6297\u83cc\u85ac\u306e\u9069\u6b63\u4f7f\u7528\u6d3b\u52d5\u3078\u306e\u53d6\u308a\u7d44\u307f\u3068\u305d\u306e\u52b9\u679c <\/td>\n \u7b2c68\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6709\u6751 \u6602\u592a\u6717\uff0c\u8302\u898b \u831c\u91cc\uff0c\u5ddd\u6751 \u82f1\u6a39\uff0c\u5929\u9054 \u83dc\u7dd2\uff0c\u5150\u7389 \u7950\u4e00\uff0c \u897f \u9806\u4e00\u90ce\uff0c\u6b66\u7530 \u6cf0\u751f <\/td>\n \u30ea\u30d5\u30a1\u30f3\u30d4\u30b7\u30f3\u5358\u5264\u6cbb\u7642\u3067\u30ea\u30d5\u30a1\u30f3\u30d4\u30b7\u30f3\u8010\u6027\u3092\u8a98\u5c0e\u3057\u305fMRSA\u306b\u3088\u308b\u4eba\u5de5\u95a2\u7bc0\u611f\u67d3\u306e1\u4f8b <\/td>\n \u7b2c68\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc\uff0c\u5ddd\u6751 \u82f1\u6a39\uff0c\u6709\u6751 \u6602\u592a\u6717\uff0c\u5929\u9054 \u83dc\u7dd2\uff0c\u5150\u7389 \u7950\u4e00\uff0c\u897f \u9806\u4e00\u90ce <\/td>\n \u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662\u3067\u306e\u771f\u83cc\u8840\u75c7\u306b\u304a\u3051\u308b\u30ab\u30f3\u30b8\u30c0\u5c5e\u306e\u5206\u96e2\u72b6\u6cc1\u3068\u6297\u771f\u83cc\u85ac\u611f\u53d7\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n \u7b2c68\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b\u3000\u831c\u91cc <\/td>\n Antifungal stewardship\u63a8\u9032\u306e\u305f\u3081\u306e\u591a\u9762\u7684\u30a2\u30d7\u30ed\u30fc\u30c1\u3000\u85ac\u5264\u90e8\u304b\u3089\u306e\u30a2\u30d7\u30ed\u30fc\u30c1 <\/td>\n \u7b2c68\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5c0f\u516b\u91cd \u85ab\u5b50\uff0c\u5bfa\u8597 \u82f1\u4e4b\uff0c\u6b66\u7530 \u6cf0\u751f <\/td>\n \u30b2\u30eb\u57cb\u5305\u6cd5\u306b\u3088\u308b\u8840\u4e2d\u5faa\u74b0\u304c\u3093\u7d30\u80de\u306e\u9ad8\u611f\u5ea6\u691c\u51fa\u6cd5\u306e\u958b\u767a <\/td>\n \u7b2c73\u56de \u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u897f\u5357\u90e8\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5c4b\u5730 \u6176\u5b50 <\/td>\n \u30b3\u30ed\u30ca\u798d\u306e\u4eca\u3053\u305d\u300c\u3075\u308b\u3055\u3068\u5b9f\u7fd2\u300d\u3092\u898b\u76f4\u3057\u3066\u307f\u307e\u305b\u3093\u304b\uff1f <\/td>\n \u7b2c30\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5bfa\u8597 \u82f1\u4e4b\uff0c\u5c0f\u516b\u91cd\u3000\u85ab\u5b50\uff0c\u6b66\u7530 \u6cf0\u751f <\/td>\n \u5fae\u5c0f\u6db2\u6ef4\u57f9\u990a\u306b\u3088\u308b\u7a00\u5c11\u304c\u3093\u7d30\u80de\u9ad8\u611f\u5ea6\u691c\u51fa\u6cd5\u306e\u958b\u767a <\/td>\n \u7b2c30\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5c71\ufa11 \u667a\u4e45\uff0c\u5bfa\u8597 \u82f1\u4e4b\uff0c\u4e2d\u5d8b \u6d0b\u751f\uff0c\u6b66\u7530 \u6cf0\u751f <\/td>\n \u30d3\u30c3\u30b0\u30c7\u30fc\u30bf\u3092\u7528\u3044\u305f\u30b9\u30c6\u30a3\u30fc\u30f4\u30f3\u30b9\uff65\u30b8\u30e7\u30f3\u30bd\u30f3\u75c7\u5019\u7fa4\uff65\u4e2d\u6bd2\u6027\u8868\u76ae\u58ca\u6b7b\u878d\u89e3\u75c7\u767a\u75c7\u60a3\u8005\u306b\u304a\u3051\u308b\u4f75\u7528\u85ac\u306e\u30a2\u30bd\u30b7\u30a8\u30fc\u30b7\u30e7\u30f3\u89e3\u6790 <\/td>\n \u7b2c30\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cbHideyuki Terazono\uff0cTomohisa Yamasaki\uff0cTaiyo Arima\uff0c Takayuki Takahashi\uff0cYasuo Takeda <\/td>\n Association analysis of coadministrated drugs in patients with serotonin syndrome using big data <\/td>\n \u7b2c30\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6709\u99ac \u592a\u967d\uff0c\u5bfa\u8597 \u82f1\u4e4b\uff0c\u6b66\u7530 \u6cf0\u751f <\/td>\n \u30d3\u30c3\u30b0\u30c7\u30fc\u30bf\u3092\u7528\u3044\u305f\u9ad8\u30a2\u30f3\u30e2\u30cb\u30a2\u8840\u75c7\u767a\u75c7\u60a3\u8005\u306b\u304a\u3051\u308b\u4f75\u7528\u85ac\u306e\u89e3\u6790 <\/td>\n \u7b2c41\u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5bfa\u8597 \u82f1\u4e4b\uff0c\u5c0f\u516b\u91cd \u85ab\u5b50\uff0c\u6b66\u7530 \u6cf0\u751f <\/td>\n \u8840\u4e2d\u304c\u3093\u7d30\u80de\u306e\u540c\u5b9a\u6280\u8853\u306e\u958b\u767a\u3068\u500b\u5225\u5316\u533b\u7642\u306b\u5411\u3051\u3066 <\/td>\n \u7b2c41\u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5bfa\u8597 \u82f1\u4e4b\uff0c\u6c60\u7530 \u9f8d\u4e8c\uff0c\u6709\u99ac \u7d14\u5b50\uff0c\u83c5\u539f \u82f1\u8f1d\uff0c\u9234\u6728 \u7d33\u4ecb\uff0c \u4e0a\u91ce \u771f\u4e00\uff0c\u6b66\u7530 \u6cf0\u751f <\/td>\n \u304c\u3093\u5c02\u9580\u533b\u7642\u4eba\u6750\uff08\u304c\u3093\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\uff09\u990a\u6210\u30d7\u30e9\u30f3\u306b\u304a\u3051\u308b\u5730\u57df\u533b\u7642\u9023\u643a <\/td>\n \u81e8\u5e8a\u816b\u760d\u85ac\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a2020 <\/td>\n<\/tr>\n
\u25cb\u5bfa\u8597 \u82f1\u4e4b\uff0c\u5c0f\u516b\u91cd \u85ab\u5b50\uff0c\u6b66\u7530 \u6cf0\u751f <\/td>\n \u9ad8\u5206\u5b50\u30b2\u30eb\u3092\u7528\u3044\u305f\u8840\u4e2d\u5faa\u74b0\u304c\u3093\u7d30\u80de\u306e\u540c\u5b9a\u6280\u8853\u306e\u958b\u767a <\/td>\n \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c141\u5e74\u4f1a <\/td>\n<\/tr>\n<\/table><\/div>\n<\/div>\n

<\/path><\/svg><\/blocsicon> 2019\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u6b27\u6587<\/h3>\n
\n\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Suga Y, Uchida M, Suzuki S, Sugawara H, Torigoe K, Futamura A, Uesawa Y, Nakagawa T, Takase H <\/td>\n Current Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database <\/td>\n Biological and Pharmaceutical Bulletin <\/td>\n 42(5): 801-806 <\/td>\n<\/tr>\n
Nishikawa T, Yamaguchi H, Ikawa K, Nakayama K, Higashi E, Miyahara E, Abematsu T, Nakagawa S, Kodama Y, Tanabe T, Shigemi A, Shinkoda Y, Okamoto Y, Takeda Y, Kawano Y. <\/td>\n Influence of GST polymorphisms on busulfan pharmacokinetics in Japanese children <\/td>\n Pediatrics International <\/td>\n 61\uff1a 558\u2013565 <\/td>\n<\/tr>\n
Sugawara H, Uchida M, Suzuki S, Suga Y, Uesawa Y, Nakagawa T and Takase H <\/td>\n Analyses of respiratory depression associated with opioids in cancer patients based on the Japanese Adverse Drug Event Report Database <\/td>\n Biological and Pharmaceutical Bulletin <\/td>\n 42(7) <\/td>\n<\/tr>\n
Nishizawa Y, Ikeda R, Yamamoto M, Kawahara K, Shinsato Y, Minami K, Nitta M, Terazono H, Akiyama SI, Furukawa T, Takeda Y <\/td>\n 5-Aza-2-deoxycytidine Enhances the Sensitivity of 5-Fluorouracil by Demethylation of the Thymidine Phosphorylase Promoter <\/td>\n Anticaner Research <\/td>\n 39(8):4129-4136 <\/td>\n<\/tr>\n<\/table>\n

\u548c\u6587<\/h4>\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
\u963f\u90e8\u61b2\u4ecb\u3001\u795e\u5c3e\u54b2\u7559\u672a\u3001\u8fd1\u85e4\u65ed\u3001\u82e5\u751f\u6cbb\u53cb\u3001\u5185\u5c71\u771f\u7406\u5b50\u3001\u65b0\u6728\u8cb4\u5927\u3001\u5c4b\u5730\u6176\u5b50\u3001\u4f50\u85e4\u9ebb\u5e0c\u3001\u5409\u91ce\u5b97\u5b8f\u3001\u4f0a\u85e4\u4fca\u5e83\u3001\u5f8c\u85e4\u9054\u4e5f <\/td>\n \u85ac\u5b66\u90e8\u5b9f\u52d9\u5b9f\u7fd2\u751f\u306b\u5bfe\u3059\u308bHIV\u611f\u67d3\u75c7\/AIDS\u95a2\u9023\u6559\u80b2\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u5b9f\u8df5 <\/td>\n \u65e5\u672c\u30a8\u30a4\u30ba\u5b66\u4f1a\u8a8c <\/td>\n 21(2)\uff1a103-109 <\/td>\n<\/tr>\n<\/table>\n

\u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09 <\/th>\n \u6f14\u984c\u540d <\/th>\n \u767a\u8868\u5b66\u4f1a\u7b49 <\/th>\n<\/tr>\n
\u25cb\u5929\u9054 \u83dc\u7dd2\u3001\u8302\u898b \u831c\u91cc\u3001\u5ddd\u6751 \u82f1\u6a39\u3001\u5150\u7389 \u7950\u4e00\u3001\u4e2d\u6751 \u96bc\u4eba\u3001\u897f \u9806\u4e00\u90ce\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u6297\u771f\u83cc\u85ac\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u306b\u3088\u308b\u6297\u771f\u83cc\u85ac\u4f7f\u7528\u72b6\u6cc1\u306e\u8a55\u4fa1\u3068\u9069\u6b63\u4f7f\u7528\u652f\u63f4\u6d3b\u52d5\u306e\u6709\u7528\u6027\u306e\u691c\u8a0e <\/td>\n \u7b2c67\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc <\/td>\n \u30b7\u30f3\u30dd\u30b8\u30a6\u30e018\u300cAST \u6d3b\u52d5\u306b\u304a\u3051\u308b\u85ac\u5264\u5e2b\u306e\u5f79\u5272\u2015\u57fa\u790e\u3068\u5b9f\u8df5\u2015\u300d
\n \u2f24\u5b66\u75c5\u9662\u306b\u304a\u3051\u308bAST\u6d3b\u52d5\u306e\u5b9f\u8df5 <\/td>\n		 \u7b2c67\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc <\/td>\n \u30b7\u30f3\u30dd\u30b8\u30a6\u30e01\u300c\u85ac\u7269\u52d5\u614b\u95a2\u9023\u5206\u5b50\u306e\u907a\u4f1d\u5b50\u591a\u578b\u3068TDM\u300d
\n CYP2C9\/2C19\u306e\u907a\u4f1d\u5b50\u591a\u578b\u3068\u30dc\u30ea\u30b3\u30ca\u30be\u30fc\u30eb\u306eTDM <\/td>\n		 \u7b2c36\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5965\u91ce \u771f\u7406\u3001\u4e8c\u5ddd \u4fca\u9686\u3001\u76ca\u7530 \u5c06\u543e\u3001\u90e1\u5c71 \u4e9c\u7531\u7f8e\u3001\u4e2d\u5cf6 \u8302\u4eba\u3001\u4e95\u4e0a \u548c\u5553\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308b\u6cbb\u9a13\u85ac\u7ba1\u7406\u696d\u52d9\u306e\u6a19\u6e96\u5316\u306b\u5411\u3051\u305f\u53d6\u308a\u7d44\u307f <\/td>\n \u7b2c19\u56deCRC\u3068\u81e8\u5e8a\u8a66\u9a13\u306e\u3042\u308a\u65b9\u3092\u8003\u3048\u308b\u4f1a\u8b702019 <\/td>\n<\/tr>\n
\u25cb\u5c4b\u5730 \u6176\u5b50\u3001\u76ca\u7530 \u5c06\u543e\u3001\u6e80\u5c3e \u660e\u6075\u3001\u83c5\u539f \u82f1\u8f1d\u3001\u5bfa\u8597 \u82f1\u4e4b\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u9ad8\u5ea6\u60aa\u5fc3\u306b\u3088\u308a\u5185\u670d\u56f0\u96e3\u306b\u306a\u3063\u305f\u60a3\u8005\u306b\u5bfe\u3057\u670d\u85ac\u652f\u63f4\u3068\u7de9\u548c\u30c1\u30fc\u30e0\u306e\u4ecb\u5165\u306b\u3088\u308a\u6297\u30ec\u30c8\u30ed\u30a6\u30a4\u30b9\u30eb\u7642\u6cd5\uff08ART\uff09\u3092\u518d\u958b\u3067\u304d\u305f\u4e00\u75c7\u4f8b <\/td>\n \u7b2c29\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5bfa\u8597\u82f1\u4e4b\u3001\u65e5\u9ad8\u670b\u3001\u9ad9\u6a4b\u6bc5\u884c\u3001\u5965\u6d25\u679c\u512a\u3001\u5409\u6e80\u8aa0\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u96e3\u75c5\u8a3a\u65ad\u306e\u6e2c\u5b9a\u7cfb\u78ba\u7acb\u306b\u3088\u308b\u85ac\u5264\u5e2b\u3068\u3057\u3066\u306e\u8a3a\u7642\u79d1\u3078\u306e\u8ca2\u732e\u3000\uff5e\u30b4\u30fc\u30b7\u30a7\u75c5\u306e\u6cbb\u7642\u306b\u5411\u3051\u3066\uff5e <\/td>\n \u7b2c29\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc\u3001\u897f\u5ddd \u62d3\u6717\u3001\u732a\u5ddd \u548c\u6717\u3001\u5c71\u53e3 \u535a\u6a39\u3001\u4e2d\u5c71 \u4e00\u9686\u3001\u6771 \u82f1\u91cc\u9999\u3001\u5bae\u539f \u6075\u5f25\u5b50\u3001\u3042\u3079\u677e \u8cb4\u6210 \u3001\u4e2d\u5ddd \u4fca\u8f14\u3001\u5150\u7389 \u7950\u4e00\u3001\u7530\u908a \u8cb4\u5e78\u3001\u65b0\u5c0f\u7530 \u96c4\u4e00\u3001\u5ca1\u672c \u5eb7\u88d5\u3001\u6cb3\u91ce \u5609\u6587\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u9020\u8840\u5e79\u7d30\u80de\u79fb\u690d\u60a3\u5150\u306b\u304a\u3051\u308bGST\u907a\u4f1d\u5b50\u591a\u578b\u304c\u30d6\u30b9\u30eb\u30d5\u30a1\u30f3\u306e\u85ac\u7269\u52d5\u614b\u306b\u53ca\u307c\u3059\u5f71\u97ff <\/td>\n \u7b2c29\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc <\/td>\n \u30b7\u30f3\u30dd\u30b8\u30a6\u30e031\u300c\u6297\u83cc\u85ac\u9069\u6b63\u4f7f\u7528\u652f\u63f4\u30c1\u30fc\u30e0\u306e\u85ac\u5264\u5e2b\u304c\u77e5\u3063\u3066\u304a\u304f\u3079\u304d\u6297\u611f\u67d3\u75c7\u85ac\u306e\u57fa\u790e\u3068\u5b9f\u8df5\u7684\u4f7f\u3044\u65b9\u300dCDI \u611f\u67d3\u75c7\u6cbb\u7642\u306e\u5b9f\u8df5 <\/td>\n \u7b2c29\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc <\/td>\n \u30b7\u30f3\u30dd\u30b8\u30a6\u30e056\u300c\u85ac\u5264\u5e2b\u306b\u3088\u308b\u611f\u67d3\u75c7\u8a3a\u7642\u652f\u63f4\u306e\u30ec\u30d9\u30eb\u30a2\u30c3\u30d7\u306b\u5411\u3051\u3066\u5927\u5b66\u75c5\u9662\uff08\u611f\u67d3\u75c7\u79d1\u7121\u3057\uff09\u306b\u304a\u3051\u308b\u85ac\u5264\u5e2b\u306e\u611f\u67d3\u75c7\u8a3a\u7642\u652f\u63f4 <\/td>\n \u7b2c29\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc <\/td>\n \u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3 4\u300c\u814e\u6a5f\u80fd\u4f4e\u4e0b\u3001\u814e\u4ee3\u66ff\u7642\u6cd5\u306b\u304a\u3051\u308b\u6297MRSA\u85ac\u306e\u6295\u4e0e\u8a2d\u8a08\u300d\u814e\u6a5f\u80fd\u4f4e\u4e0b\u306b\u304a\u3051\u308b\u30b0\u30ea\u30b3\u30da\u30d7\u30c1\u30c9\u7cfb\u85ac\u306e\u6295\u4e0e <\/td>\n \u7b2c89\u56de\u2f47\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u2ec4\u2f47\u672c\u5730\u2f45\u4f1a\u5b66\u8853\u96c6\u4f1a
\n \u7b2c62\u56de\u2f47\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u2f47\u672c\u5730\u2f45\u4f1a\u5b66\u8853\u96c6\u4f1a
\n \u7b2c67\u56de\u2f47\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u2ec4\u2f47\u672c\u2f40\u90e8\u7dcf\u4f1a\u3000\u5408\u540c\u958b\u50ac <\/td>\n<\/tr>\n
\u25cb\u7530\u9089 \u5fb9\u3001\u6c60\u7530 \u9f8d\u4e8c\u3001\u5c0f\u516b\u91cd \u85ab\u5b50\u3001\u5bfa\u8597 \u82f1\u4e4b\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u30d2\u30c8\u795e\u7d4c\u81a0\u82bd\u816b\u7d30\u80deU251 cancer stem-like cells\u306b\u304a\u3051\u308b\u85ac\u7269\u8010\u6027\u6a5f\u5e8f\u306e\u89e3\u660e <\/td>\n \u7b2c72\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u897f\u5357\u90e8\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc <\/td>\n \u30b7\u30f3\u30dd\u30b8\u30a6\u30e010\u300cPK\/PD\u306b\u57fa\u3065\u3044\u305f\u611f\u67d3\u75c7\u6cbb\u7642\u306e\u57fa\u672c\u3068\u5b9f\u8df5\u300dPK\/PD\u306b\u57fa\u3065\u3044\u305f\u9ad8\u9f62\u8005\u306b\u304a\u3051\u308b\u611f\u67d3\u75c7\u6cbb\u7642 <\/td>\n \u7b2c35\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u65e5\u9ad8 \u670b\u3001\u5bfa\u8597 \u82f1\u4e4b\u3001\u9ad9\u6a4b \u6bc5\u884c\u3001\u5965\u6d25 \u679c\u512a\u3001\u5409\u6e80\u3000 \u8aa0\u3001\u77f3\u585a \u8ce2\u6cbb\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n LC-MS\/MS\u3092\u7528\u3044\u305f\u30b4\u30fc\u30b7\u30a7\u75c5\u8a3a\u65ad\u306e\u6e2c\u5b9a\u7cfb\u78ba\u7acb <\/td>\n \u7b2c140\u56de\u65e5\u672c\u85ac\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5bfa\u8597 \u82f1\u4e4b\u3001\u9ad9\u6a4b \u6bc5\u884c\u3001\u83c5\u539f \u82f1\u8f1d\u3001\u65b0\u7530 \u7f8e\u5948\u3001\u4e2d\u5d8b \u6d0b\u751f\u3001\u6c34\u91ce \u572d\u5b50\u3001\u4e95\u4e0a \u535a\u96c5\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u5206\u5b50\u6a19\u7684\u85ac\u30a2\u30d5\u30a1\u30c1\u30cb\u30d6\u306e\u8840\u4e2d\u6fc3\u5ea6\u6e2c\u5b9a\u306b\u3088\u308b\u500b\u5225\u5316\u533b\u7642 <\/td>\n \u7b2c140\u56de\u65e5\u672c\u85ac\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5bae\u672c \u611b, \u698e\u6728 \u88d5\u7d00, \u7530\u53e3 \u548c\u660e, \u5929\u9054 \u83dc\u7dd2, \u91d1\u6fa4 \u76f4\u5b50, \u725b\u4e4b\u6ff1 \u98a8\u898b, \u8302\u898b \u831c\u91cc, \u6b66\u7530 \u6cf0\u751f, \u5ddd\u6751 \u82f1\u6a39, \u897f \u9806\u4e00\u90ce, \u5b89\u7530 \u667a\u55e3, \u57a3\u82b1 \u6cf0\u4e4b, \u677e\u5143 \u4e00\u660e <\/td>\n \u6301\u7d9a\u7684\u8840\u6db2\u6ffe\u904e\u900f\u6790(CHDF)\u65bd\u884c\u6642\u306b\u304a\u3051\u308b\u6297\u83cc\u85ac\u306e\u85ac\u7269\u52d5\u614b\u306b\u95a2\u3059\u308b\u7814\u7a76 <\/td>\n \u7b2c140\u56de\u65e5\u672c\u85ac\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5bfa\u8597 \u82f1\u4e4b <\/td>\n \u30b7\u30f3\u30dd\u30b8\u30a6\u30e01\u300c\u7b2c4\u56de \u81e8\u5e8a\u5316\u5b66\u306e\u9032\u6b69\u304c\u5909\u3048\u308b\u85ac\u7269\u6cbb\u7642 \uff5e\u89e3\u6790\u6280\u8853\u306e\u9769\u65b0\u3068\u81e8\u5e8a\u5fdc\u7528\uff5e\u300d\u4e00\u7d30\u80de\u5fae\u5c0f\u6db2\u6ef4\u57f9\u990a\u306b\u3088\u308b\u7a00\u5c11\u7d30\u80de\u9ad8\u611f\u5ea6\u691c\u51fa\u6cd5\u306e\u958b\u767a <\/td>\n \u7b2c140\u56de\u65e5\u672c\u85ac\u5b66\u4f1a <\/td>\n<\/tr>\n<\/table><\/div>\n<\/div>\n

<\/path><\/svg><\/blocsicon> 2018\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u6b27\u6587<\/h3>\n
\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Nariaki Tomiyama, Ryuji Ikeda, Yukihiko Nishizawa, Shogo Masuda, Yusuke Tajitsu and Yasuo Takeda <\/td>\n S100A16 up-regulates Oct4 and Nanog expression in cancer stem-like cells (CSCs) of Yumoto human cervical carcinoma cells <\/td>\n Oncology Letters <\/td>\n 15(6):9929-9933 <\/td>\n<\/tr>\n<\/table>\n

\u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09 <\/th>\n \u6f14\u984c\u540d <\/th>\n \u767a\u8868\u5b66\u4f1a\u7b49 <\/th>\n<\/tr>\n
\u25cb\u67f4\u7530\u7531\u9999\u91cc\u3001\u91cd\u4e45\u3000\u53cb\u7d00\u3001\u7551\u3000\u3053\u305a\u6075\u3001\u4e95\u4e0a\u3000\u548c\u5553\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n \u9662\u5916\u51e6\u65b9\u7b8b\u306b\u8868\u793a\u3059\u308b\u81e8\u5e8a\u691c\u67fb\u9805\u76ee\u306e\u691c\u8a0e <\/td>\n \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e0 2018\uff0f\u7b2c26\u56de\u30af\u30ea\u30cb\u30ab\u30eb\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u83c5\u539f \u82f1\u8f1d\u3001\u6709\u99ac \u7d14\u5b50\u3001\u4e95\u4e0a \u548c\u5553\u3001\u5bfa\u8597 \u82f1\u4e4b\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u304c\u3093\u60a3\u8005\u306b\u304a\u3051\u308b\u98df\u6b32\u4e0d\u632f\u3068\u96fb\u89e3\u8cea\u7570\u5e38 <\/td>\n \u7b2c28\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u7551 \u7f8e\u7a42\u3001\u4e8c\u5ddd \u4fca\u9686\u3001\u539f\u7530 \u4e9c\u5e0c\u5b50\u3001\u76ca\u7530 \u5c06\u543e\u3001\u7551\u9ce5 \u5f8b\u5b50\u3001\u90e1\u5c71 \u4e9c\u7531\u7f8e\u3001\u6afb\u4e95 \u667a\u5b50\u3001\u5965\u91ce\u3000\u771f\u7406\u3001\u539f\u7530 \u3055\u3084\u304b\u3001\u5409\u6e80 \u7f8e\u4fdd\u5b50\u3001\u5965\u8597 \u5bff\u6c5f\u3001\u4e95\u4e0a \u548c\u5553\u3001\u6c38\u91ce \u8061\u3001\u5c0f\u621d \u5065\u4e00\u90ce\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u691c\u67fb\u5024CTCAE\u91cd\u75c7\u5ea6\u8a55\u4fa1\u8868\u3092\u6d3b\u7528\u3057\u305f\u533b\u5e2b\u4e3b\u5c0e\u6cbb\u9a13\uff08\u7b2c\u2160\u76f8\u8a66\u9a13\uff09\u306e\u5b9f\u65bd\u306b\u3064\u3044\u3066 <\/td>\n \u7b2c3\u56de \u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u3000\u4e5d\u5dde\u30fb\u6c96\u7e04\u5730\u65b9\u4f1a <\/td>\n<\/tr>\n
\u25cb\u77e2\u91ce\u3000\u611b\u7406\u3001\u6df1\u6c34\u3000\u77e5\u82f1\u3001\u67f4\u7530\u3000\u7531\u9999\u91cc\u3001\u5bfa\u8597\u3000\u82f1\u4e4b\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n \u30a2\u30df\u30ce\u9178\u52a0\u7cd6\u96fb\u89e3\u8cea\u8f38\u6db2\u4f7f\u7528\u306b\u3088\u308b\u814e\u6a5f\u80fd\u969c\u5bb3\u767a\u73fe\u306b\u3064\u3044\u3066\u306e\u8a55\u4fa1 <\/td>\n \u7b2c28\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u9ad9\u6a4b\u6bc5\u884c\u3001\u5bfa\u8597\u82f1\u4e4b\u3001\u83c5\u539f\u82f1\u8f1d\u3001\u65b0\u7530\u7f8e\u5948\u3001\u4e2d\u5d8b\u6d0b\u751f\u3001\u6c34\u91ce\u572d\u5b50\u3001\u4e95\u4e0a\u535a\u96c5\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30a2\u30d5\u30a1\u30c1\u30cb\u30d6\u8840\u4e2d\u6fc3\u5ea6\u30c8\u30e9\u30d5\u5024\u3068\u814e\u6a5f\u80fd\u691c\u67fb\u5024\u3068\u306e\u95a2\u4fc2 <\/td>\n \u7b2c28\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5bfa\u8597\u3000\u82f1\u4e4b\u3001\u77e2\u91ce\u3000\u611b\u7406\u3001\u9ad9\u6a4b\u3000\u6bc5\u884c\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n \u7570\u306a\u308b\u7269\u6027\u5fdc\u7b54\u9ad8\u5206\u5b50\u3092\u5229\u7528\u3057\u305f\u5e0c\u5c11\u7d30\u80de\u540c\u5b9a\u6cd5\u306e\u958b\u767a <\/td>\n \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e0 2018\uff0f\u7b2c26\u56de\u30af\u30ea\u30cb\u30ab\u30eb\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u5bfa\u8597\u3000\u82f1\u4e4b\u3001\u5c0f\u516b\u91cd\u3000\u85ab\u5b50\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n\u5e0c\u5c11\u795e\u7d4c\u7d30\u80de\u56de\u53ce\u3092\u76ee\u7684\u306b\u3057\u305f\u30de\u30a4\u30af\u30ed\u30ab\u30d7\u30bb\u30eb\u6cd5\u306e\u958b\u767a <\/td>\n \u7b2c16\u56de\u9e7f\u5150\u5cf6\u30cb\u30e5\u30fc\u30ed\u30d5\u30a9\u30fc\u30e9\u30e0 <\/td>\n<\/tr>\n
\u25cb\u5bfa\u8597\u3000\u82f1\u4e4b\u3001\u5c0f\u516b\u91cd\u3000\u85ab\u5b50\u3001\u9ad9\u6a4b\u3000\u6bc5\u884c\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n A novel method to identify profiferative cells in heterogenetic cell population <\/td>\n \u7b2c28\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5bfa\u8597\u3000\u82f1\u4e4b\u3001\u9ad9\u6a4b\u3000\u6bc5\u884c\u3001\u83c5\u539f\u3000\u82f1\u8f1d\u3001\u65b0\u7530\u3000\u7f8e\u5948\u3001\u4e2d\u5d8b\u3000\u6d0b\u751f\u3001\u6c34\u91ce\u3000\u572d\u5b50\u3001\u4e95\u4e0a\u3000\u535a\u96c5\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n \u5206\u5b50\u6a19\u7684\u85ac\u30a2\u30d5\u30a1\u30c1\u30cb\u30d6\u306e\u8840\u4e2d\u6fc3\u5ea6\u6e2c\u5b9a\u306b\u3088\u308b\u500b\u5225\u5316\u533b\u7642 <\/td>\n \u7b2c139\u56de\u65e5\u672c\u85ac\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u897f\u6fa4\u3000\u7531\u7d00\u5f66\u3001\u6c60\u7530\u3000\u9f8d\u4e8c\u3001\u7530\u5be6\u3000\u88d5\u4ecb\u3001\u5357\u3000\u8b19\u592a\u90ce\u3001\u65b0\u7530\u3000\u7f8e\u5948\u3001\u5bfa\u8597\u3000\u82f1\u4e4b\u3001\u53e4\u5ddd\u3000\u9f8d\u5f66\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n 5-axa-2-deoxycytidine(5-Aza)\u306b\u3088\u308b5-fuluorouracil(5-FU)\u306e\u6297\u816b\u760d\u52b9\u679c\u5897\u5f37\u4f5c\u7528\u306e\u6a5f\u5e8f\u89e3\u660e <\/td>\n \u7b2c71\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u897f\u5357\u90e8\u4f1a <\/td>\n<\/tr>\n
\u25cb\u65b0\u7530\u3000\u7f8e\u5948\u3001\u771e\u5b50\u3000\u3042\u3064\u304d\u3001\u7530\u9089\u3000\u4ea8\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n \u5375\u5de3\u304c\u3093\u60a3\u8005\u306b\u7740\u76ee\u3057\u305fTC\u7642\u6cd5\u65bd\u884c\u6642\u306e\u30d1\u30af\u30ea\u30bf\u30ad\u30bb\u30eb\u904e\u654f\u75c7\u3068\u6307\u793a\u7642\u6cd5\u306e\u4e88\u9632\u52b9\u679c\u30fb\u767a\u75c7\u8981\u56e0\u306e\u691c\u8a0e <\/td>\n \u7b2c71\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u897f\u5357\u90e8\u4f1a <\/td>\n<\/tr>\n
\u25cb\u51a8\u5c71\u3000\u6210\u7ae0\u3001\u6c60\u7530\u3000\u9f8d\u4e8c\u3001\u897f\u6fa4\u3000\u7531\u7d00\u5f66\u3001\u76ca\u7530\u3000\u7701\u543e\u3001\u7530\u5be6\u3000\u88d5\u4ecb\u3001\u5bfa\u8597\u3000\u82f1\u4e4b\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n Yumoto\u5b50\u5bae\u9838\u764c\u7d30\u80de\u306eCancer stem-like cells\u306b\u304a\u3044\u3066S100A16\u306fOct4\u3068Nanog\u306e\u767a\u73fe\u3092\u5236\u5fa1\u3057\u3066\u3044\u308b <\/td>\n \u7b2c71\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u897f\u5357\u90e8\u4f1a <\/td>\n<\/tr>\n
\u25cb\u65b0\u7530\u7f8e\u5948\u3001\u698e\u6728\u88d5\u7d00\u3001\u9ad8\u5d0e\u7d18\u4f51\u3001\u5bfa\u8597\u82f1\u4e4b\u3001\u524d\u7530\u5f18\u5fd7\u3001\u6771\u548c\u535a\u3001\u5927\u5800\u7d14\u4e00\u90ce\u3001\u798f\u5ca1\u9f8d\u4e00\u3001\u82b1\u725f\u79ae\u8c4a\u3001\u9ed2\u91ce\u7950\u4e00\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u9ad8\u7528\u91cf\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\u7642\u6cd5\u6642\u306e\u814e\u969c\u5bb3\u4e88\u9632\u306b\u4e0e\u3048\u308b\u30de\u30b0\u30cd\u30b7\u30a6\u30e0\u88fd\u5264\u306e\u7528\u91cf\u306e\u6bd4\u8f03 <\/td>\n \u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u3000\u7b2c56\u56de\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n<\/table><\/div>\n<\/div>\n

<\/path><\/svg><\/blocsicon> 2017\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u8457\u66f8<\/h3>\n
\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u66f8\u540d\uff08\u5206\u62c5\u306e\u5834\u5408\u306f+\u6a19\u984c\u540d\uff09 <\/th>\n \u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
\u5206\u7b46\u62c5\u5f53\uff1a\u83c5\u539f\u82f1\u8f1d\uff0c\u76e3\u4fee\uff1a\u7247\u5c71\u5fd7\u90ce\uff0c\u5e73\u4e95\u307f\u3069\u308a\uff0c\u7de8\u8457\uff1a\u9ad9\u702c\u4e45\u5149\uff0c\u4e95\u624b\u53e3\u76f4\u5b50 <\/td>\n \u30b1\u30fc\u30b9\u30b9\u30bf\u30c7\u30a3\u3067\u5b66\u3076\u3000\u304c\u3093\u60a3\u8005\u30ed\u30b8\u30ab\u30eb\u30fb\u30c8\u30fc\u30bf\u30eb\u30b5\u30dd\u30fc\u30c8\uff0c\u76ae\u75b9 <\/td>\n p.105-122 <\/td>\n<\/tr>\n
\u5206\u7b46\u62c5\u5f53\uff1a\u83c5\u539f\u82f1\u8f1d\uff0c\u76e3\u4fee\uff1a\u7247\u5c71\u5fd7\u90ce\uff0c\u5e73\u4e95\u307f\u3069\u308a\uff0c\u7de8\u8457\uff1a\u9ad9\u702c\u4e45\u5149\uff0c\u4e95\u624b\u53e3\u76f4\u5b50 <\/td>\n \u30b1\u30fc\u30b9\u30b9\u30bf\u30c7\u30a3\u3067\u5b66\u3076\u3000\u304c\u3093\u60a3\u8005\u30ed\u30b8\u30ab\u30eb\u30fb\u30c8\u30fc\u30bf\u30eb\u30b5\u30dd\u30fc\u30c8\uff0c\u96fb\u89e3\u8cea\u7570\u5e38 <\/td>\n p.123-141 <\/td>\n<\/tr>\n<\/table>\n

\u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09 <\/th>\n \u6f14\u984c\u540d <\/th>\n \u767a\u8868\u5b66\u4f1a\u7b49 <\/th>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc\u3001\u6e21\u8fba \u82f1\u91cc\u9999\u3001\u677e\u5143 \u4e00\u660e\u3001\u6a2a\u5c71 \u96c4\u592a\u3001\u732a\u5ddd \u548c\u6717\u3001\u6885\ufa11 \u9756\u5f18\u3001\u68ee\u5ddd \u5247\u6587\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u30dc\u30ea\u30b3\u30ca\u30be\u30fc\u30eb\u4ee3\u8b1d\u7269\u6fc3\u5ea6\u3068CYP2C19\u907a\u4f1d\u5b50\u591a\u578b\u3092\u8003\u616e\u3057\u305fTDM\u306e\u6709\u7528\u6027 <\/td>\n \u7b2c91\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a\/\u7b2c65\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3000\u5408\u540c\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751 \u82f1\u6a39\u3001\u8302\u898b \u831c\u91cc\u3001\u53e4\u57ce \u525b\u3001\u5fb3\u7530 \u6d69\u4e00\u3001\u5b89\u7530 \u667a\u55e3\u3001\u57a3\u82b1 \u6cf0\u4e4b\u3001\u897f \u9806\u4e00\u90ce <\/td>\n ICU\u306b\u304a\u3051\u308b\u7dd1\u81bf\u83cc\u85ac\u5264\u611f\u53d7\u6027\u3068\u6297\u83cc\u85ac\u4f7f\u7528\u5bc6\u5ea6\u30fb\u6297\u83cc\u85ac\u5747\u8cea\u5ea6\uff08AHI\uff09\u306e\u95a2\u9023\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n \u7b2c91\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a\/\u7b2c65\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3000\u5408\u540c\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u83c5\u539f \u82f1\u8f1d\u3001\u6e80\u5c3e \u660e\u6075\u3001\u91d1\u6fa4 \u76f4\u5b50\u3001\u9ad9\u6a4b \u6bc5\u884c\u3001\u7a32\u8449 \u308b\u308a\u3001\u5b87\u6cbb\u91ce \u793c\u7f8e\u3001\u6709\u6751 \u6602\u592a\u6717\u3001\u4e95\u4e0a \u548c\u5553\u3001\u6c60\u7530 \u9f8d\u4e8c\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u30aa\u30d4\u30aa\u30a4\u30c9\u93ae\u75db\u85ac\u306b\u95a2\u3059\u308b\u30a4\u30f3\u30b7\u30c7\u30f3\u30c8\u5831\u544a\u306e\u89e3\u6790\u7d50\u679c\u304b\u3089\u307f\u305f\u85ac\u5264\u5e2b\u306e\u5f79\u5272 <\/td>\n \u7b2c11\u56de\u65e5\u672c\u7de9\u548c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5c4b\u5730 \u6176\u5b50\u3001\u83c5\u539f \u82f1\u8f1d\u3001\u4e95\u4e0a \u548c\u5553\u3001\u6c60\u7530 \u9f8d\u4e8c\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u6539\u8a02\u85ac\u5b66\u6559\u80b2\u30e2\u30c7\u30eb\u30fb\u30b3\u30a2\u30ab\u30ea\u30ad\u30e5\u30e9\u30e0\u306e\u4ee3\u8868\u76848\u75be\u60a3\u306b\u95a2\u3059\u308b\u5b9f\u7fd2\u5b9f\u65bd\u72b6\u6cc1 <\/td>\n \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e02017\/\u7b2c25\u56de\u30af\u30ea\u30cb\u30ab\u30eb\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
Erika Watanabe,Kazuaki Matsumoto,Kazuro Ikawa, Yuta Yokoyama,Akari Shigemi,Yasuhiro Umezaki, Koyo Nakamura,Keiichiro Ueno,Norifumi Morikawa, \u25cbYasuo Takeda <\/td>\n Pharmacokinetic\/pharmacodynamic evaluation of teicoplanin against Staphylococcus aureus in murine thigh infection model <\/td>\n 15th International Congress of Therapeutic Drug Monitoring \uff06 Clinical Toxicology <\/td>\n<\/tr>\n
\u25cbAkari shigemi,Kazuaki Matsumoto,Erika Watanabe, Kazuro Ikawa,Naoko Kanazawa,Yuta Yokoyama, Ryuji Ikeda,Norifumi Morikawa,Yasuo Takeda <\/td>\n Voriconazole TDM based on both unchanged drug and metabolite concentrations in Japanese patients <\/td>\n 15th International Congress of Therapeutic Drug Monitoring \uff06 Clinical Toxicology <\/td>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc <\/td>\n“\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u306eTDM\u306e\u5b9f\u969b
\n \u30fc \u6297\u83cc\u85acTDM\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32016\u306e\u6d3b\u7528\uff0d” <\/td>\n		 \u7b2c65\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a\/\u7b2c60\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a\/\u7b2c87\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751 \u82f1\u6a39\u3001\u8302\u898b \u831c\u91cc\u3001\u4e2d\u5d8b \u6d0b\u751f\u3001\u5929\u9054 \u83dc\u7dd2\u3001\u897f \u9806\u4e00\u90ce <\/td>\n \u5f53\u9662\u306b\u304a\u3051\u308b\u8853\u5f8c\u611f\u67d3\u4e88\u9632\u6297\u83cc\u85ac\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u3068\u9069\u6b63\u4f7f\u7528\u6d3b\u52d5\u306e\u52b9\u679c <\/td>\n \u7b2c65\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a\/\u7b2c60\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a\/\u7b2c87\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u91cd\u4e45 \u53cb\u7d00\u3001\u67f4\u7530 \u7531\u9999\u91cc\u3001\u4e2d\u76ee \u9806\u5b50\u3001\u6df1\u6c34 \u77e5\u82f1\u3001\u83c5\u539f \u82f1\u8f1d\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u30cf\u30a4\u30cd\u30a4\u30fc\u30b2\u30eb\u00ae\u4f7f\u7528\u60a3\u8005\u306b\u304a\u3051\u308bPPI\u306e\u4f75\u7528\u306b\u95a2\u3059\u308b\u8abf\u67fb <\/td>\n \u7b2c27\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u3007\u91d1\u6fa4 \u76f4\u5b50\u3001\u9ce5\u8d8a \u5343\u79cb\u3001\u65b0\u99ff\u6cb3 \u6d0b\u5b50\u3001\u6ff5\u7530 \u502b\u53f2\u3001\u5927\u5409 \u9054\u6a39\u3001\u5185\u9580 \u6cf0\u6597\u3001\u6749\u6d66 \u525b\u3001\u5927\u77f3 \u5145 <\/td>\n \u81ea\u5df1\u7ba1\u7406\u85ac\u306e\u5185\u670d\u30a8\u30e9\u30fc\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u306b\u8981\u56e0\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e <\/td>\n \u7b2c12\u56de\u533b\u7642\u306e\u8cea\u30fb\u5b89\u5168\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc <\/td>\n C. difficile\u611f\u67d3\u75c7\u5bfe\u7b56\u3078\u306e\u85ac\u5264\u5e2b\u306e\u95a2\u308f\u308a <\/td>\n \u7b2c10\u56de\u4e5d\u5dde\u5c71\u53e3\u85ac\u5b66\u4f1a\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30b1\u30a2\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc <\/td>\n \u30d0\u30f3\u30b3\u30de\u30a4\u30b7\u30f3\u306b\u304a\u3051\u308bTDM\u3068\u6295\u4e0e\u8a2d\u8a08 <\/td>\n \u7b2c33\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n<\/table><\/div>\n<\/div>\n

<\/path><\/svg><\/blocsicon> 2016\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u6b27\u6587<\/h3>\n
\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Matsumoto K, Abematsu K, Shigemi A, Kanazawa N, Watanabe E, Yokoyama Y, Ikawa K, Morikawa N, Takeda Y. <\/td>\n Therapeutic drug monitoring of voriconazole in Japanese patients: analysis based on clinical practice data. <\/td>\n Journal of Chemotherapy <\/td>\n 28(3):198-202 <\/td>\n<\/tr>\n
Kawamura H, Matsumoto K, Shigemi A, Orita M, Nakagawa A, Nozima S, Tominaga H, Setoguchi T, Komiya S, Tokuda K, Nishi J <\/td>\n A bundle that includes active surveillance, contact precaution for carriers, and cefazolin-based antimicrobial prophylaxis prevents methicillin-resistant Staphylococcus aureus infections in clean orthopedic surgery. <\/td>\n American Journal of Infection Control <\/td>\n 44(2)\uff1a210-214 <\/td>\n<\/tr>\n
Matsumoto K, Watanabe E, Kanazawa N, Fukamizu T, Shigemi A, Yokoyama Y, Ikawa K, Morikawa N, Takeda Y. <\/td>\n Pharmacokinetic\/pharmacodynamic analysis of teicoplanin in patients with MRSA infections. <\/td>\n Clinical Pharmacology: Advances and Applications <\/td>\n 8\uff1a15\u201318 <\/td>\n<\/tr>\n<\/table>\n

\u548c\u6587<\/h4>\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
\u8302\u898b\u831c\u91cc\u3001\u677e\u5143\u4e00\u660e\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u732a\u5ddd\u548c\u6717\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u6885\ufa11\u9756\u5f18\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n CYP2C19\u907a\u4f1d\u5b50\u591a\u578b\u3068\u4ee3\u8b1d\u7269\u6fc3\u5ea6\u3092\u3075\u307e\u3048\u305fTDM\u306b\u3088\u308b\u30dc\u30ea\u30b3\u30ca\u30be\u30fc\u30eb\u6295\u4e0e\u91cf\u9069\u6b63\u5316\u304c\u6709\u7528\u3067\u3042\u3063\u305f2\u4f8b <\/td>\n \u65e5\u672c\u5916\u79d1\u611f\u67d3\u75c7\u5b66\u4f1a\u96d1\u8a8c <\/td>\n 13\uff086\uff09\uff1a661-667 <\/td>\n<\/tr>\n<\/table>\n

\u7dcf\u8aac<\/h4>\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Yasuo Takeda, Ryuji Ikeda, Tomoko Kondo <\/td>\n Incretin as a novel treatment strategy for NAFLD\/NASH <\/td>\n YAKUGAKU ZASSHI <\/td>\n 136(4): 573-577 <\/td>\n<\/tr>\n<\/table>\n

\u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09 <\/th>\n \u6f14\u984c\u540d <\/th>\n \u767a\u8868\u5b66\u4f1a\u7b49 <\/th>\n<\/tr>\n
\u25cb\u9ad8\u6ff1\u548c\u5f18\uff0c\u4e8c\u5ddd\u4fca\u9686\uff0c\u5927\u5ddd\u5185\u5bff\u6c5f\uff0c\u8fd1\u85e4\u667a\u5b50\uff0c\u5bae\u5730\u4e9c\u7531\u7f8e\uff0c\u7551\u9ce5\u5f8b\u5b50\uff0c\u5c0f\u5009\u667a\u5b50\uff0c\u4e95\u4e0a\u548c\u5553\uff0c\u6709\u7530\u548c\u5fb3\uff0c\u6b66\u7530\u6cf0\u751f <\/td>\n \u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308b\u6cbb\u9a13\u85ac\u6e29\u5ea6\u7ba1\u7406\u4f53\u5236\u306e\u69cb\u7bc9\u3068\u305d\u306e\u904b\u7528\u304b\u3089\u898b\u3048\u3066\u304d\u305f\u8ab2\u984c-\u6cbb\u9a13\u5b9f\u65bd\u65bd\u8a2d\u306b\u304a\u3051\u308b\u9069\u5207\u306a\u6e29\u5ea6\u7ba1\u7406\u4f53\u5236\u3068\u306f\uff0d <\/td>\n <\/td>\n<\/tr>\n
\u25cb\u5ca1\u5cf6\u96bc\u8f14\u3001\u65b0\u7530\u7f8e\u5948\u3001\u7530\u908a\u5fb9\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6c38\u91ce\u5e83\u6d77\u3001\u9ed2\u91ce\u7950\u4e00\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u982d\u9838\u90e8\u764c\u60a3\u8005\u306b\u304a\u3051\u308b\u30bb\u30c4\u30ad\u30b7\u30de\u30d6\u6295\u4e0e\u306b\u3088\u308b\u96fb\u89e3\u8cea\u7570\u5e38\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n <\/td>\n<\/tr>\n
\u25cb\u6c60\u7530\u9f8d\u4e8c\u3001\u5c71\u7530\u52dd\u58eb\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30b2\u30e0\u30b7\u30bf\u30d3\u30f3\u8010\u6027\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\u7d30\u80de\u306e\u8010\u6027\u6a5f\u5e8f\u3068\u8010\u6027\u514b\u670d\u85ac\u5264\u306e\u958b\u767a <\/td>\n <\/td>\n<\/tr>\n
\u25cb\u51a8\u5c71\u6210\u7ae0\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u897f\u6fa4\u7531\u7d00\u5f66\u3001\u76ca\u7530\u5c06\u543e\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n Cancer stem-like cells \u306b\u304a\u3051\u308bS100A16\u306e\u5f79\u5272 <\/td>\n <\/td>\n<\/tr>\n
\u25cb\u9ad8\u6a4b\u6bc5\u884c\u3001\u83c5\u539f\u82f1\u8f1d\u3001\u6e80\u5c3e\u660e\u6075\u3001\u672c\u6728\u4e0b\u771f\u4e9c\u7d17\u3001\u8feb\u7530\u53cb\u7406\u3001\u4e2d\u5d8b\u6d0b\u751f\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30d7\u30ed\u30c8\u30f3\u30dd\u30f3\u30d7\u963b\u5bb3\u85ac\u304a\u3088\u3073H2\u53d7\u5bb9\u4f53\u906e\u65ad\u85ac\u306e\u4f75\u7528\u306b\u304a\u3051\u308b\u30b2\u30d5\u30a3\u30c1\u30cb\u30d6\u6cbb\u7642\u671f\u9593\u3068\u526f\u4f5c\u7528\u767a\u73fe\u72b6\u6cc1\u306e\u8abf\u67fb <\/td>\n <\/td>\n<\/tr>\n
\u25cb\u677e\u7530\u7d79\u4ee3\u3001\u4e45\u571f\u7dbe\u9999\u3001\u6a4b\u53e3\u601c\u672a\u3001\u6709\u99ac\u7531\u4f73\u3001\u65b0\u7530\u7f8e\u5948\u3001\u6709\u99ac\u7d14\u5b50\u3001\u83c5\u539f\u82f1\u8f1d\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u4e95\u4e0a\u548c\u5553\u3001\u771e\u7530\u5b8f\u6a39\u3001\u6c34\u91ce\u572d\u5b50\u3001\u4e95\u4e0a\u535a\u96c5\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\u8a98\u767a\u6027\u814e\u6a5f\u80fd\u969c\u5bb3\u306b\u5bfe\u3059\u308b\u30de\u30b0\u30cd\u30b7\u30a6\u30e0\u306e\u814e\u4fdd\u8b77\u4f5c\u7528\u306b\u95a2\u3059\u308b\u524d\u5411\u304d\u7814\u7a76 <\/td>\n <\/td>\n<\/tr>\n
\u25cb\u6709\u99ac\u7531\u4f73\u3001\u677e\u7530\u7d79\u4ee3\u3001\u725b\u4e4b\u6ff5\u98a8\u898b\u3001\u65b0\u7530\u7f8e\u5948\u3001\u83c5\u539f\u82f1\u8f1d\u3001\u6709\u99ac\u7d14\u5b50\u3001\u4e95\u4e0a\u548c\u5553\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u7d4c\u53e3\u6297\u304c\u3093\u5264\u5185\u670d\u4e2d\u5916\u6765\u60a3\u8005\u306b\u5bfe\u3059\u308bB\u578b\u809d\u708e\u30a6\u30a4\u30eb\u30b9\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u5b9f\u65bd\u5b9f\u614b\u8abf\u67fb\u3068\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u5b9f\u65bd\u7387\u5411\u4e0a\u3092\u76ee\u6307\u3057\u305f\u53d6\u308a\u7d44\u307f <\/td>\n <\/td>\n<\/tr>\n
\u25cb\u9ad8\u6a4b\u6bc5\u884c\u3001\u83c5\u539f\u82f1\u8f1d\u3001\u6e80\u5c3e\u660e\u6075\u3001\u672c\u6728\u4e0b\u771f\u4e9c\u7d17\u3001\u8feb\u7530\u53cb\u7406\u3001\u4e2d\u5d8b\u6d0b\u751f\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30d7\u30ed\u30c8\u30f3\u30dd\u30f3\u30d7\u963b\u5bb3\u85ac\u304a\u3088\u3073H2\u53d7\u5bb9\u4f53\u906e\u65ad\u85ac\u306e\u4f75\u7528\u306b\u304a\u3051\u308b\u30b2\u30d5\u30a3\u30c1\u30cb\u30d6\u6cbb\u7642\u671f\u9593\u3068\u6cbb\u7642\u7d42\u4e86\u7406\u7531\u306e\u8abf\u67fb <\/td>\n <\/td>\n<\/tr>\n
\u25cb\u725b\u4e4b\u6ff5\u98a8\u898b\u3001\u68ee\u5ddd\u7531\u68a8\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u5c71\u4e0b\u516b\u91cd\u4e43\u3001\u5ca1\u5cf6\u96bc\u8f14\u3001\u65b0\u7530\u7f8e\u5948\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30d6\u30ec\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30a8\u30c8\u30dd\u30b7\u30c9\u3001\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\uff08BEP\uff09\u7642\u6cd5\u6642\u306e\u30d6\u30ec\u30aa\u30de\u30a4\u30b7\u30f3\u306b\u3088\u308b\u767a\u71b1\u306b\u5bfe\u3059\u308b\u30b9\u30c6\u30ed\u30a4\u30c9\u306e\u6291\u5236\u52b9\u679c <\/td>\n <\/td>\n<\/tr>\n
“\u25cbKazami Ushinohama, Yuri Morikawa, Mina Nitta, Ryuji Ikeda,
\n Masayuki Nakagawa\u3001Yasuo Takeda” <\/td>\n		 Corticosteroid decrease the fever incidence after the administration of bleomycin during chemotherapy with bleomycin, etoposide and cisplatin <\/td>\n <\/td>\n<\/tr>\n
\u25cb\u8302\u898b \u831c\u91cc\u3001\u6885\ufa11 \u9756\u5f18\u3001\u677e\u5143 \u4e00\u660e\u3001\u5ddd\u6751 \u82f1\u6a39\u3001\u5fb3\u7530 \u6d69\u4e00\u3001\u897f \u9806\u4e00\u90ce\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n“\u30ea\u30cd\u30be\u30ea\u30c9\u306b\u3088\u308b\u8840\u5c0f\u677f\u6e1b\u5c11\u306e\u4e88\u6e2c\u56e0\u5b50\u306b\u95a2\u3059\u308b\u691c\u8a0e
\n \uff0d\u5e73\u5747\u8840\u5c0f\u677f\u5bb9\u7a4d\uff08MPV\uff09\u3001\u8840\u5c0f\u677f\u5206\u5e03\u5e45\uff08PDW\uff09\u7b49\u306e\u5909\u52d5\u8a55\u4fa1\uff0d” <\/td>\n		 \u7b2c64\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u8302\u898b\u831c\u91cc\u3001\u6885\u5d0e\u9756\u5f18\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u897f\u9806\u4e00\u90ce <\/td>\n \u30c0\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u6cbb\u7642\u3092\u884c\u3063\u305fMRSA\u83cc\u8840\u75c7\u306b\u95a2\u3059\u308b\u5f8c\u65b9\u8996\u7684\u691c\u8a0e <\/td>\n \u7b2c64\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b\u831c\u91cc\u3001\u677e\u5143\u4e00\u660e\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30ac\u30f3\u30b7\u30af\u30ed\u30d3\u30eb\u8a98\u767a\u6027\u306e\u8840\u5c0f\u677f\u6e1b\u5c11\u304a\u3088\u3073\u767d\u8840\u7403\u6e1b\u5c11\u306e\u30ea\u30b9\u30af\u56e0\u5b50\u306e\u89e3\u6790 <\/td>\n \u7b2c64\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u98ef\u7530\u660c\u5b50\u3001\u5c0f\u5c71\u5fb9\u5e73\u3001\u4eca\u6751\u8449\u5b50\u3001\u5c4b\u5730\u6176\u5b50\u3001\u53e4\u5ddd\u826f\u5c1a <\/td>\n HIV\u691c\u67fb\u76f8\u8ac7\u7814\u4fee\u4f1a\u5b9f\u65bd\u304c\u5730\u57df\u9023\u643a\u306b\u3082\u305f\u3089\u3057\u305f\u52b9\u679c <\/td>\n \u7b2c30\u56de\u30a8\u30a4\u30ba\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6885\u5d0e\u9756\u5f18\u3001\u8302\u898b\u831c\u91cc\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u897f\u9806\u4e00\u90ce\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u6297\u771f\u83cc\u85ac\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9\u306b\u3088\u308b\u5f53\u9662\u306e\u6297\u771f\u83cc\u85ac\u4f7f\u7528\u72b6\u6cc1\u8a55\u4fa1\u3068\u9069\u6b63\u4f7f\u7528\u4ecb\u5165\u306e\u5fc5\u8981\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n \u7b2c64\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u8302\u898b\u831c\u91cc\u3001\u5bfa\u7530\u664b\u4f5c\u3001\u4e8c\u6728\u8cb4\u5f18\u3001\u5c71\u53e3\u6842\u53f8\u3001\u53e4\u5225\u5e9c\u88d5\u660e\u3001\u67f3\u5143\u5b5d\u4ecb\u3001\u5b89\u7530\u667a\u55e3\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u897f\u9806\u4e00\u90ce\u3001\u57a3\u82b1\u6cf0\u4e4b <\/td>\n \u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308bRapid Respose System\uff08RRS\uff09\u5bfe\u5fdc\u60a3\u8005\u306b\u5bfe\u3059\u308b\u611f\u67d3\u75c7\u8a3a\u7642\u652f\u63f4\u306e\u72b6\u6cc1 <\/td>\n \u7b2c86\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u3007\u5185\u9580\u6cf0\u6597\u3001\u5927\u5409\u9054\u6a39\u3001\u6c5f\u4e26\u4eac\u5b50\u3001\u9ce5\u8d8a\u5343\u79cb\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u4e2d\u6751\u5178\u53f2\u3001\u590f\u8d8a\u7965\u6b21 <\/td>\n \u533b\u5e2b\u30fb\u6b6f\u79d1\u533b\u5e2b\u306e\u30a4\u30f3\u30b7\u30c7\u30f3\u30c8\u5831\u544a\u306e\u73fe\u72b6\u3068\u5831\u544a\u63a8\u9032\u306e\u53d6\u308a\u7d44\u307f <\/td>\n \u7b2c11\u56de\u533b\u7642\u306e\u8cea\u30fb\u5b89\u5168\u5b66\u4f1a <\/td>\n<\/tr>\n<\/table><\/div>\n<\/div>\n

<\/path><\/svg><\/blocsicon> 2015\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u6b27\u6587<\/h3>\n
\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Kentaro Minamia, Yoshinari Shinsato, Masatatsu Yamamoto, Homare Takahashi,Shaoxuan Zhang, Yukihiko Nishizawa, Sho Tabata, Ryuji Ikeda, Kohich Kawahara, Kazutake Tsujikawa, Kazuo Chijiiwa, Katsushi Yamada, Shin-ichi Akiyama, Sandra P\u00e9rez-Torras, Marcal Pastor-Anglada, Tatsuhiko Furukawa, Yasuo Takeda <\/td>\n Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors. <\/td>\n J Pharmacol Sci. <\/td>\n 127; 319-325 <\/td>\n<\/tr>\n
Izumi Haruta, Yuki Fuku, Kazuhisa Kinoshita, Koichi Yoneda, Akinori Morinaga, Marie Amitani\uff0cHaruka Amitani\uff0cAkihiro Asakawa\uff0cHideki Sugawara\uff0cYasuo Takeda\uff0cCyril Y. Bowers\uff0cAkio Inui <\/td>\n One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient. <\/td>\n J Cachexia Sarcopenia Muscle <\/td>\n 6 (3); 237-241 <\/td>\n<\/tr>\n
Kazuaki Matsumoto, Akari Shigemi, Kazuro Ikawa, Naoko Kanazawa, Yuko Fujisaki, Norifumi Morikawa, Yasuo Takeda <\/td>\n Risk factors for ganciclovir-induced thrombocytopenia and leukopenia. <\/td>\n Biological and Pharmaceutical Bulletin <\/td>\n 38, 235-238 <\/td>\n<\/tr>\n<\/table>\n

\u8457\u66f8<\/h4>\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u66f8\u540d\uff08\u5206\u62c5\u306e\u5834\u5408\u306f+\u6a19\u984c\u540d\uff09 <\/th>\n \u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
\u9ad8\u6ff1\u548c\u5f18\uff0c\u6b66\u7530\u6cf0\u751f <\/td>\n“\u533b\u85ac\u30b8\u30e3\u30fc\u30ca\u30eb\u3000\u7b2c52\u5dfb\u3000\u5897\u520a\u53f7\u300c\u65b0\u85ac\u5c55\u671b\u30002016\u300d\u3000
\n \u7b2c\u2162\u90e8\u3000\u6cbb\u7642\u306b\u304a\u3051\u308b\u6700\u8fd1\u306e\u65b0\u85ac\u306e\u4f4d\u7f6e\u4ed8\u3051
\n <\u85ac\u52b9\u5225>\u3000\uff5e\u65b0\u85ac\u306e\u5e83\u5834\uff5e\u3000\u7d71\u5408\u5931\u8abf\u75c7\u6cbb\u7642\u85ac” <\/td>\n		 262\uff0d273 <\/td>\n<\/tr>\n<\/table>\n

\u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09 <\/th>\n \u6f14\u984c\u540d <\/th>\n \u767a\u8868\u5b66\u4f1a\u7b49 <\/th>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u8302\u898b\u831c\u91cc\u3001\u677e\u5143\u4e00\u660e\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u897f\u9806\u4e00\u90ce <\/td>\n MRSA\u975e\u4fdd\u83cc\u8005\u306b\u304a\u3051\u308b\u6574\u5f62\u5916\u79d1\u9818\u57dfMRSA\u624b\u8853\u90e8\u4f4d\u611f\u67d3\uff08SSI\uff09\u767a\u75c7\u30ea\u30b9\u30af\u306e\u691c\u8a0e <\/td>\n \u7b2c63\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8fd1\u85e4\u667a\u5b50 <\/td>\n“\u30ea\u30b9\u30af\u7ba1\u7406\u8a08\u753b\uff08RMP\uff09\u3092\u52b9\u679c\u7684\u306b\u5b9f\u8df5\u3059\u308b\u2015\u85ac\u7269\u6cbb\u7642\u3092\u53d7\u3051\u3066\u3044\u308b\u60a3\u8005\u306e\u30ea\u30b9\u30af\u6700\u5c0f\u5316\u306b\u5411\u3051\u3066\u2015
\n CRC\u7d4c\u9a13\u3092\u6d3b\u304b\u3057\u305fRMP\u3078\u306e\u8ca2\u732e” <\/td>\n		 \u7b2c18\u56de\u65e5\u672c\u533b\u85ac\u54c1\u60c5\u5831\u5b66\u4f1a \u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ca1\u5cf6\u96bc\u8f14\u3001\u65b0\u7530\u7f8e\u5948\u3001\u7530\u908a\u5fb9\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6c38\u91ce\u5e83\u6d77\u3001\u9ed2\u91ce\u7950\u4e00\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u982d\u9838\u90e8\u764c\u60a3\u8005\u306b\u304a\u3051\u308b\u30bb\u30c4\u30ad\u30b7\u30de\u30d6\u6295\u4e0e\u306b\u3088\u308b\u96fb\u89e3\u8cea\u7570\u5e38\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e02015 <\/td>\n<\/tr>\n
\u25cb\u6c60\u7530\u9f8d\u4e8c\u3001\u5c71\u7530\u52dd\u58eb\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30b2\u30e0\u30b7\u30bf\u30d3\u30f3\u8010\u6027\u975e\u5c0f\u7d30\u80de\u80ba\u304c\u3093\u7d30\u80de\u306e\u8010\u6027\u6a5f\u5e8f\u3068\u8010\u6027\u514b\u670d\u85ac\u5264\u306e\u958b\u767a <\/td>\n \u7b2c8\u56de\u30c8\u30e9\u30f3\u30b9\u30dd\u30fc\u30bf\u30fc\u7814\u7a76\u4f1a\u4e5d\u5dde\u90e8\u4f1a JTRAQ2015 <\/td>\n<\/tr>\n
\u25cb\u76ca\u7530\u3000\u5c06\u543e\uff0c\u4e8c\u5ddd\u3000\u4fca\u9686\uff0c\u5c71\u53e3\u3000\u6c99\u7e54\uff0c\u5c71\u7530\u3000\u52dd\u58eb\uff0c\u6c60\u7530\u3000\u9f8d\u4e8c\uff0c\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n <\/td>\n \u7b2c26\u56de \u9727\u5cf6\u795e\u7d4c\u85ac\u7406\u30d5\u30a9\u30fc\u30e9\u30e0 <\/td>\n<\/tr>\n
\u25cbKazami Ushinohama, Yuri Morikawa, Mina Nitta, Ryuji Ikeda, Masayuki Nakagawa\u3001Yasuo Takeda <\/td>\n Corticosteroid decrease the fever incidence after the administration of bleomycin during chemotherapy with bleomycin, etoposide and cisplatin <\/td>\n \u7b2c75\u56de\u56fd\u969b\u85ac\u5264\u5e2b\u30fb\u85ac\u5b66\u9023\u5408\u56fd\u969b\u4f1a\u8b70 <\/td>\n<\/tr>\n
\u25cb\u9ad8\u6a4b\u6bc5\u884c\u3001\u83c5\u539f\u82f1\u8f1d\u3001\u6e80\u5c3e\u660e\u6075\u3001\u672c\u6728\u4e0b\u771f\u4e9c\u7d17\u3001\u8feb\u7530\u53cb\u7406\u3001\u4e2d\u5d8b\u6d0b\u751f\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30d7\u30ed\u30c8\u30f3\u30dd\u30f3\u30d7\u963b\u5bb3\u85ac\u304a\u3088\u3073H2\u53d7\u5bb9\u4f53\u906e\u65ad\u85ac\u306e\u4f75\u7528\u306b\u304a\u3051\u308b\u30b2\u30d5\u30a3\u30c1\u30cb\u30d6\u6cbb\u7642\u671f\u9593\u3068\u6cbb\u7642\u7d42\u4e86\u7406\u7531\u306e\u8abf\u67fb <\/td>\n \u7b2c9\u56de\u65e5\u672c\u7de9\u548c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u8302\u898b\u831c\u91cc\u3001\u677e\u5143\u4e00\u660e\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u897f\u9806\u4e00\u90ce <\/td>\n \u5f53\u9662ICU\u306b\u304a\u3051\u308b\u7dd1\u81bf\u83cc\u85ac\u5264\u611f\u53d7\u6027\u7387\u3068\u6297\u83cc\u85ac\u4f7f\u7528\u91cf\u306e\u95a2\u9023\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n \u7b2c63\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8fd1\u85e4\u667a\u5b50, \u8fd1\u85e4\u60a0\u5e0c, \u5fa1\u624b\u6d17\u8299\u7f8e, \u5165\u5009\u5145, \u77f3\u585a\u6d0b\u4e00, \u6b66\u7530\u6cf0\u751f, \u5165\u6c5f\u5fb9\u7f8e <\/td>\n \u6a5f\u68b0\u7684\u4eba\u5de5\u63db\u6c17\u96e2\u8131\u5f8c\u306e\u7121\u547c\u5438\u767a\u4f5c\u4e88\u9632\u306b\u5bfe\u3059\u308b\u30c6\u30aa\u30d5\u30a3\u30ea\u30f3\u88fd\u5264\u306e\u6709\u52b9\u6027\u53ca\u3073\u5b89\u5168\u6027\u306b\u95a2\u9023\u3059\u308b\u56e0\u5b50\u306e\u89e3\u6790 <\/td>\n \u7b2c42\u56de\u65e5\u672c\u5c0f\u5150\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u725b\u4e4b\u6ff5\u98a8\u898b\u3001\u68ee\u5ddd\u7531\u68a8\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u5c71\u4e0b\u516b\u91cd\u4e43\u3001\u5ca1\u5cf6\u96bc\u8f14\u3001\u65b0\u7530\u7f8e\u5948\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30d6\u30ec\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30a8\u30c8\u30dd\u30b7\u30c9\u3001\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\uff08BEP\uff09\u7642\u6cd5\u6642\u306e\u30d6\u30ec\u30aa\u30de\u30a4\u30b7\u30f3\u306b\u3088\u308b\u767a\u71b1\u306b\u5bfe\u3059\u308b\u30b9\u30c6\u30ed\u30a4\u30c9\u306e\u6291\u5236\u52b9\u679c <\/td>\n \u7b2c25\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u68ee\u5ddd\u7531\u68a8\u3001\u725b\u4e4b\u6ff5\u98a8\u898b\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u5c71\u4e0b\u516b\u91cd\u4e43\u3001\u5ca1\u5cf6\u96bc\u8f14\u3001\u65b0\u7530\u7f8e\u5948\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u5f53\u9662\u306b\u304a\u3051\u308b\u30da\u30b0\u30d5\u30a3\u30eb\u30b0\u30e9\u30b9\u30c1\u30e0\u306e\u4f7f\u7528\u7d4c\u9a13\u304a\u3088\u3073\u4ed6\u306eG-CSF\u88fd\u5264\u8ffd\u52a0\u6295\u4e0e\u306e\u52b9\u679c\u767a\u73fe\u72b6\u6cc1 <\/td>\n \u7b2c25\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b\u831c\u91cc\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u677e\u5143\u4e00\u660e\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u732a\u5ddd\u548c\u6717\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u6885\ufa11\u9756\u5f18\u3001\u7af9\u4e0b\u9b8e\u7f8e\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u5c0f\u5150\u306b\u304a\u3051\u308b\u9759\u6ce8\u30fb\u7d4c\u53e3\u30dc\u30ea\u30b3\u30ca\u30be\u30fc\u30eb\u81f3\u9069\u7528\u91cf\u306e\u691c\u8a0e <\/td>\n \u7b2c25\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6709\u99ac\u79c0\u6a39, \u8fd1\u85e4\u76f4\u6a39, \u8fd1\u85e4\u667a\u5b50, \u7530\u5d0e\u6b63\u4fe1, \u5bfa\u5143\u525b, \u6c34\u4e95\u8cb4\u8a5e, \u6e21\u9089\u9054\u4e5f <\/td>\n \u533b\u85ac\u54c1\u30ea\u30b9\u30af\u7ba1\u7406\u8a08\u753b\u306b\u5411\u3051\u305f\u75c5\u9662\u85ac\u5264\u5e2b\u306e\u88fd\u9020\u8ca9\u58f2\u5f8c\u8abf\u67fb\u652f\u63f4\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n \u5e73\u621027\u5e74\u5ea6\u65e5\u672c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u75c5\u9662\u85ac\u5c40\u5354\u8b70\u4f1a\uff0f\u5b66\u8853\u30d5\u30a9\u30fc\u30e9\u30e0 <\/td>\n<\/tr>\n
\u25cb\u9ad8\u6ff1\u548c\u5f18\uff0c\u4e8c\u5ddd\u4fca\u9686\uff0c\u5927\u5ddd\u5185\u5bff\u6c5f\uff0c\u8fd1\u85e4\u667a\u5b50\uff0c\u5bae\u5730\u4e9c\u7531\u7f8e\uff0c\u7551\u9ce5\u5f8b\u5b50\uff0c\u5c0f\u5009\u667a\u5b50\uff0c\u4e95\u4e0a\u548c\u5553\uff0c\u6709\u7530\u548c\u5fb3\uff0c\u6b66\u7530\u6cf0\u751f <\/td>\n \u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308b\u6cbb\u9a13\u85ac\u6e29\u5ea6\u7ba1\u7406\u4f53\u5236\u306e\u69cb\u7bc9\u3068\u305d\u306e\u904b\u7528\u304b\u3089\u898b\u3048\u3066\u304d\u305f\u8ab2\u984c-\u6cbb\u9a13\u5b9f\u65bd\u65bd\u8a2d\u306b\u304a\u3051\u308b\u9069\u5207\u306a\u6e29\u5ea6\u7ba1\u7406\u4f53\u5236\u3068\u306f\uff0d <\/td>\n \u7b2c36\u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u51a8\u5c71\u6210\u7ae0\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u897f\u6fa4\u7531\u7d00\u5f66\u3001\u76ca\u7530\u5c06\u543e\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n Cancer stem-like cells \u306b\u304a\u3051\u308bS100A16\u306e\u5f79\u5272 <\/td>\n \u7b2c32\u56de\u65e5\u672c\u85ac\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8fd1\u85e4\u667a\u5b50, \u4e8c\u5ddd\u4fca\u9686, \u5927\u5ddd\u5185\u5bff\u6c5f, \u9ad9\u6ff1\u548c\u5f18, \u5bae\u5730\u4e9c\u7531\u7f8e, \u7551\u9ce5\u5f8b\u5b50, \u5c0f\u5009\u667a\u5b50, \u4e95\u4e0a\u548c\u5553, \u6709\u7530\u548c\u5fb3, \u6b66\u7530\u6cf0\u751f <\/td>\n \u88fd\u85ac\u4f1a\u793e\u304b\u3089\u307f\u305f\u533b\u7642\u6a5f\u95a2\u306b\u304a\u3051\u308b\u88fd\u9020\u8ca9\u58f2\u5f8c\u8abf\u67fb\u306e\u5b9f\u614b <\/td>\n \u7b2c36\u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u9ad8\u6a4b\u6bc5\u884c\u3001\u83c5\u539f\u82f1\u8f1d\u3001\u6e80\u5c3e\u660e\u6075\u3001\u672c\u6728\u4e0b\u771f\u4e9c\u7d17\u3001\u8feb\u7530\u53cb\u7406\u3001\u4e2d\u5d8b\u6d0b\u751f\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30d7\u30ed\u30c8\u30f3\u30dd\u30f3\u30d7\u963b\u5bb3\u85ac\u304a\u3088\u3073H2\u53d7\u5bb9\u4f53\u906e\u65ad\u85ac\u306e\u4f75\u7528\u306b\u304a\u3051\u308b\u30b2\u30d5\u30a3\u30c1\u30cb\u30d6\u6cbb\u7642\u671f\u9593\u3068\u526f\u4f5c\u7528\u767a\u73fe\u72b6\u6cc1\u306e\u8abf\u67fb <\/td>\n \u65e5\u672c\u81e8\u5e8a\u816b\u760d\u85ac\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a2016 <\/td>\n<\/tr>\n
\u25cb\u677e\u7530\u7d79\u4ee3\u3001\u4e45\u571f\u7dbe\u9999\u3001\u6a4b\u53e3\u601c\u672a\u3001\u6709\u99ac\u7531\u4f73\u3001\u65b0\u7530\u7f8e\u5948\u3001\u6709\u99ac\u7d14\u5b50\u3001\u83c5\u539f\u82f1\u8f1d\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u4e95\u4e0a\u548c\u5553\u3001\u771e\u7530\u5b8f\u6a39\u3001\u6c34\u91ce\u572d\u5b50\u3001\u4e95\u4e0a\u535a\u96c5\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\u8a98\u767a\u6027\u814e\u6a5f\u80fd\u969c\u5bb3\u306b\u5bfe\u3059\u308b\u30de\u30b0\u30cd\u30b7\u30a6\u30e0\u306e\u814e\u4fdd\u8b77\u4f5c\u7528\u306b\u95a2\u3059\u308b\u524d\u5411\u304d\u7814\u7a76 <\/td>\n \u65e5\u672c\u81e8\u5e8a\u816b\u760d\u85ac\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a2016 <\/td>\n<\/tr>\n
\u25cb\u6709\u99ac\u7531\u4f73\u3001\u677e\u7530\u7d79\u4ee3\u3001\u725b\u4e4b\u6ff5\u98a8\u898b\u3001\u65b0\u7530\u7f8e\u5948\u3001\u83c5\u539f\u82f1\u8f1d\u3001\u6709\u99ac\u7d14\u5b50\u3001\u4e95\u4e0a\u548c\u5553\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u7d4c\u53e3\u6297\u304c\u3093\u5264\u5185\u670d\u4e2d\u5916\u6765\u60a3\u8005\u306b\u5bfe\u3059\u308bB\u578b\u809d\u708e\u30a6\u30a4\u30eb\u30b9\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u5b9f\u65bd\u5b9f\u614b\u8abf\u67fb\u3068\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u5b9f\u65bd\u7387\u5411\u4e0a\u3092\u76ee\u6307\u3057\u305f\u53d6\u308a\u7d44\u307f <\/td>\n \u65e5\u672c\u81e8\u5e8a\u816b\u760d\u85ac\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a2016 <\/td>\n<\/tr>\n
\u25cb\u4e95\u9580\u656c\u5b50\u3001\u6728\u6751\u535a\u53f2\u3001\u7530\u4e2d\u4eae\u88d5\u3001\u5409\u91ce\u3000\u5b97\u5b8f\u3001\u5ca9\u9928\u3000\u6587\u4f73\u3001\u5de5\u85e4\u3000\u6b63\u6a39\u3001\u963f\u90e8\u3000\u61b2\u4ecb\u3001\u5185\u5c71\u3000\u771f\u7406\u5b50\u3001\u77f3\u539f\u3000\u6b63\u5fd7\u3001\u65e5\u7b20\u3000\u771f\u4e00\u3001\u6cbb\u7530\u3000\u5321\u5e73\u3001\u6728\u6751\u667a\u5b50\u3001\u5e38\u53cb\u3000\u76db\u52dd\u3001\u4e95\u4e0a\u3000\u5343\u9db4\u3001\u85e4\u4e95\u3000\u5065\u53f8\u3001\u5dba\u3000\u8c4a\u6625\u3001\u5c4b\u5730\u3000\u6176\u5b50\u3001\u8352\u6728\u3000\u535a\u967d <\/td>\n \u85ac\u5b66\u90e8\u5b9f\u52d9\u5b9f\u7fd2\u306b\u304a\u3051\u308bHIV\u5b9f\u7fd2\u666e\u53ca\u306b\u5411\u3051\u3066\u306e\u691c\u8a0e <\/td>\n \u7b2c29\u56de\u65e5\u672c\u30a8\u30a4\u30ba\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a2015 <\/td>\n<\/tr>\n
\u25cb\u725b\u4e4b\u6ff5\u98a8\u898b <\/td>\n“\u85ac\u5264\u5e2b\u304c\u7e4b\u3050\u304c\u3093\u85ac\u7269\u7642\u6cd5\u306e\u5411\u4e0a\u3068\u5b9f\u8df5 \uff5e\u30c1\u30fc\u30e0\u533b\u7642\u304b\u3089\u5730\u57df\u533b\u7642\u9023\u643a\u3078\uff5e
\n \u6297\u304c\u3093\u5264\u6cbb\u7642\u4e2d\u306e\u85ac\u5264\u5e2b\u306e\u5f79\u5272” <\/td>\n		 \u65e5\u672c\u81e8\u5e8a\u816b\u760d\u85ac\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a2016 <\/td>\n<\/tr>\n<\/table><\/div>\n<\/div>\n

<\/path><\/svg><\/blocsicon> 2014\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u6b27\u6587<\/h3>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Kazuaki Matsumoto, Naoko Kanazawa, Akari Shigemi, Kazuro Ikawa, Norifumi Morikawa, Toyoyasu Kooriyama, Michiyo Orita, Hideki Kawamura, Kouichi Tokuda, Junichirou Nishi, Yasuo Takeda. <\/td>\n Factors Affecting Treatment and Recurrence of Clostridium difficile infections. <\/td>\n Biological and Pharmaceutical Bulletin <\/td>\n 37: 1811-1815 <\/td>\n<\/tr>\n
Kazuaki Matsumoto, Akari Shigemi,Ayumi Takeshita, Erika Watanabe, Yuta Yokoyama, Kazuro Ikawa, Norifumi Morikawa, Yasuo Takeda. <\/td>\n Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics. <\/td>\n Journal of Infection and Chemotherapy <\/td>\n 21; 70-73 <\/td>\n<\/tr>\n
Kazuaki Matsumoto, Akari Shigemi,Ayumi Takeshita, Erika Watanabe, Yuuta Yokoyama, Kazuro Ikawa, Norifumi Morikawa, Yasuo Takeda. <\/td>\n Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid : a dosage strategy according to the trough concentration target and renal function in adult patient. <\/td>\n International Journal of Antimicrobial Agents <\/td>\n 44: 242-247 <\/td>\n<\/tr>\n
Yuta Yokoyama, Kazuaki Matsumoto, Kazuro Ikawa, Erika Watanabe, Akari Shigemi, Yasuhiro Umezaki, Kouyou Nakamura, Keiichirou Ueno, Norifumi Morikawa, Yasuo Takeda. <\/td>\n Pharmacokinetic\/pharacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models. <\/td>\n International Journal of Antimicrobial Agents <\/td>\n 43: 547-552 <\/td>\n<\/tr>\n
Hideki Sugawara, Aiko Tominaga, Kazuhiko Inoue, Yasuo Takeda, Katsushi Yamada, Atsuro Miyata <\/td>\n Functional Characterization of Neural-restrictive Silencer Element in Mouse Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Gene Expression. <\/td>\n Journal of Molecular Neuroscience <\/td>\n 54: 526-534 <\/td>\n<\/tr>\n
Ryuji Ikeda, Yukihiko Nishizawa, Yusuke Tajitsu, Kentaro Minami, Hironori Mataki, Shogo Masuda, Tatsuhiko Furukawa, Shin-Ichi Akiyama, Katsushi Yamada, Yasuo Takeda <\/td>\n Regulation of major vault protein expression by upstream stimulating factor 1 in SW620 human colon cancer cells <\/td>\n Oncolgy Reports <\/td>\n 31: 197-201 <\/td>\n<\/tr>\n
Shigeru Oiso, Yui Takayama, Rie Nakazaki, Naoko Matsunaga, Chie Motooka, Asuka Yamamura, Ryuji Ikeda, Kazuo Nakamura, Yasuo Takeda, Hiroko Kariyazono <\/td>\n Factors involved in the cisplatin resistance of KCP 4 human epidermoid carcinoma cells <\/td>\n Oncolgy Reports <\/td>\n 31: 719-726 <\/td>\n<\/tr>\n
Jun-Ichoro Sonoda, Ryuji Ikeda, Yasutaka BabA, Keiko Narumi, Akio Kawachi, Erisa Tomishige, Kazuya Nishihara, Yasuo Takeda, Katsushi Yamada, Keizo Sato, and Toshiro Motoya <\/td>\n Green tea catechin, epigallocatechin-3-gallate, attenuates the cell viability of human non-small-cell lung cancer A549 cells via reducing Bcl-xL expression <\/td>\n Experimental and Therpeutic Medicine <\/td>\n 8: 59-63 <\/td>\n<\/tr>\n
Sho Tabata, Ryuji Ikeda, Masatatsu Yamamoto, Shunji Shimaoka, Naofumi Mukaida, Yasuo Takeda, Katsushi Yamada, Tomoyoshi Soga, Tatsuhiko Furukawa, Shin-ichi Akiyama <\/td>\n Thymidine phosphorylase activates NF\u03baB and stimulates the expression of angiogenic and metastatic factors in human cancer cells <\/td>\n Oncotarget <\/td>\n 5: 10473-10485 <\/td>\n<\/tr>\n
Yin Feng-Ting, Futagawa Toshitaka, Li Di, Ma Yan-Xia, Lu Mei-Hong, Lu Li, Li Shen, Chen Yao, Cao Yong-Jun, Yang Zara Zhuyun, Oiso Shigeru, Nishida Kentaro, Kuchiiwa Satoshi, Watanabe Kazutada, Yamada Katsushi, Takeda Yasuo, Xiao Zhi-Cheng, and Ma Quan-Hong. <\/td>\n Contactin-Associated Protein 4 Interaction with Ligand of Numb Protein X2 Modulates the Proliferation and Neuronal Differentiation of Mouse Neural Progenitor Cells <\/td>\n Stem Cells and Development <\/td>\n 24; 640-652 <\/td>\n<\/tr>\n<\/table>\n

\u8457\u66f8<\/h4>\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u66f8\u540d\uff08\u5206\u62c5\u306e\u5834\u5408\u306f+\u6a19\u984c\u540d\uff09 <\/th>\n \u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
“\u7de8\u96c6\u3000\u4e00\u822c\u793e\u56e3\u6cd5\u4eba\u3000\u65e5\u672c\u533b\u7642\u60c5\u5831\u5b66\u4f1a\u533b\u7642\u60c5\u5831\u6280\u5e2b\u80b2\u6210\u90e8\u4f1a
\n \u5206\u62c5\uff1a\u4e0b\u5802\u8597\u3000\u6a29\u6d0b” <\/td>\n		“\u533b\u7642\u60c5\u5831\u3000\u7b2c2\u7248\u3000\u533b\u5b66\u30fb\u533b\u7642\u7de8
\n 6\uff0e1\uff0e3\u3000\u85ac\u7269\u6cbb\u7642\u306b\u95a2\u3059\u308b\u57fa\u790e\u77e5\u8b58” <\/td>\n		 348-352 <\/td>\n<\/tr>\n<\/table>\n

\u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09 <\/th>\n \u6f14\u984c\u540d <\/th>\n \u767a\u8868\u5b66\u4f1a\u7b49 <\/th>\n<\/tr>\n
\u25cb\u6885\ufa11\u9756\u5f18\u3001\u677e\u5143\u4e00\u660e\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u5927\u576a\u9756\u6cbb\u3001\u6c38\u53cb\u5bdb\u4e00\u90ce\u3001\u9ad8\u6a4b\u7fa9\u535a\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f. <\/td>\n <\/td>\n \u7b2c31\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u83c5\u539f\u82f1\u8f1d\u3001\u725b\u4e4b\u6ff1\u98a8\u898b\u3001\u91cd\u6c38\u660e\u6075\u3001\u6709\u99ac\u7531\u4f73\u3001\u672c\u6728\u4e0b\u771f\u4e9c\u7d17\u3001\u8feb\u7530\u53cb\u7406\u3001\u677e\u4e0b\u683c\u53f8\u3001\u5c0f\u7389\u54f2\u53f2\u3001\u5ca9\u576a\u7b11\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30aa\u30d4\u30aa\u30a4\u30c9\u93ae\u75db\u85ac\u306b\u3088\u308b\u91cd\u7be4\u306a\u526f\u4f5c\u7528\u767a\u73fe\u306b\u95a2\u9023\u3059\u308b\u8981\u56e0\u306e\u8abf\u67fb <\/td>\n \u7b2c19\u56de\u65e5\u672c\u7de9\u548c\u533b\u7642\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b\u831c\u91cc\u3001\u677e\u5143\u4e00\u660e\u3001\u7af9\u4e0b\u9b8e\u7f8e\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n PK-PD\u306b\u57fa\u3065\u3044\u305f\u5c0f\u5150\u306b\u304a\u3051\u308b\u30ea\u30cd\u30be\u30ea\u30c9\u306e\u81f3\u9069\u7528\u91cf\u306e\u691c\u8a0e <\/td>\n \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e02014\/\u7b2c22\u56de\u30af\u30ea\u30cb\u30ab\u30eb\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u6a4b\u53e3\u601c\u672a\u3001\u8fd1\u85e4\u667a\u5b50\u3001\u5185\u6751\u5f18\u5f66\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308b\u7d4c\u53e3\u8840\u7cd6\u964d\u4e0b\u85ac\u3068\u6301\u52b9\u578b\u30a4\u30f3\u30b9\u30ea\u30f3\u306e\u4f75\u7528\u7642\u6cd5\u306e\u5b9f\u614b\u8abf\u67fb <\/td>\n \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e02014\/\u7b2c22\u56de\u30af\u30ea\u30cb\u30ab\u30eb\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u4e2d\u6751\u5b8f\u6d0b\u3001\u677e\u5143\u4e00\u660e\u3001\u8302\u898b\u831c\u91cc\u3001\u6885\ufa11\u9756\u5f18\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u897f\u9806\u4e00\u90ce\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n DOT\uff08Days of Therapy\uff09\u3092\u7528\u3044\u305f\u30ab\u30eb\u30d0\u30da\u30cd\u30e0\u7cfb\u85ac\u306e\u4f7f\u7528\u72b6\u6cc1\u306e\u8a55\u4fa1 <\/td>\n \u7b2c17\u56de\u65e5\u672c\u533b\u85ac\u54c1\u60c5\u5831\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6709\u99ac\u7531\u4f73\u3001\u65b0\u7530\u7f8e\u5948\u3001\u6709\u99ac\u7d14\u5b50\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u51e6\u65b9\u76e3\u67fb\u624b\u9806\u306e\u6539\u8a02\u306b\u3088\u308b\u304c\u3093\u5316\u5b66\u7642\u6cd5\u76e3\u67fb\u4f53\u5236\u5747\u3066\u3093\u5316\u3078\u306e\u53d6\u308a\u7d44\u307f <\/td>\n \u7b2c17\u56de\u65e5\u672c\u533b\u85ac\u54c1\u60c5\u5831\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u4e2d\u76ee\u9806\u5b50\u3001\u6df1\u6c34\u77e5\u82f1\u3001\u67f4\u7530\u7531\u9999\u91cc\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u9ad8\u30ab\u30ed\u30ea\u30fc\u8f38\u6db2\u65bd\u884c\u6642\u306b\u304a\u3051\u308b\u8102\u80aa\u4e73\u5264\u306e\u4f75\u7528\u72b6\u6cc1\u304a\u3088\u3073\u305d\u306e\u809d\u969c\u5bb3\u6291\u5236\u52b9\u679c\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e <\/td>\n \u7b2c17\u56de\u65e5\u672c\u533b\u85ac\u54c1\u60c5\u5831\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u4e2d\u5ddd\u5f69\u3001\u5e02\u6751\u30ab\u30c4\u5b50\u3001\u6298\u7530\u7f8e\u5343\u4ee3\u3001\u611f\u67d3\u30ea\u30f3\u30af\u30ca\u30fc\u30b9\u9023\u7d61\u4f1a\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u8302\u898b\u831c\u91cc\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u897f\u9806\u4e00\u90ce. <\/td>\n \u30ea\u30f3\u30af\u30ca\u30fc\u30b9\u306b\u3088\u308b\u64e6\u5f0f\u624b\u6307\u6d88\u6bd2\u5b9f\u5730\u76e3\u67fb\u306e\u53d6\u308a\u7d44\u307f\u306b\u3064\u3044\u3066 <\/td>\n \u65e5\u672c\u533b\u7642\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u5b66\u4f1a\u7b2c13\u56de\u4e5d\u5dde\u30fb\u5c71\u53e3\u9023\u5408\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5c4b\u5730\u3000\u6176\u5b50\u3001\u798f\u5ca1\u3000\u9f8d\u4e00\u3001\u4e2d\u6751\u3000\u5343\u9db4\u5b50\u3001\u5cb8\u672c\u3000\u771f\u3001\u7acb\u548c\u7530\u3000\u3068\u3082\u306d\u3001\u767e\u539f\u3000\u8b72\u6cbb\u3001\u5c71\u672c\u3000\u4f73\u4ee3\u5b50\u3001\u3000\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n \u9e7f\u5150\u5cf6\u770c\u4e0b\u306e\u75c5\u9662\u306b\u304a\u3051\u308b\u533b\u7642\u5b89\u5168\u7ba1\u7406\u4f53\u5236\u306e\u5b9f\u72b6 <\/td>\n \u533b\u7642\u85ac\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u8302\u898b\u831c\u91cc\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u677e\u5143\u4e00\u660e\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u897f\u9806\u4e00\u90ce. <\/td>\n \u91cd\u75c7\u4e0b\u80a2\u865a\u8840\u306b\u304a\u3051\u308b\u60a3\u90e8\u691c\u51fa\u83cc\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9 <\/td>\n \u7b2c84\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u53e4\u57ce\u525b\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u8302\u898b\u831c\u91cc\u3001\u4e45\u4fdd\u7530\u77e5\u6d0b\u3001\u5c71\u9060\u525b\u3001\u862d\u725f\u7530\u76f4\u5b50\u3001\u897f\u9806\u4e00\u90ce. <\/td>\n Brevibacterium casei\u306b\u3088\u308b\u4e2d\u5fc3\u9759\u8108\u30ab\u30c6\u30fc\u30c6\u30eb\u95a2\u9023\u8840\u6d41\u611f\u67d3\u306e\u5c0f\u5150\u4f8b <\/td>\n \u7b2c84\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8fd1\u85e4\u667a\u5b50, \u5185\u6751\u5f18\u5f66, \u51fa\u53e3\u5c1a\u5bff, \u4e0b\u5802\u8597\u6a29\u6d0b, \u6c60\u7530\u9f8d\u4e8c, \u897f\u5c3e\u5584\u5f66, \u6b66\u7530\u6cf0\u751f <\/td>\n \u30a4\u30f3\u30b9\u30ea\u30f3 \u30c7\u30b0\u30eb\u30c7\u30af\u304b\u3089\u30a4\u30f3\u30b9\u30ea\u30f3 \u30b0\u30e9\u30eb\u30ae\u30f3\u3078\u306e\u5909\u66f4\u306b\u3088\u308a\u4f4e\u8840\u7cd6\u304c\u9077\u5ef6\u3057\u305f2\u578b\u7cd6\u5c3f\u75c5\u306e1\u4f8b <\/td>\n \u7b2c3\u56de\u65e5\u672c\u304f\u3059\u308a\u3068\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u6297\u304c\u3093\u5264\u8010\u6027\u6a5f\u5e8f\u306e\u89e3\u660e\u3068\u81e8\u5e8a\u5fdc\u7528\u306b\u5411\u3051\u3066 <\/td>\n \u7b2c8\u56de\u6b21\u4e16\u4ee3\u3092\u62c5\u3046\u82e5\u624b\u533b\u7642\u85ac\u79d1\u5b66\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u5c4b\u5730\u3000\u6176\u5b50\u3001\u4e80\u4e4b\u5712\u3000\u5b66\u3001\u4e0b\u5802\u8597\u3000\u6a29\u6d0b\u3001\u6c60\u7530\u3000\u9f8d\u4e8c\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n \u85ac\u5b66\u90e8\u9577\u671f\u5b9f\u52d9\u5b9f\u7fd2\u306b\u304a\u3051\u308b\u75c5\u9662\u3068\u85ac\u5c40\u306e\u5171\u540c\u51e6\u65b9\u89e3\u6790\u6f14\u7fd2\u306e\u8a66\u307f <\/td>\n \u4e5d\u5dde\u5c71\u53e3\u85ac\u5b66\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6885\ufa11\u9756\u5f18\u3001\u677e\u5143\u4e00\u660e\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u5927\u576a\u9756\u6cbb\u3001\u6c38\u53cb\u5bdb\u4e00\u90ce\u3001\u9ad8\u6a4b\u7fa9\u535a\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f. <\/td>\n <\/td>\n \u7b2c67\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u897f\u5357\u90e8\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u8302\u898b\u831c\u91cc\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u6298\u7530\u7f8e\u5343\u4ee3\u3001\u4e2d\u5ddd\u5f69\u3001\u677e\u5143\u4e00\u660e\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u5c0f\u5bae\u7bc0\u90ce\u3001\u897f\u9806\u4e00\u90ce. <\/td>\n \u8853\u5f8c\u611f\u67d3\u4e88\u9632\u6297\u83cc\u85ac\u306e\u6295\u4e0e\u671f\u9593\u9069\u6b63\u5316\u306f\u6574\u5f62\u5916\u79d1\u8853\u5f8c\u9818\u57dfMRSA\u624b\u8853\u90e8\u4f4d\u611f\u67d3\u3092\u6e1b\u5c11\u3055\u305b\u308b <\/td>\n \u7b2c27\u56de\u65e5\u672c\u5916\u79d1\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6b66\u7530\u6cf0\u751f, \u6c60\u7530\u9f8d\u4e8c, \u8fd1\u85e4\u667a\u5b50 <\/td>\n“\u6211\u304c\u56fd\u306b\u304a\u3051\u308b\u975e\u30a2\u30eb\u30b3\u30fc\u30eb\u6027\u8102\u80aa\u6027\u809d\u75be\u60a3\uff08NAFLD\uff09\u306e\u73fe\u72b6\u3068\u5c06\u6765\u5c55\u671b\u2015\u81e8\u5e8a\u30fb\u57fa\u790e\u7814\u7a76\u304b\u3089\u85ac\u7269\u6cbb\u7642\u304a\u3088\u3073\u85ac\u5264\u5e2b\u6d3b\u52d5\u3078\u306e\u30d5\u30a3\u30fc\u30c9\u30d0\u30c3\u30af\u2015
\n \u30a4\u30f3\u30af\u30ec\u30c1\u30f3\u95a2\u9023\u85ac\u306e NAFLD\/NASH \u6cbb\u7642\u3078\u306e\u5fdc\u7528” <\/td>\n		 \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c135\u56de\u5e74\u4f1a <\/td>\n<\/tr>\n<\/table><\/div>\n<\/div>\n

<\/path><\/svg><\/blocsicon> 2013\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u6b27\u6587<\/h3>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Kazuaki Matsumoto, Naoko Kanazawa, Erika Watanabe, Yuta Yokoyama, Tomohide Fukamizu, Yoshihiro Shimodozono, Chiharu Maeda, Tomotsugu Yasuda, Yasuyuki Kakihana, Kazuro Ikawa, Norifumi Morikawa, Yasuo Takeda. <\/td>\n Development of initial loading procedure for teicoplanin in critically ill patients with severe infections. <\/td>\n Biological and Pharmaceutical Bulletin <\/td>\n 36: 1024-1026 <\/td>\n<\/tr>\n
Kazuaki Matsumoto, Yoshio Takesue, Norio Ohmagari, Takahiro Mochizuki, Hiroshige Mikamo, Masafumi Seki, Shunji Takakura, Issei Tokimatsu, Yoshiko Takahashi, Kei Kasahara, Kenji Okada, Masahiro Igarashi, Masahiro Kobayashi, Yukihiro Hamada, Masao Kimura, Yoshifumi Nishi, Yusuke Tanigawara, Toshimi Kimura. <\/td>\n Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. <\/td>\n Journal of Infection and Chemotherapy <\/td>\n 19: 365-380 <\/td>\n<\/tr>\n
Yukihiro Hamada, Issei Tokimatsu, Hiroshige Mikamo, Masao Kimura, Masafumi Seki, Shunji Takakura, Norio Ohmagari, Yoshiko Takahashi, Kei Kasahara, Kazuaki Matsumoto, Kenji Okada, Masahiro Igarashi, Masahiro Kobayashi,Takahiro Mochizuki, Yoshifumi Nishi, Yusuke Tanigawara, Toshimi Kimura, Yoshio Takesue. <\/td>\n Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. <\/td>\n Journal of Infection and Chemotherapy <\/td>\n 19: 381-392 <\/td>\n<\/tr>\n
Kenji Okada, Toshimi Kimura, Hiroshige Mikamo, Kei Kasahara, Masafumi Seki, Shunji Takakura, Issei Tokimatsu, Norio Ohmagari, Yoshiko Takahashi, Kazuaki Matsumoto, Masahiro Igarashi, Masahiro Kobayashi, Yukihiro Hamada, Takahiro Mochizuki, Masao Kimura, Yoshifumi Nishi, Yusuke Tanigawara, Yoshio Takesue. <\/td>\n Clinical practice guidelines for therapeutic drug monitoring of arbekacin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. <\/td>\n Journal of Infection and Chemotherapy <\/td>\n <\/td>\n<\/tr>\n
Yusuke Tajitsu, Ryuji Ikeda, Yukihiko Nishizawa, Hirofumi Mataki, Xiao-Fang Che, Tomoyuki Sumizawa, Mina Nitta, Tatsuya Yamaguchi, Masatatsu Yamamot, Sho Tabata, Shin-ichi Akiyama, Katsushi Yamada, Tatsuhiko Furukawa, and Yasuo Takeda <\/td>\n Molecular basis for the expression of major vault protein induced by hyperosmotic stress in SW620 human colon cancer cells <\/td>\n International Journal of Molecular Medicine <\/td>\n 32(3):703-8 <\/td>\n<\/tr>\n
Ryuji Ikeda, Yukihiko Nishizawa, Yusuke Tajitsu, Kentaro Minami, Hironori Mataki, Shogo Masuda, Tatsuhiko Furukawa, Shin-Ichi Akiyama, Katsushi Yamada, Yasuo Takeda <\/td>\n Regulation of major vault protein expression by upstream stimulating factor 1 in SW620 human colon cancer cells <\/td>\n Oncology Reports <\/td>\n 31(1):197-201. <\/td>\n<\/tr>\n
Ryuji Ikeda, Sho Tabata, Yusuke Tajitsu, Yukihiko Nishizawa, Kentaro Minami, Tatsuhiko Furukawa, Masatatsu Yamamoto, Yoshinari Shinsato, Shin-Ichi Akiyama, Katsushi Yamada, Yasuo Takeda <\/td>\n Molecular basis for the regulation of hypoxia-inducible factor-1\u03b1 levels by 2-deoxy-D-ribose. <\/td>\n Oncology Reports <\/td>\n 30(3):1444-8 <\/td>\n<\/tr>\n
Jia Wang, Ryuji Ikeda, Xiao-Fang Che, Akio Ooyama, Masatatsu Yamamoto, Tatsuhiko Furukawa, Kazuhisa Hasui, Chun-Lei Zheng, Yusuke Tajitsu, Toshinori Oka, Sho Tabata, Yukihiko Nishizawa, Yoshito Eizuru, Shin-Ichi Akiyama <\/td>\n VEGF expression is augmented by hypoxia\u2011induced PGIS in human fibroblasts. <\/td>\n Int J Oncol <\/td>\n 43(3):746-54 <\/td>\n<\/tr>\n
Hiroki Saito, Tomoya Nakamachi, Kazuhiko Inoue, Ryuji Ikeda, Kazuo Kitamura, Naoto Minamino, Seiji Shioda, and Atsuro Miyata <\/td>\n Autocrine effects of neuromedin B stimulate the proliferation of rat primary osteoblasts. <\/td>\n J Endocrinol <\/td>\n 217(2):141-50 <\/td>\n<\/tr>\n
Yoshinari Shinsato, Tatsuhiko Furukawa, Shunji Yunoue, Hajime Yonezawa, Kentarou Minami, Yukihiko Nishizawa, Ryuji Ikeda, Kohichi Kawahara, Masatatsu Yamamoto, Hirofumi Hirano, Hiroshi Tokimura, and Kazunori Arita <\/td>\n Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma. <\/td>\n Oncotarget <\/td>\n 4(12):2212-2224 <\/td>\n<\/tr>\n
Mariko Tamai, Shigeto Matsushita, Hiroaki Miyanohara, Naoko Imuta, Ryuji Ikeda, Kazuhiro Kawai, Junichiro Nishi, Akihiro Sakamoto, Takanori Shigihara, Takuro Kanekura <\/td>\n Antimicrobial effect of an ultrasonic levitation washer disinfector with silver electrolysis and ozone oxidation on methicillin-resistant Staphylococcus aureus. <\/td>\n J Dermatol <\/td>\n 40(12):1020-6 <\/td>\n<\/tr>\n
Shigeru Oiso, Yui Takayama, Rie Nakazaki, Naoko Matsunaga, Chie Motooka, Asuka Yamamura, Ryuji Ikeda, Kazuo Nakamura, Yasuo Takeda, Hiroko Kariyazono <\/td>\n Factors involved in the cisplatin resistance of KCP\u20114 human epidermoid carcinoma cells. <\/td>\n Oncology Reports <\/td>\n 31(2):719-26 <\/td>\n<\/tr>\n<\/table>\n

\u548c\u6587<\/h4>\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
\u5ddd\u6751\u82f1\u6a39, \u6298\u7530\u7f8e\u5343\u4ee3, \u4e2d\u5ddd\u5f69, \u677e\u5143\u4e00\u660e, \u8302\u898b\u831c\u91cc, \u90e1\u5c71\u8c4a\u6cf0, \u897f\u9806\u4e00\u90ce. <\/td>\n \u5927\u5b66\u75c5\u9662\u3067\u306eICT\u75c5\u68df\u30e9\u30a6\u30f3\u30c9\u306b\u304a\u3051\u308b\u6307\u6458\u4e8b\u9805\u306e\u89e3\u6790. <\/td>\n \u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u8a8c <\/td>\n 28: 25-28 <\/td>\n<\/tr>\n
\u5ba4\u9ad8\u5e83, \u5317\u539f\u9686\u5fd7, \u4f0a\u6771\u5f18\u6a39, \u5165\u6c5f\u5229\u884c, \u91ce\u4e2d\u654f\u6cbb, \u85e4\u4e95\u88d5\u53f2, \u677e\u5143\u4e00\u660e, \u5c71\u5d0e\u535a\u53f2, \u67f3\u539f\u514b\u7d00, \u4f50\u3005\u6728\u5747. <\/td>\n \u4e5d\u5dde\u5c71\u53e3\u5730\u533a\u306b\u304a\u3051\u308b\u57fa\u8cea\u62e1\u5f35\u578b\u03b2\u30e9\u30af\u30bf\u30de\u30fc\u30bc\u7523\u751f\u83cc\u306e\u691c\u51fa\u72b6\u6cc1\u3068\u6297\u83cc\u85ac\u4f7f\u7528\u72b6\u6cc1\u306b\u95a2\u3059\u308b\u5408\u540c\u8abf\u67fb. <\/td>\n \u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u8a8c <\/td>\n 29: 32-39 <\/td>\n<\/tr>\n<\/table>\n

\u8457\u66f8<\/h4>\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u66f8\u540d\uff08\u5206\u62c5\u306e\u5834\u5408\u306f+\u6a19\u984c\u540d\uff09 <\/th>\n \u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
“\u7de8\u96c6\u3000\u4e00\u822c\u793e\u56e3\u6cd5\u4eba\u3000\u65e5\u672c\u533b\u7642\u60c5\u5831\u5b66\u4f1a\u533b\u7642\u60c5\u5831\u6280\u5e2b\u80b2\u6210\u90e8\u4f1a
\n \u5206\u62c5\uff1a\u4e0b\u5802\u8597\u3000\u6a29\u6d0b” <\/td>\n		“\u533b\u7642\u60c5\u5831\u3000\u7b2c2\u7248\u3000\u533b\u5b66\u30fb\u533b\u7642\u7de8
\n 6\uff0e1\uff0e3\u3000\u85ac\u7269\u6cbb\u7642\u306b\u95a2\u3059\u308b\u57fa\u790e\u77e5\u8b58” <\/td>\n		 348-352 <\/td>\n<\/tr>\n<\/table>\n

\u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09 <\/th>\n \u6f14\u984c\u540d <\/th>\n \u767a\u8868\u5b66\u4f1a\u7b49 <\/th>\n<\/tr>\n
\u25cb\u6885\ufa11\u9756\u5f18\u3001\u677e\u5143\u4e00\u660e\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u5927\u576a\u9756\u6cbb\u3001\u6c38\u53cb\u5bdb\u4e00\u90ce\u3001\u9ad8\u6a4b\u7fa9\u535a\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f. <\/td>\n \u7dd1\u81bf\u83cc\u306b\u3088\u308b\u30de\u30a6\u30b9\u5927\u817f\u90e8\u611f\u67d3\u30e2\u30c7\u30eb\u3092\u7528\u3044\u305f\u30d1\u30ba\u30d5\u30ed\u30ad\u30b5\u30b7\u30f3\u306epharmacokinetics – pharmacodynamics\uff08PK-PD\uff09\u30d1\u30e9\u30e1\u30fc\u30bf\u306e\u540c\u5b9a. <\/td>\n \u7b2c30\u56de\u65e5\u672c\u85ac\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u85fa\u725f\u7530\u76f4\u5b50\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u677e\u5143\u4e00\u660e\u3001\u8302\u898b\u831c\u91cc\u3001\u897f\u9806\u4e00\u90ce. <\/td>\n MRSA\u611f\u67d3\u75c7\u30a2\u30a6\u30c8\u30d6\u30ec\u30a4\u30af\u7591\u3044\u4e8b\u4f8b\u306b\u304a\u3051\u308bPOT\u6cd5\u3068PFGE\u6cd5\u306b\u3088\u308b\u907a\u4f1d\u5b50\u30bf\u30a4\u30d4\u30f3\u30b0\u306e\u6bd4\u8f03. <\/td>\n \u7b2c87\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff0f\u7b2c61\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ba4\u9ad8\u5e83\u3001\u5317\u539f\u9686\u5fd7\u3001\u4f0a\u6771\u5f18\u6a39\u3001\u5165\u6c5f\u5229\u884c\u3001 \u91ce\u4e2d\u654f\u6cbb\u3001\u85e4\u4e95\u88d5\u53f2\u3001\u677e\u5143\u4e00\u660e\u3001\u5c71\u5d0e\u535a\u53f2\u3001\u67f3\u539f\u514b\u7d00\u3001\u4f50\u3005\u6728\u5747. <\/td>\n \u4e5d\u5dde\u5c71\u53e3\u5730\u533a\u306b\u304a\u3051\u308b\u57fa\u8cea\u62e1\u5f35\u578b\u03b2\u30e9\u30af\u30bf\u30de\u30fc\u30bc\u7523\u751f\u83cc\u306e\u691c\u51fa\u72b6\u6cc1\u3068\u6297\u83cc\u85ac\u4f7f\u7528\u72b6\u6cc1\u306b\u95a2\u3059\u308b\u5408\u540c\u8abf\u67fb. <\/td>\n \u7b2c87\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff0f\u7b2c61\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6a2a\u5c71\u96c4\u592a\u3001\u677e\u5143\u4e00\u660e\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u8302\u898b\u831c\u91cc\u3001\u6885\ufa11\u9756\u5f18\u3001\u4e2d\u6751\u5b8f\u6d0b\u3001\u4e0a\u91ce\u6842\u4e00\u90ce\u3001\u5965\u91ce\u771f\u7406\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f. <\/td>\n Acinetobacter baumannii\u306b\u3088\u308b\u30de\u30a6\u30b9\u80ba\u708e\u30e2\u30c7\u30eb\u3092\u7528\u3044\u305fSulbactam\u306e\u90e8\u4f4d\u7279\u7570\u7684PK-PD\u89e3\u6790. <\/td>\n \u7b2c30\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6a2a\u5c71\u96c4\u592a\u3001\u677e\u5143\u4e00\u660e\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u8302\u898b\u831c\u91cc\u3001\u6885\ufa11\u9756\u5f18\u3001\u7af9\u4e0b\u9b8e\u7f8e\u3001\u4e2d\u6751\u5b8f\u6d0b\u3001\u5965\u91ce\u771f\u7406\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f. <\/td>\n Acinetobacter baumannii\u611f\u67d3\u75c7\u306b\u5bfe\u3059\u308bPK-PD\u306b\u57fa\u3065\u3044\u305fSulbactam\u306e\u6295\u4e0e\u6cd5\u306e\u78ba\u7acb. <\/td>\n \u7b2c30\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6df1\u6c34\u77e5\u82f1\u3001\u67f4\u7530\u7531\u9999\u91cc\u3001\u4e2d\u76ee\u9806\u5b50\u3001\u677e\u5143\u4e00\u660e\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f. <\/td>\n \u8102\u80aa\u4e73\u5264\u6295\u4e0e\u901f\u5ea6\u306e\u76e3\u67fb\u610f\u7fa9\u306b\u3064\u3044\u3066. <\/td>\n \u7b2c23\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b\u831c\u91cc\u3001\u677e\u5143\u4e00\u660e\u3001\u7af9\u4e0b\u9b8e\u7f8e\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f. <\/td>\n \u30ea\u30cd\u30be\u30ea\u30c9\u306b\u3088\u308b\u8840\u5c0f\u677f\u6e1b\u5c11\u3092\u56de\u907f\u3059\u308b\u305f\u3081\u306e\u30c8\u30e9\u30d5\u6fc3\u5ea6\u57df\u306e\u89e3\u660e. <\/td>\n \u7b2c26\u56de\u65e5\u672c\u5916\u79d1\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u8302\u898b\u831c\u91cc\u3001\u6298\u7530\u7f8e\u5343\u4ee3\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u677e\u5143\u4e00\u660e\u3001\u51a8\u6c38\u535a\u4e4b\u3001\u5c0f\u5bae\u7bc0\u90ce\u3001\u897f\u9806\u4e00\u90ce. <\/td>\n \u6574\u5f62\u5916\u79d1\u9818\u57df\u306b\u304a\u3051\u308b\u7a4d\u6975\u7684\u76e3\u8996\u57f9\u990a\u3068\u63a5\u89e6\u611f\u67d3\u4e88\u9632\u7b56\u9075\u5b88\u3092\u4e2d\u5fc3\u3068\u3057\u305fMRSA\u624b\u8853\u90e8\u4f4d\u611f\u67d3\u5bfe\u7b56\u306e\u52b9\u679c. <\/td>\n \u7b2c26\u56de\u65e5\u672c\u5916\u79d1\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u8302\u898b\u831c\u91cc\u3001\u6298\u7530\u7f8e\u5343\u4ee3\u3001\u4e2d\u5ddd\u5f69\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u677e\u5143\u4e00\u660e\u3001\u897f\u9806\u4e00\u90ce. <\/td>\n \u7a4d\u6975\u7684\u76e3\u8996\u57f9\u990a\u3068\u63a5\u89e6\u4e88\u9632\u7b56\u9075\u5b88\u3092\u4e2d\u5fc3\u3068\u3057\u305f\u6574\u5f62\u5916\u79d1\u9818\u57dfMRSA\u624b\u8853\u90e8\u4f4d\u611f\u67d3\u5bfe\u7b56\u306e\u52b9\u679c. <\/td>\n \u7b2c29\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6298\u7530\u7f8e\u5343\u4ee3\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u677e\u5143\u4e00\u660e\u3001\u8302\u898b\u831c\u91cc\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u897f\u9806\u4e00\u90ce. <\/td>\n MRSA\u306b\u3088\u308b\u624b\u8853\u90e8\u4f4d\u611f\u67d3\u767a\u75c7\u306b\u4f34\u3046\u533b\u7642\u30b3\u30b9\u30c8\u3078\u306e\u5f71\u97ff\u306b\u3064\u3044\u3066. <\/td>\n \u7b2c29\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6298\u7530\u7f8e\u5343\u4ee3\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u677e\u5143\u4e00\u660e\u3001\u8302\u898b\u831c\u91cc\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u897f\u9806\u4e00\u90ce\u3001\u53d6\u9644\u3000\u548c\u6210. <\/td>\n \u9023\u643a\u65bd\u8a2d\u3067\u306e\u30a2\u30a6\u30c8\u30d6\u30ec\u30a4\u30af\u4e8b\u4f8b\u306b\u5bfe\u3059\u308b\u75c5\u68df\u30e9\u30a6\u30f3\u30c9\u3068\u75c5\u9662\u306e2\u6b21\u611f\u67d3\u9632\u6b62\u7b56. <\/td>\n \u7b2c29\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u8302\u898b\u831c\u91cc\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u677e\u5143\u4e00\u660e\u3001\u4e2d\u6751\u5065\u592a\u90ce\u3001\u5b89\u7530\u667a\u55e3\u3001\u897f\u9806\u4e00\u90ce. <\/td>\n \u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662ICU\u306b\u304a\u3051\u308bMRSA\u30fb\u8010\u6027\u7dd1\u81bf\u83cc\u30b5\u30fc\u30d9\u30a4\u30e9\u30f3\u30b9. <\/td>\n \u7b2c61\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a\/\u7b2c56\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a\/\u7b2c83\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cbYuta Yokoyama, Kazuaki Matsumoto, Erika Watanabe, Akari Shigemi, Yasuhiro Umezaki, Ayumi Takeshita, Koyo Nakamura, Mari Okuno, Kazuro Ikawa, Norifumi Morikawa, Yasuo Takeda. <\/td>\n Pharmacokinetic and pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in a murine thigh infection model. <\/td>\n 28th International Congress of Chemotherapy and Infection <\/td>\n<\/tr>\n
\u25cbHideki Kawamura, Akari Shigemi, Toyoyasu Koriyama, Kazuaki Matsumoto, Michiyo Orita, Setsuro Komiya, Koichi Tokuda, Junichiro Nishi. <\/td>\n Effects of Care Bundle for Preventing Orthopedic Methicillin-resistant Staphylococcus aureus (MRSA) Surgical Site Infections (SSI). <\/td>\n 51th Annual Meeting of the Infectious Diseases Society of America <\/td>\n<\/tr>\n
\u25cb\u677e\u5143\u4e00\u660e <\/td>\n“\u30b7\u30f3\u30dd\u30b8\u30a6\u30e04\uff1a\u6297\u83cc\u5316\u5b66\u7642\u6cd5\u8a8d\u5b9a\u85ac\u5264\u5e2b\u306e\u6d3b\u52d5\u3068\u5c06\u6765\u50cf
\n \u73fe\u5834\u3067\u6307\u5c0e\u3059\u308b\u7acb\u5834\u306e\u85ac\u5264\u5e2b\u304b\u3089.” <\/td>\n		 \u7b2c61\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a\/\u7b2c56\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a\/\u7b2c83\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u677e\u5143\u4e00\u660e <\/td>\n“\u30df\u30cb\u30ec\u30af\u30c1\u30e3\u30fc2\uff1a\u6297MRSA\u85ac\u9069\u6b63\u4f7f\u7528
\n \u30d0\u30f3\u30b3\u30de\u30a4\u30b7\u30f3\u30fb\u30c6\u30a4\u30b3\u30d7\u30e9\u30cb\u30f3.” <\/td>\n		 \u7b2c26\u56de\u65e5\u672c\u5916\u79d1\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u677e\u5143\u4e00\u660e <\/td>\n“\u6559\u80b2\u8b1b\u6f141
\n \u6297MRSA\u85ac\u306eTDM Up to Date.” <\/td>\n		 \u7b2c30\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u677e\u5143\u4e00\u660e\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u6885\ufa11\u9756\u5f18\u3001\u4e2d\u6751\u5b8f\u6d0b\u3001\u5965\u91ce\u771f\u7406\u3001\u4e0a\u91ce\u6842\u4e00\u90ce\u3001\u8302\u898b\u831c\u91cc\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n MRSA\u611f\u67d3\u30de\u30a6\u30b9\u30e2\u30c7\u30eb\u3092\u7528\u3044\u305f\u30c6\u30a4\u30b3\u30d7\u30e9\u30cb\u30f3\u306ePK-PD\u89e3\u6790 <\/td>\n \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c134\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u67f4\u7530\u7531\u9999\u91cc\u3001\u6df1\u6c34\u77e5\u82f1\u3001\u798f\u7530\u3086\u304b\u308a\u3001\u7530\u4e2d\u7766\u7f8e\u3001\u51fa\u53e3\u5c1a\u5bff\u3001\u5927\u8107\u54f2\u6d0b <\/td>\n \u30a8\u30ec\u30f3\u30bf\u30fc\u30eb\u914d\u5408\u5185\u7528\u5264\u306e\u300c\u6c34\u3067\u4f5c\u308c\u308b\u30bc\u30ea\u30fc\u30df\u30c3\u30af\u30b9\u300d\u3092\u7528\u3044\u305f\u30bc\u30ea\u30fc\u5316\u306e\u5fdc\u7528 <\/td>\n \u7b2c29\u56de\u65e5\u672c\u9759\u8108\u7d4c\u8178\u6804\u990a\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u7530\u5be6\u88d5\u4ecb\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u897f\u6fa4\u7531\u7d00\u5f66\u3001\u5c71\u53e3\u8fb0\u54c9\u3001\u5c71\u672c\u96c5\u9054\u3001\u7530\u7551\u7965\u3001\u79cb\u5c71\u4f38\u4e00\u3001\u5c71\u7530\u52dd\u58eb\u3001\u53e4\u5ddd\u9f8d\u5f66\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u9ad8\u6d78\u900f\u5727\u306b\u3088\u3063\u3066\u8a98\u5c0e\u3055\u308c\u308b Major vault protein (MVP)\u306e\u767a\u73fe\u4ea2\u9032\u6a5f\u5e8f <\/td>\n \u7b2c86\u56de\u65e5\u85ac\u7406\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6c60\u7530\u9f8d\u4e8c <\/td>\n“\u304c\u3093\u6cbb\u7642\u306e\u6700\u5148\u7aef-\u57fa\u790e\u3068\u81e8\u5e8a\u304b\u3089-
\n \u6297\u304c\u3093\u5264\u6cbb\u7642\u306b\u304a\u3051\u308b\u73fe\u72b6\u3068\u554f\u984c\u70b9” <\/td>\n		 \u7b2c30\u56de\u65e5\u672c\u85ac\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6c60\u7530\u9f8d\u4e8c\u3001\u897f\u6fa4\u7531\u7d00\u5f66\u3001\u7530\u5be6\u88d5\u4ecb\u3001\u53e4\u5ddd\u9f8d\u5f66\u3001\u5c71\u7530\u52dd\u58eb\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n Vault \u306e\u9ad8\u6d78\u900f\u5727\u8010\u6027\u5316\u6a5f\u69cb <\/td>\n \u7b2c66\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u897f\u5357\u90e8\u4f1a <\/td>\n<\/tr>\n
\u25cbRyuji Ikeda, Yukihiko Nishizawa, Yusuke Tajitsu, Katsushi Yamada, Yasuo Takeda <\/td>\n Molecular basis for the regulation of hypoxia-inducible factor-1alpha level by 2-deoxy-D-ribose <\/td>\n \u7b2c\uff17\u56de\u6b21\u4e16\u4ee3\u3092\u62c5\u3046\u82e5\u624b\u533b\u7642\u85ac\u79d1\u5b66\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u7551\u9ce5\u5f8b\u5b50\u3001\u8fd1\u85e4\u667a\u5b50\u3001\u4e8c\u5ddd\u4fca\u9686\u3001\u5927\u5ddd\u5185\u5bff\u6c5f\u3001\u9ad9\u6ff1\u548c\u5f18\u3001\u4e0b\u5712\u307f\u3086\u304d\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f\u3001\u6709\u7530\u548c\u5fb3 <\/td>\n \u30d0\u30a4\u30bf\u30eb\u30b5\u30a4\u30f3\u306b\u304a\u3051\u308bALCOA\u539f\u5247\u306b\u57fa\u3065\u3044\u305f\u539f\u8cc7\u6599\u4f5c\u6210\u3078\u306e\u53d6\u308a\u7d44\u307f <\/td>\n \u7b2c13\u56deCRC\u3068\u81e8\u5e8a\u8a66\u9a13\u306e\u3042\u308a\u65b9\u3092\u8003\u3048\u308b\u4f1a\u8b70 <\/td>\n<\/tr>\n
\u25cb\u5fa1\u624b\u6d17\u8299\u7f8e\u3001\u8fd1\u85e4\u667a\u5b50\u3001\u6b66\u7530\u6cf0\u751f\u3001\u5165\u5009\u5145\u3001\u77f3\u585a\u6d0b\u4e00\u3001\u5165\u6c5f\u5fb9\u7f8e <\/td>\n \u6a5f\u68b0\u7684\u4eba\u5de5\u63db\u6c17\u96e2\u8131\u5f8c\u306e\u672a\u719f\u5150\u7121\u547c\u5438\u767a\u4f5c\u4e88\u9632\u306b\u5bfe\u3059\u308b\u30c6\u30aa\u30d5\u30a3\u30ea\u30f3\u88fd\u5264\u306e\u6709\u52b9\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n \u7b2c40\u56de\u65e5\u672c\u5c0f\u5150\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u76ca\u7530 \u5c06\u543e\u3001\u4e8c\u5ddd \u4fca\u9686\u3001\u5c71\u53e3 \u6c99\u7e54\u3001\u5c71\u7530 \u52dd\u58eb\u3001\u6c60\u7530 \u9f8d\u4e8c\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n Caspr1\u306fJNK\u30b7\u30b0\u30ca\u30eb\u4f9d\u5b58\u6027\u306e\u30b0\u30ea\u30aa\u30d6\u30e9\u30b9\u30c8\u30fc\u30de\u7d30\u80de\u306e\u6d78\u6f64\u3092\u8ca0\u306b\u5236\u5fa1\u3059\u308b <\/td>\n \u7b2c66\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u897f\u5357\u90e8\u4f1a <\/td>\n<\/tr>\n
\u25cb\u76ca\u7530 \u5c06\u543e\u3001\u4e8c\u5ddd \u4fca\u9686\u3001\u5c71\u53e3 \u6c99\u7e54\u3001\u5c71\u7530 \u52dd\u58eb\u3001\u6c60\u7530 \u9f8d\u4e8c\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u795e\u7d4c\u63a5\u7740\u95a2\u9023\u5206\u5b50Caspr1\u306f\u30b0\u30ea\u30aa\u30d6\u30e9\u30b9\u30c8\u30fc\u30de\u7d30\u80de\u306e\u6d78\u6f64\u3092\u8abf\u7bc0\u3059\u308b <\/td>\n \u7b2c26\u56de\u3000\u9e7f\u5150\u5cf6\u30d6\u30ec\u30a4\u30f3\u30b5\u30a4\u30a8\u30f3\u30b9\u30ab\u30f3\u30d5\u30a1\u30e9\u30f3\u30b9 <\/td>\n<\/tr>\n
\u25cb\u76ca\u7530 \u5c06\u543e\u3001\u4e8c\u5ddd \u4fca\u9686\u3001\u5c71\u53e3 \u6c99\u7e54\u3001\u5c71\u7530 \u52dd\u58eb\u3001\u6c60\u7530 \u9f8d\u4e8c\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u795e\u7d4c\u63a5\u7740\u95a2\u9023\u5206\u5b50 Caspr1 \u306f MMP-9 \u306e\u767a\u73fe\u4f4e\u4e0b\u3092\u4ecb\u3057\u3066\u30b0\u30ea\u30aa\u30fc\u30de\u7d30\u80de\u306e\u6d78\u6f64\u3092\u6291\u5236\u3059\u308b <\/td>\n \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c133\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5c4b\u5730\u3000\u6176\u5b50\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u4e0b\u5802\u5712\u3000\u6a29\u6d0b\u3001\u7530\u5ddd\u3000\u307e\u3055\u307f\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u85ac\u5b66\u5b9f\u52d9\u5b9f\u7fd2\u751f\u3068\u533b\u5b66\u90e8\u751f\u306b\u3088\u308b\u30c1\u30fc\u30e0\u533b\u7642\u5b9f\u7fd2\u306e\u8a66\u307f\u3068\u305d\u306e\u52b9\u679c <\/td>\n \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c134\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6709\u99ac\u3000\u7531\u4f73\u3001\u6709\u99ac\u3000\u7d14\u5b50\u3001\u65b0\u7530\u3000\u7f8e\u5948\u3001\u4e0b\u5802\u8597\u3000\u6a29\u6d0b\u3001\u6c60\u7530\u3000\u9f8d\u4e8c\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n \u51e6\u65b9\u76e3\u67fb\u624b\u9806\u66f8\u3068\u6297\u304c\u3093\u5264\u30c1\u30a7\u30c3\u30af\u30ea\u30b9\u30c8\u306e\u5c0e\u5165\u306b\u3088\u308b\u304c\u3093\u5316\u5b66\u7642\u6cd5\u76e3\u67fb\u4f53\u5236\u5747\u3066\u3093\u5316\u3078\u306e\u53d6\u308a\u7d44\u307f <\/td>\n \u65e5\u672c\u81e8\u5e8a\u816b\u760d\u85ac\u5b66\u4f1a\u3000\u5b66\u8853\u5927\u4f1a2014 <\/td>\n<\/tr>\n<\/table><\/div>\n<\/div>\n

<\/path><\/svg><\/blocsicon> 2012\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u6b27\u6587<\/h3>\n
\n\n\n\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Kazuaki Matsumoto, Akari Shigemi, Keiko Yaji, Yoshihiro Shimodozono, Yasuo Takeda, Kazuro Ikawa, Norifumi Morikawa, Hiroaki Miyanohara, Hideki Kawamura, Michiyo Orita, Koichi Tokuda, Junichiro Nishi, Katsushi Yamada. <\/td>\n Reduction in the incidence of MRSA with use of alcohol-based hand rub solutions and gloves <\/td>\n Journal of Infection and Chemotherapy <\/td>\n 18:269-271 <\/td>\n<\/tr>\n
Yuta Yokoyama, Kazuaki Matsumoto, Hiroyuki Yamamoto, Yoshifumi Iguro, Yutaka Imoto, Kazuro Ikawa, Norifumi Morikawa, Shiro Ishida, Yoshiro Okano, Erika Watanabe, Yoshihiro Shimodozono, Katsushi Yamada, Yasuo Takeda. <\/td>\n Pharmacokinetics of ampicillin-sulbactam and the renal function-based optimization of dosing regimens for prophylaxis in patients undergoing cardiovascular surgery <\/td>\n Journal of Infection and Chemotherapy <\/td>\n 18:878-882 <\/td>\n<\/tr>\n
Tomoko Somekawa-Kondo, Keitaro Yamaguchi, Yoichi Ishitsuka, Sachiko Ito, Kaori Tanaka, Mitsuru Irikura, Hiroshi Moriuchi, Kazuo Takahama, Yukio Ando, Toshio Yamasaki, Tetsumi Irie <\/td>\n Aminophylline, administered at usual doses for rodents in pharmacological studies, induces hippocampal neuronal cell injury under low tidal volume hypoxic conditions in guinea-pigs <\/td>\n Journal of Pharmacy and Pharmacology <\/td>\n 65:102-114 <\/td>\n<\/tr>\n
Shigeru Oiso, Ryuji Ikeda, Kazuo Nakamura, Yasuo Takeda, Shin-Ichi Akiyama, Hiroko Kariyazono <\/td>\n Involvement of NF-\u03baB activation in the cisplatin resistance of human epidermoid carcinoma KCP-4 cells <\/td>\n Oncology Reports <\/td>\n 28: 895-902 <\/td>\n<\/tr>\n
Sho Tabata, Ryuji Ikeda, Masatatu Yamamoto, Tatsuhiko Furukawa, Takuya Kuramoto, Yasuo Takeda, Katsushi Yamada, Misako Haraguchi, Yasuhiko Nishioka, Saburo Sone, Shin-Ichi Akiyama <\/td>\n Thymidine phosphorylase enhances reactive oxygen species generation and interleukin-8 expression in human cancer cells <\/td>\n Oncology Reports <\/td>\n 28\uff1a895-902 <\/td>\n<\/tr>\n
“Shigeto Matsushita, Ryuji Ikeda, Tomoko Fukushige,
\n Yusuke Tajitsu, Kanayo Gunshina, Hiroshi Okumura, Mina Ushiyama, Shin-ichi Akiyama, Kazuhiro Kawai, Yasuo Takeda, Katsushi Yamada, Takuro Kanekura” <\/td>\n		 p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells <\/td>\n Journal of Dermatological Science <\/td>\n 68\uff1a19\u201324 <\/td>\n<\/tr>\n<\/table>\n

\u548c\u6587<\/h4>\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
\u9ad9\u5009\u4fca\u4e8c\u3001\u7af9\u672b\u82b3\u751f\u3001\u5927\u66f2\u8cb4\u592b\u3001\u7b20\u539f\u656c\u3001\u95a2\u96c5\u6587\u3001\u9ad8\u6a4b\u4f73\u5b50\u3001\u6642\u677e\u4e00\u6210\u3001\u677e\u5143\u4e00\u660e\u3001\u4e09\u9d28\u5ee3\u7e41 <\/td>\n \u30c6\u30a4\u30b3\u30d7\u30e9\u30cb\u30f3\u306b\u304a\u3051\u308b\u8840\u4e2d\u30c8\u30e9\u30d5\u6fc3\u5ea620\u03bcg\/mL\u4ee5\u4e0a\u306e\u81e8\u5e8a\u7684\u52b9\u679c\u3001\u5b89\u5168\u6027 <\/td>\n \u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u96d1\u8a8c <\/td>\n 60:501-505 <\/td>\n<\/tr>\n
\u5ddd\u6751\u82f1\u6a39\u3001\u6298\u7530\u7f8e\u5343\u4ee3\u3001\u4e2d\u5ddd\u5f69\u3001\u677e\u5143\u4e00\u660e\u3001\u8302\u898b\u831c\u91cc\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u897f\u9806\u4e00\u90ce <\/td>\n \u5927\u5b66\u75c5\u9662\u3067\u306eICT\u75c5\u68df\u30e9\u30a6\u30f3\u30c9\u306b\u304a\u3051\u308b\u6307\u6458\u4e8b\u9805\u306e\u89e3\u6790 <\/td>\n \u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u8a8c <\/td>\n <\/td>\n<\/tr>\n<\/table>\n

\u8457\u66f8<\/h4>\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u66f8\u540d <\/th>\n \u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
\u8fd1\u85e4\u667a\u5b50\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n“\u533b\u85ac\u30b8\u30e3\u30fc\u30ca\u30eb 2012\u5e7412\u6708\u53f7\uff08Vol. 48 No. 12\uff09
\n \u7279\u96c6\u3000\u751f\u6d3b\u7fd2\u6163\u75c5\u3068\u3057\u3066\u306e\u809d\u75be\u60a3\uff5e\u975e\u30a2\u30eb\u30b3\u30fc\u30eb\u6027\u8102\u80aa\u6027\u809d\u75be\u60a3\uff08NAFLD\uff09\/\u975e\u30a2\u30eb\u30b3\u30fc\u30eb\u6027\u8102\u80aa\u809d\u708e\uff08NASH\uff09\u306e\u73fe\u72b6\u3068\u5bfe\u5fdc\uff5e
\n 11. \u65b0\u898f\u306e\u751f\u6d3b\u7fd2\u6163\u75c5\u6cbb\u7642\u85ac\uff5e\u30a4\u30f3\u30af\u30ec\u30c1\u30f3\u95a2\u9023\u85ac\u306e\u4f5c\u7528\u6a5f\u5e8f\u3068NAFLD\/NASH\u6cbb\u7642\u3078\u306e\u5fdc\u7528\uff5e” <\/td>\n		 121-126 <\/td>\n<\/tr>\n<\/table>\n

\u7dcf\u8aac<\/h4>\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
\u677e\u5143\u4e00\u660e\u3001\u6df1\u6c34\u77e5\u82f1\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u65e5\u9ad9\u4f38\u4e4b\u4ecb\u3001\u68c8\u677e\u548c\u5b50\u3001\u8302\u898b\u831c\u91cc\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u6297MRSA\u85ac\u6295\u4e0e\u6642\u306eTDM\u306e\u5b9f\u969b <\/td>\n \u65e5\u672c\u5916\u79d1\u611f\u67d3\u75c7\u5b66\u4f1a\u96d1\u8a8c <\/td>\n 9:113-123 <\/td>\n<\/tr>\n
\u677e\u5143\u4e00\u660e <\/td>\n \u6297\u83cc\u85ac\u306e\u85ac\u52b9\u8a55\u4fa1\u3068\u526f\u4f5c\u7528\u89e3\u6790\u306b\u57fa\u3065\u3044\u305f\u81f3\u9069\u6295\u4e0e\u65b9\u6cd5\u306e\u958b\u767a <\/td>\n YAKUGAKU ZASSHI <\/td>\n 132:1171-1177 <\/td>\n<\/tr>\n
\u7af9\u672b\u82b3\u751f\u3001\u5927\u66f2\u8cb4\u592b\u3001\u7b20\u539f\u656c\u3001\u95a2\u96c5\u6587\u3001\u9ad9\u5009\u4fca\u4e8c\u3001\u9ad8\u6a4b\u4f73\u5b50\u3001\u6642\u677e\u4e00\u6210\u3001\u677e\u5143\u4e00\u660e\u3001\u4e09\u9d28\u5ee3\u7e41\u3001\u6728\u6751\u5229\u7f8e\u3001\u8c37\u5ddd\u539f\u7950\u4ecb\u3001\u4e94\u5341\u5d50\u6b63\u535a\u3001\u5ca1\u7530\u8ce2\u4e8c\u3001\u6728\u6751\u5321\u7537\u3001\u5c0f\u6797\u660c\u5b8f\u3001\u897f\u572d\u53f2\u3001\u6d5c\u7530\u5e78\u5b8f\u3001\u671b\u6708\u656c\u6d69 <\/td>\n \u6297\u83cc\u85acTDM\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3 <\/td>\n \u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u96d1\u8a8c <\/td>\n 60:393-445 <\/td>\n<\/tr>\n<\/table>\n

\u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09 <\/th>\n \u6f14\u984c\u540d <\/th>\n \u767a\u8868\u5b66\u4f1a\u7b49 <\/th>\n<\/tr>\n
\u25cb\u8fd1\u85e4\u667a\u5b50\u3001\u7551\u9ce5\u5f8b\u5b50\u3001\u5800\u5c3e\u798f\u5b50\u3001\u76ca\u7530\u5c06\u543e\u3001\u4e8c\u5ddd\u4fca\u9686\u3001\u5c71\u53e3\u8fb0\u54c9\u3001\u68ee\u5185\u662d\u535a\u3001\u4e95\u6238\u7ae0\u96c4\u3001\u576a\u5185\u535a\u4ec1\u3001\u6b66\u7530\u6cf0\u751f\u3001\u6709\u7530\u548c\u5fb3 <\/td>\n“CRC\u304b\u3089\u307f\u305f\u88fd\u9020\u8ca9\u58f2\u5f8c\u8abf\u67fb\u306e\u554f\u984c\u70b9\u3068\u8ab2\u984c
\n \u2015\u88fd\u9020\u8ca9\u58f2\u5f8c\u8abf\u67fb\u306e\u652f\u63f4\u3092\u901a\u3058\u3066\u3001\u305d\u306e\u3042\u308a\u65b9\u3092\u8003\u3048\u308b\u2015” <\/td>\n		 \u7b2c33\u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u677e\u5143\u4e00\u660e <\/td>\n“\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e06\uff1a\u300cTDM\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u300d\u30b3\u30f3\u30bb\u30f3\u30b5\u30b9\u30df\u30fc\u30c6\u30a3\u30f3\u30b0\u3011
\n \u30d0\u30f3\u30b3\u30de\u30a4\u30b7\u30f3” <\/td>\n		 \u7b2c60\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u677e\u5143\u4e00\u660e <\/td>\n“\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e01\uff1a\u6297\u83cc\u85acTDM\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3011
\n \u30d0\u30f3\u30b3\u30de\u30a4\u30b7\u30f3” <\/td>\n		 \u7b2c29\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u677e\u5143\u4e00\u660e <\/td>\n“\u3010\u30b7\u30f3\u30dd\u30b8\u30a6\u30e010\uff1a\u30c1\u30fc\u30e0\u533b\u7642\u306b\u5bfe\u5fdc\u3067\u304d\u308b\u85ac\u5264\u5e2b\u306e\u990a\u6210\u306b\u5411\u3051\u3066\u306e\u57fa\u790e\u7814\u7a76\u3001\u85ac\u5b66\u6559\u80b2\u3001\u81e8\u5e8a\u7814\u7a76\u306f\u3069\u3046\u3042\u308b\u3079\u304d\u304b\u3011
\n \u30c1\u30fc\u30e0\u533b\u7642\u306e\u4e2d\u3067\u3053\u305d\u767a\u63ee\u3055\u308c\u308bpharmacist scientist\u306e\u80fd\u529b” <\/td>\n		 \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e02012\/\u7b2c20\u56de\u30af\u30ea\u30cb\u30ab\u30eb\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u90e1\u5c71\u8c4a\u6cf0\u3001\u677e\u5143\u4e00\u660e\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u897f\u9806\u4e00\u90ce <\/td>\n \u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308b\u904e\u53bb3\u5e74\u9593\u306e\u57fa\u8cea\u62e1\u5f35\u578b\u03b2-\u30e9\u30af\u30bf\u30de\u30fc\u30bc\uff08ESBL\uff09\u7523\u751f\u83cc\u306e\u907a\u4f1d\u5b50\u578b\u89e3\u6790\u3068\u85ac\u5264\u611f\u53d7\u6027\u8a66\u9a13 <\/td>\n \u7b2c86\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u677e\u5143\u4e00\u660e\u3001\u8302\u898b\u831c\u91cc\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u6a4b\u53e3\u7167\u4eba\u3001\u897f\u9806\u4e00\u90ce <\/td>\n \u7a4d\u6975\u7684\u76e3\u8996\u57f9\u990a\u30fb\u8853\u5f8c\u611f\u67d3\u4e88\u9632\u6297\u83cc\u85ac\u9069\u6b63\u4f7f\u7528\u3092\u4e2d\u5fc3\u3068\u3057\u305f\u6574\u5f62\u5916\u79d1\u9818\u57dfMRSA\u624b\u8853\u90e8\u4f4d\u611f\u67d3\u5bfe\u7b56\u306e\u52b9\u679c <\/td>\n \u7b2c86\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b\u831c\u91cc\u3001\u677e\u5143\u4e00\u660e\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30ac\u30f3\u30b7\u30af\u30ed\u30d3\u30eb\u6ce8\u5c04\u6db2\u306b\u3088\u308b\u8840\u6db2\u6bd2\u6027\u767a\u73fe\u306b\u4fc2\u308b\u30ea\u30b9\u30af\u56e0\u5b50\u306e\u89e3\u6790 <\/td>\n \u7b2c60\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6a2a\u5c71\u96c4\u592a\u3001\u677e\u5143\u4e00\u660e\u3001\u6885\ufa11\u9756\u5f18\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u8302\u898b\u831c\u91cc\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u5bae\u4e4b\u539f\u5f18\u6643\u3001\u6298\u7530\u7f8e\u5343\u4ee3\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u897f\u9806\u4e00\u90ce\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308bMRSA\u306e\u5404\u7a2e\u6297\u83cc\u85ac\u306b\u5bfe\u3059\u308b5\u5e74\u9593\u306eMIC\u5206\u5e03 <\/td>\n \u7b2c60\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u897f\u9806\u4e00\u90ce\u3001\u5ddd\u7551\u76f4\u4e5f\u3001\u677e\u5143\u4e00\u660e\u3001\u8302\u898b\u3000\u831c\u91cc\u3001\u5bae\u4e4b\u539f\u3000\u5f18\u6643\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u6298\u7530\u7f8e\u5343\u4ee3\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u5584\u660e\u7f8e\u5343\u4e45\u3001\u5c0f\u5bae\u7bc0\u90ce <\/td>\n \u5f53\u9662\u306b\u304a\u3051\u308bcare bundle \u7684\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u3088\u308bMRSA \u611f\u67d3\u5bfe\u7b56\u306e\u52b9\u679c <\/td>\n \u7b2c85\u56de\u65e5\u672c\u6574\u5f62\u5916\u79d1\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6885\ufa11\u9756\u5f18\u3001\u677e\u5143\u4e00\u660e\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u5c71\u7530\u52dd\u58eb\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30d1\u30ba\u30d5\u30ed\u30ad\u30b5\u30b7\u30f3\u306e\u7dd1\u81bf\u83cc\u611f\u67d3\u75c7\u6cbb\u7642\u306b\u5bfe\u3059\u308bPK-PD\u30a2\u30d7\u30ed\u30fc\u30c1 <\/td>\n \u7b2c29\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6a2a\u5c71\u96c4\u592a\u3001\u677e\u5143\u4e00\u660e\u3001\u5c71\u672c\u88d5\u4e4b\u3001\u4e95\u7554\u80fd\u6587\u3001\u4e95\u672c\u6d69\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n PK-PD\u306b\u57fa\u3065\u3044\u305fAcinetobacter baumannii\u611f\u67d3\u75c7\u306b\u5bfe\u3059\u308bampicillin\/sulbactam\u306e\u814e\u6a5f\u80fd\u5225\u6295\u4e0e\u6cd5\u306e\u78ba\u7acb <\/td>\n \u7b2c29\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u677e\u5143\u4e00\u660e\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u8302\u898b\u831c\u91cc\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u5bae\u4e4b\u539f\u5f18\u6643\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u5c71\u7530\u52dd\u58eb\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n PK-PD\u3092\u7528\u3044\u305f\u30c6\u30a4\u30b3\u30d7\u30e9\u30cb\u30f3\u306eMRSA\u611f\u67d3\u75c7\u306b\u5bfe\u3059\u308b\u52b9\u679c\u3068\u305d\u306e\u6307\u6a19 <\/td>\n \u7b2c29\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u7fbd\u7530\u91ce\u8cb4\u88d5\u3001\u677e\u5143\u4e00\u660e\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u809d\u969c\u5bb3\u60a3\u8005\u306b\u304a\u3044\u3066micafungin\u306e\u8840\u4e2d\u6fc3\u5ea6\u304c\u9ad8\u5024\u3092\u793a\u3057\u305f\u75c7\u4f8b <\/td>\n \u7b2c29\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6885\ufa11\u9756\u5f18\u3001\u677e\u5143\u4e00\u660e\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u7dd1\u81bf\u83cc\u306b\u5bfe\u3059\u308b\u5404\u7a2e\u30ad\u30ce\u30ed\u30f3\u7cfb\u6297\u83cc\u85ac\u306e\u611f\u53d7\u6027\u8a55\u4fa1 <\/td>\n \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e02012\uff0f\u7b2c20\u56de\u30af\u30ea\u30cb\u30ab\u30eb\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u68c8\u677e\u548c\u5b50\u3001\u677e\u5143\u4e00\u660e\u3001\u8302\u898b\u831c\u91cc\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30dc\u30ea\u30b3\u30ca\u30be\u30fc\u30eb\u306b\u3088\u308b\u771f\u83cc\u611f\u67d3\u75c7\u6cbb\u7642\u306b\u5bfe\u3059\u308bTDM\u306e\u6709\u7528\u6027-\u91cd\u7be4\u306a\u809d\u969c\u5bb3\u56de\u907f\u3068\u6cbb\u7642\u7d99\u7d9a\u3078\u306e\u5bc4\u4e0e- <\/td>\n \u7b2c22\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u8302\u898b\u831c\u91cc\u3001\u677e\u5143\u4e00\u660e\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u897f\u9806\u4e00\u90ce <\/td>\n \u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308b\u30ab\u30eb\u30d0\u30da\u30cd\u30e0\u7cfb\u85ac\u5c4a\u3051\u51fa\u5236\u5c0e\u5165\u306e\u52b9\u679c\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n \u7b2c60\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a\/\u7b2c55\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u5b66\u8853\u96c6\u4f1a\/\u7b2c82\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6a2a\u5c71\u96c4\u592a\u3001\u677e\u5143\u4e00\u660e\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u8302\u898b\u831c\u91cc\u3001\u6885\ufa11\u9756\u5f18\u3001\u7af9\u4e0b\u9b8e\u7f8e\u3001\u4e2d\u6751\u5b8f\u6d0b\u3001\u5965\u91ce\u771f\u7406\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n Sulbactam\u306eAcinetobacter baumannii\u306b\u3088\u308b\u30de\u30a6\u30b9\u5927\u817f\u90e8\u611f\u67d3\u30e2\u30c7\u30eb\u3092\u7528\u3044\u305fPK-PD\u89e3\u6790 <\/td>\n \u7b2c29\u56de\u65e5\u672c\u85ac\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u677e\u5143\u4e00\u660e\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u8302\u898b\u831c\u91cc\u3001\u6df1\u6c34\u77e5\u82f1\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30c6\u30a4\u30b3\u30d7\u30e9\u30cb\u30f3\u306e\u521d\u671f\u6295\u4e0e\u8a2d\u8a08\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff5e\u9ad8\u7528\u91cf\u8ca0\u8377\u6295\u4e0e\u65b9\u6cd5\u306e\u78ba\u7acb\uff5e <\/td>\n \u7b2c29\u56de\u65e5\u672c\u85ac\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u4f50\u85e4\u53f2\u7e54\u3001\u6709\u99ac\u7d14\u5b50\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u85ac\u5264\u5e2b\u306e\u4ecb\u5165\u306b\u3088\u308b\u624b\u8853\u90e8\u306e\u85ac\u5264\u95a2\u9023\u696d\u52d9\u306e\u6539\u5584 <\/td>\n \u7b2c22\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6709\u99ac\u7d14\u5b50\u3001\u4f50\u85e4\u53f2\u7e54\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u624b\u8853\u90e8\u306b\u304a\u3051\u308b\u85ac\u5264\u5e2b\u306e\u53d6\u308a\u7d44\u307f\u3068\u7d4c\u6e08\u52b9\u679c <\/td>\n \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e02012\uff0f\u7b2c20\u56de\u30af\u30ea\u30cb\u30ab\u30eb\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cbYoshihiro Shimodozono,keiko Yaji,Ryuji Ikeda, Yasuo Takeda <\/td>\n A survey on communidation skills for the trainees pharmaceutical practice <\/td>\n \u7b2c22\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u67f4\u7530\u7531\u9999\u91cc\u3001\u6df1\u6c34\u77e5\u82f1\u3001\u3001\u798f\u7530\u3086\u304b\u308a\u3001\u7530\u4e2d\u7766\u7f8e\u3001\u51fa\u53e3\u5c1a\u5bff\u3001\u5927\u8107\u54f2\u6d0b <\/td>\n \u30d7\u30ed\u30c8\u30f3\u30dd\u30f3\u30d7\u963b\u5bb3\u85ac\u306e\u7d4c\u9f3b\u30fb\u7d4c\u53e3\u80c3\u30c1\u30e5\u30fc\u30d6\u304b\u3089\u306e\u6ce8\u5165\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n \u7b2c28\u56de\u65e5\u672c\u9759\u8108\u7d4c\u8178\u6804\u990a\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cbYukari Shibata, Tomohide Fukamizu, Yasuo Takeda <\/td>\n Outcome of nutrition support tearm intervention in patients with diarrhea <\/td>\n \u7b2c22\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u672c\u7530\u4fee\u5e73\u3001\u897f\u539f\u548c\u4e5f\u3001\u5712\u7530\u7d14\u4e00\u90ce\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u9cf4\u6d77\u6075\u5b50\u3001\u6cb3\u5185\u660e\u592b\u3001\u51a8\u91cd\u6075\u5229\u7d17\u3001\u6b66\u7530\u6cf0\u751f\u3001\u672c\u5c4b\u654f\u90ce <\/td>\n \u7dd1\u8336\u30ab\u30c6\u30ad\u30f3Epigallocatechin-3-gallate (EGCg)\u306e\u6297\u304c\u3093\u7279\u6027 <\/td>\n \u7b2c29\u56de\u65e5\u672c\u85ac\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cbRyuji Ikeda, Yusuke Tajitsu, Yukihiko Nishizawa, Nariaki Tomiyama, Hironori Mataki, Katsushi Yamada, Yasuo Takeda <\/td>\n Molecular basis for the induction ofvaults by anti-cancer agents, and the role of vaults in resistance to anti-cancer sagents <\/td>\n \u7b2c6\u56de\u6b21\u4e16\u4ee3\u3092\u62c5\u3046\u82e5\u624b\u533b\u7642\u85ac\u79d1\u5b66\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u6c60\u7530\u9f8d\u4e8c\u3001\u7530\u5be6\u88d5\u4ecb\u3001\u897f\u6fa4\u7531\u7d00\u5f66\u3001\u53e4\u5ddd\u9f8d\u5f66\u3001\u79cb\u5c71\u4f38\u4e00\u3001\u5c71\u7530\u52dd\u58eb\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u9ad8\u6d78\u900f\u5727\u3067\u8a98\u5c0e\u3055\u308b\u30f4\u30a9\u30fc\u30eb\u30c8\u306e\u767a\u73fe\u4ea2\u9032\u6a5f\u5e8f\u3068\u9ad8\u6d78\u900f\u5727\u8010\u6027\u5316\u6a5f\u69cb <\/td>\n \u7b2c86\u56de\u65e5\u85ac\u7406\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u77f3\u585a\u6d0b\u4e00\u3001\u8fd1\u85e4\u667a\u5b50\u3001\u5c71\u53e3\u572d\u592a\u90ce\u3001\u4f0a\u85e4\u798e\u5b50\u3001\u7530\u4e2d\u9999\u7e54\u3001\u5165\u5009\u5145\u3001\u68ee\u5185\u5b8f\u5fd7\u3001\u9ad8\u6ff1\u548c\u592b\u3001\u5b89\u6771\u7531\u559c\u96c4\u3001\u5c71\u5d0e\u4fca\u592b\u3001\u5165\u6c5f\u5fb9\u7f8e <\/td>\n \u4f4e\u9178\u7d20\u8840\u75c7\u52d5\u7269\u30e2\u30c7\u30eb\u306b\u304a\u3051\u308b\u547c\u5438\u8208\u596e\u85ac\u306b\u3088\u308b\u4e2d\u67a2\u795e\u7d4c\u50b7\u5bb3\u6027 <\/td>\n \u65e5\u672c\u80ba\u30b5\u30fc\u30d5\u30a1\u30af\u30bf\u30f3\u30c8\u30fb\u754c\u9762\u533b\u5b66\u4f1a \u7b2c48\u56de\u5b66\u8853\u7814\u7a76\u4f1a <\/td>\n<\/tr>\n
\u25cb\u76ca\u7530 \u5c06\u543e\u3001\u4e8c\u5ddd \u4fca\u9686\u3001\u5c71\u53e3 \u6c99\u7e54\u3001\u5c71\u7530 \u52dd\u58eb\u3001\u6c60\u7530 \u9f8d\u4e8c\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u30b0\u30ea\u30aa\u30fc\u30de\u7d30\u80de\u306e\u79fb\u52d5\u30fb\u6d78\u6f64\u306b\u304a\u3051\u308bCaspr1\u306e\u5f79\u5272 <\/td>\n \u7b2c65\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u897f\u5357\u90e8\u4f1a <\/td>\n<\/tr>\n
\u25cb\u76ca\u7530 \u5c06\u543e\u3001\u4e8c\u5ddd \u4fca\u9686\u3001\u5c71\u53e3 \u6c99\u7e54\u3001\u6c60\u7530 \u9f8d\u4e8c\u3001\u5c71\u7530 \u52dd\u58eb\u3001\u6b66\u7530 \u6cf0\u751f <\/td>\n \u30b0\u30ea\u30aa\u30fc\u30de\u7d30\u80de\u306e\u6d78\u6f64\u30fb\u8ee2\u79fb\u306b\u304a\u3051\u308bContactin associated protein(Caspr)1\u306e\u5f79\u5272 <\/td>\n \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e02012\/\u7b2c20\u56de\u30af\u30ea\u30cb\u30ab\u30eb\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u5c4b\u5730\u3000\u6176\u5b50\u3001\u4e0b\u5802\u8597\u3000\u6a29\u6d0b\u3001\u6c60\u7530\u3000\u9f8d\u4e8c\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n \u85ac\u5b66\u90e8\u5b9f\u52d9\u5b9f\u7fd2\u751f\u306b\u304a\u3051\u308b\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u80fd\u529b\u306b\u95a2\u3059\u308b\u8a8d\u8b58\u8abf\u67fb <\/td>\n \u65e5\u672c\u85ac\u5b66\u4f1a\u3000133\u5e74\u4f1a <\/td>\n<\/tr>\n<\/table><\/div>\n<\/div>\n

<\/path><\/svg><\/blocsicon> 2011\u5e74\u696d\u7e3e<\/a><\/p>\n

\n\t<\/p>\n

\u6b27\u6587<\/h3>\n
\n\n\n\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
Naoko Kanazawa, Kazuaki Matsumoto, Kazuro Ikawa, Tomohide Fukamizu, Akari Shigemi, Keiko Yaji, Yoshihiro Shimodozono, Norifumi Morikawa, Yasuo Takeda, Katsushi Yamada <\/td>\n An initial dosing method for teicoplanin based on the area under the serum concentration-time curve (AUC) required for MRSA eradication <\/td>\n Journal of Infection and Chemotherapy <\/td>\n 17, 297-300 <\/td>\n<\/tr>\n
Akari Shigemi, Kazuaki Matsumoto, Kazuro Ikawa, Keiko Yaji, Yoshihiro Shimodozono, Norifumi Morikawa, Yasuo Takeda, Katsushi Yamada <\/td>\n Safety analysis of liposomal amphotericin B in adult patients: anemia, thrombocytopenia, nephrotoxicity, hepatotoxity and hypokalemia <\/td>\n International Journal of Antimicrobial Agents <\/td>\n 38, 417-420 <\/td>\n<\/tr>\n
Yoshihiko Shibayama, Yoshitaka Iwashita, Yoshimi Yoshikawa, Tomoko Kondo, Ryuji Ikeda, Yasuo Takeda, Takayuki Osada, Mitsuru Sugawara, Katsushi Yamada, Ken Iseki <\/td>\n Effect of 5-Fluorouracil Treatment on SN-38 Absorption from Intestine in Rats <\/td>\n Biological and Pharmaceutical Bulletin <\/td>\n 34, 1418-1425 <\/td>\n<\/tr>\n
Yoshihiko Shibayama, Kou Nakano, Hiroshi Maeda, Miyuki Taguchi, Ryuji Ikeda, Mitsuru Sugawara, Ken Iseki, Yasuo Takeda, Katsushi Yamada <\/td>\n Multidrug Resistance Protein 2 Implicates Anticancer Drug-Resistance to Sorafenib <\/td>\n Biological and Pharmaceutical Bulletin <\/td>\n 34, 433-435 <\/td>\n<\/tr>\n
Ryuji Ikeda, Lee C. Vermeulen, Elim Lau, Zhisheng Jiang, Kamakshi Sachidanandam, Katsushi Yamada, Jill M. Kolesar <\/td>\n Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A549 cells <\/td>\n International Journal of Oncology <\/td>\n 38, 513-519 <\/td>\n<\/tr>\n
Ryuji Ikeda, Lee C. Vermeulen, Elim Lau, Zhisheng Jiang, Kamakshi Sachidanandam, Katsushi Yamada, Jill M. Kolesar <\/td>\n Isolation and characterization of erlotinib-resistant in human non-small cell lung cancer A549 cells <\/td>\n Oncology Letters <\/td>\n 2, 91-94 <\/td>\n<\/tr>\n<\/table>\n

\u8457\u66f8<\/h4>\n\n\n\n\n\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u66f8\u540d\uff08\u5206\u62c5\u306e\u5834\u5408\u306f+\u6a19\u984c\u540d\uff09 <\/th>\n \u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n		 \u767a\u884c\u6240 <\/th>\n<\/tr>\n
\u6df1\u6c34\u3000\u77e5\u82f1\u3001\u4e0b\u5802\u8597\u6a29\u6d0b <\/td>\n“\u85ac\u5c402011\u5e743\u6708\u53f7\u5897\u520a\u53f7
\n \u75c5\u6c17\u3068\u85ac\u3000\u30d1\u30fc\u30d5\u30a7\u30af\u30c8BOOK2011
\n \u300c\u809d\u81d3\u75be\u60a3\u85ac\u30fb\u5229\u80c6\u85ac\u300d” <\/td>\n		 24-28 <\/td>\n \u5357\u5c71\u5802\uff08\u6771\u4eac\uff09 <\/td>\n<\/tr>\n
\u5c71\u7530\u3000\u52dd\u58eb <\/td>\n“\u81e8\u5e8a\u8abf\u5264\u5b66\u3000\u7b2c\uff11\u7ae0
\n 1.\u8abf\u5264\u3068\u85ac\u5264\u5e2b
\n 2.\u8abf\u5264\u3068\u306f” <\/td>\n		 2-17 <\/td>\n \u5357\u5c71\u5802\uff08\u6771\u4eac\uff09 <\/td>\n<\/tr>\n
\u4e0b\u5802\u8597\u6a29\u6d0b <\/td>\n“\u81e8\u5e8a\u8abf\u5264\u5b66\u3000\u7b2c2\u7ae0
\n 1.\u51e6\u65b9\u305b\u3093\u3068\u51e6\u65b9\u9451\u67fb” <\/td>\n		 70-91 <\/td>\n \u5357\u5c71\u5802\uff08\u6771\u4eac\uff09 <\/td>\n<\/tr>\n
\u6df1\u6c34\u3000\u77e5\u82f1\u3001\u6b66\u7530\u3000\u6cf0\u751f <\/td>\n“\u6708\u520a\u85ac\u4e8b\u30009\u6708\u81e8\u6642\u5897\u520a\u53f7
\n \u51e6\u65b9\u8a2d\u8a08\u306b\u30c1\u30e3\u30ec\u30f3\u30b8\u3000\u3053\u308c\u3067\u308f\u304b\u308b\u9759\u8108\u6804\u990a\u6cd5
\n \u7b2c4\u7ae0\u8f38\u6db2\u7642\u6cd5\uff0b\u03b1\u3092\u5b66\u3076\u30003\uff0e\u3069\u3093\u306a\u85ac\u304c\u98df\u4e8b\u6442\u53d6\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u306e\u304b\uff1f” <\/td>\n		 257-264 <\/td>\n \u3058\u307b\u3046\uff08\u6771\u4eac\uff09 <\/td>\n<\/tr>\n
\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u677e\u5143\u4e00\u660e <\/td>\n“\u533b\u85ac\u54c1\u60c5\u5831\u5b66\u3000\uff0d\u57fa\u790e\u30fb\u8a55\u4fa1\u30fb\u5fdc\u7528\uff0d\u3000\u6539\u8a02\u7b2c2\u7248
\n 3-5\u3000\u533b\u85ac\u54c1\u5378\u304b\u3089\u306e\u60c5\u5831\u53ce\u96c6” <\/td>\n		 52-62 <\/td>\n \u5357\u5c71\u5802\uff08\u6771\u4eac\uff09 <\/td>\n<\/tr>\n
\u5c71\u7530\u3000\u52dd\u58eb <\/td>\n“\u307f\u3066\u308f\u304b\u308b\u3000\u56f3\u89e3\u81e8\u5e8a\u8abf\u5264\u5b66\u3000\u7b2c\uff11\u7ae0
\n 1.\u8abf\u5264\u3068\u85ac\u5264\u5e2b
\n 2.\u8abf\u5264\u3068\u306f” <\/td>\n		 2-17 <\/td>\n \u5357\u5c71\u5802\uff08\u6771\u4eac\uff09 <\/td>\n<\/tr>\n
\u4e0b\u5802\u8597\u6a29\u6d0b <\/td>\n“\u81e8\u5e8a\u8abf\u5264\u5b66\u3000\u7b2c2\u7ae0
\n 1.\u51e6\u65b9\u305b\u3093\u3068\u51e6\u65b9\u9451\u67fb” <\/td>\n		 74-97 <\/td>\n \u5357\u5c71\u5802\uff08\u6771\u4eac\uff09 <\/td>\n<\/tr>\n<\/table>\n

\u7dcf\u8aac<\/h4>\n\n\n\n\n
\u8457\u8005\u540d <\/th>\n \u8ad6\u6587\u540d <\/th>\n \u96d1\u8a8c\u540d\u7b49 <\/th>\n \u5dfb\u6570\uff1a
\u521d\u9801\uff0d
\u7d42\u9801 <\/th>\n<\/tr>\n
\u4e0b\u5802\u8597\u6a29\u6d0b <\/td>\n“\u5b9f\u52d9\u5b9f\u7fd2\u3092\u3088\u304f\u3059\u308b\u305f\u3081\u306b\uff08\uff12\uff09
\n \u5b9f\u52d9\u5b9f\u7fd2\u751f\u53d7\u5165\u308c\u65bd\u8a2d\u306e\u601d\u3044\u3068\u6539\u5584\u3078\u306e\u8a66\u307f” <\/td>\n		 \u533b\u85ac\u30b8\u30e3\u30fc\u30ca\u30eb <\/td>\n 47\uff1a2693-2969 <\/td>\n<\/tr>\n
\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u67f4\u7530\u7531\u9999\u91cc <\/td>\n \u5b9f\u52d9\u5b9f\u7fd2\u521d\u5e74\u5ea6\u306b\u304a\u3051\u308b\u75c5\u9662\u5b9f\u7fd2\u53d7\u5165\u308c\u5b9f\u614b\u3068\u554f\u984c\u70b9 <\/td>\n \u4e5d\u5dde\u85ac\u5b66\u4f1a\u5831 <\/td>\n 65\uff1a105-110 <\/td>\n<\/tr>\n<\/table>\n

\u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u767a\u8868\u8005\uff08\u4ee3\u8868\u25cb\uff09 <\/th>\n \u6f14\u984c\u540d <\/th>\n \u767a\u8868\u5b66\u4f1a\u7b49 <\/th>\n<\/tr>\n
\u25cb\u6df1\u6c34\u77e5\u82f1\u3001\u5927\u8107\u54f2\u6d0b\u3001\u51fa\u53e3\u5c1a\u5bff\u3001\u52a0\u6cbb\u3000\u5efa\u3001\u7532\u6590\u656c\u5b50\u3001\u4f50\u85e4\u9999\u5948\u5b50\u3001\u798f\u7530\u3086\u304b\u308a\u3001\u843d\u53f8\u6cbb\u4ee3\u3001\u67f4\u7530\u7531\u9999\u91cc\u3001\u9ad8\u677e\u82f1\u592b <\/td>\n \u5897\u7c98\u5264\u3092\u7528\u3044\u305f\u7d4c\u8178\u6804\u990a\u5264\u306e\u80c3\u5185\u534a\u56fa\u5f62\u5316\u306b\u3064\u3044\u3066\u306e\u5b9f\u9a13\u7684\u691c\u8a0e <\/td>\n \u7b2c26\u56de\u65e5\u672c\u9759\u8108\u7d4c\u8178\u6804\u990a\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5927\u8107\u54f2\u6d0b\u3001\u51fa\u53e3\u5c1a\u5bff\u3001\u7532\u6590\u656c\u5b50\u3001\u4f50\u85e4\u9999\u5948\u5b50\u3001\u6df1\u6c34\u77e5\u82f1\u3001\u798f\u7530\u3086\u304b\u308a\u3001\u52a0\u6cbb\u3000\u5efa\u3001\u9ad8\u677e\u82f1\u592b <\/td>\n \u771f\u590f\u306e\u30c8\u30ab\u30e9\u5217\u5cf6\u7686\u65e2\u65e5\u98df\u306b\u304a\u3051\u308b\u71b1\u4e2d\u75c7\u767a\u75c7\u72b6\u6cc1\u3068\u3001\u7d4c\u53e3\u88dc\u6c34\u6db2OS-1\u306e\u4f7f\u7528\u3068\u71b1\u4e2d\u75c7\u306b\u95a2\u3059\u308b\u30a2\u30f3\u30b1\u30fc\u30c8\u7d50\u679c <\/td>\n \u7b2c26\u56de\u65e5\u672c\u9759\u8108\u7d4c\u8178\u6804\u990a\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u4e2d\u539f\u771f\u7531\u7f8e\u3001\u5b89\u7530\u667a\u55e3\u3001\u751f\u99d2\u9999\u540d\u5b50\u3001\u5927\u5bae\u53f8\u660e\u5b50\u3001\u5ca1\u5c71\u5948\u7a42\u5b50\u3001\u83ca\u6c60\u5fe0\u3001\u4eca\u6797\u5fb9\u3001\u57a3\u82b1\u6cf0\u4e4b\u3001\u4e0a\u6751\u88d5\u4e00\u3001\u677e\u5143\u4e00\u660e <\/td>\n \u907a\u4f1d\u5b50\u7d44\u307f\u63db\u3048\u30c8\u30ed\u30f3\u30dc\u30e2\u30b8\u30e5\u30ea\u30f3\u306e\u85ac\u7269\u52d5\u614b\u306e\u691c\u8a0e <\/td>\n \u7b2c38\u56de\u65e5\u672c\u96c6\u4e2d\u6cbb\u7642\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u91d1\u6fa4\u76f4\u5b50\u3001\u677e\u5143\u4e00\u660e\u3001\u8302\u898b\u831c\u91cc\u3001\u5c4b\u5730\u6176\u5b50\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u5bae\u4e4b\u539f\u5f18\u6643\u3001\u6b66\u7530\u6cf0\u751f\u3001\u5c71\u7530\u52dd\u58eb <\/td>\n Clostridium difficile\u30c8\u30ad\u30b7\u30f3\u967d\u6027\u60a3\u8005\u306e\u60a3\u8005\u80cc\u666f\u304a\u3088\u3073\u6cbb\u7642\u52b9\u679c\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n \u7b2c41\u56de\u65e5\u672c\u5acc\u6c17\u6027\u83cc\u611f\u67d3\u75c7\u7814\u7a76\u4f1a <\/td>\n<\/tr>\n
\u25cb\u897f\u6fa4\u7531\u7d00\u5f66\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u677e\u4e0b\u8302\u4eba\u3001\u8eca \u6681\u82b3\u3001\u53e4\u5ddd\u9f8d\u5f66\u3001\u7530\u7551 \u7965\u3001\u725b\u5c71\u7f8e\u5948\u3001\u7530\u5be6\u88d5\u4ecb\u3001\u5c71\u672c\u96c5\u9054\u3001\u5357\u8b19\u592a\u6717\u3001\u4fe3\u6728\u535a\u5fb3\u3001\u5c71\u53e3\u8fb0\u54c9\u3001\u6b66\u7530\u6cf0\u751f\u3001\u79cb\u5c71\u4f38\u4e00\u3001\u5c71\u7530\u52dd\u58eb <\/td>\n \u764c\u7d30\u80de\u3067\u306e5-FU\u4f9d\u5b58\u7684early growth response protein-1 \u304a\u3088\u3073thrombospondin-1 \u767a\u73fe\u4ea2\u9032\u306b\u304a\u3051\u308bthymidine phosphorylase \u306e\u5f79\u5272 <\/td>\n \u7b2c84\u56de\u3000\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6a2a\u5c71\u96c4\u592a\u3001\u677e\u5143\u4e00\u660e\u3001\u5c71\u672c\u88d5\u4e4b\u3001\u4e95\u7554\u80fd\u6587\u3001\u4e95\u672c\u6d69\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u77f3\u7530\u5fd7\u6717\u3001\u5ca1\u91ce\u5584\u90ce\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f\u3001\u5c71\u7530\u52dd\u58eb <\/td>\n \u5fc3\u81d3\u8840\u7ba1\u624b\u8853\u306e\u4eba\u5de5\u5fc3\u80ba\u4f7f\u7528\u4e0b\u306b\u304a\u3051\u308bampicillin\/sulbactam\u306e\u624b\u8853\u90e8\u4f4d\u611f\u67d3\u4e88\u9632\u6295\u4e0e\u6cd5\u306e\u81f3\u9069\u5316 <\/td>\n \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c131\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u677e\u5143\u4e00\u660e\u3001\u8302\u898b\u831c\u91cc\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u897f\u9806\u4e00\u90ce <\/td>\n \u540c\u4e00\u60a3\u8005\u306b\u304a\u3051\u308bMRSA\u8853\u524d\u9f3b\u8154\u4fdd\u83cc\u682a\u3068\u8853\u5f8c\u624b\u8853\u90e8\u4f4d\u691c\u51fa\u682a\u306e\u907a\u4f1d\u5b50\u578b\u306e\u6bd4\u8f03 <\/td>\n \u7b2c85\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a <\/td>\n<\/tr>\n
\u25cb\u90e1\u5c71\u8c4a\u6cf0\u3001\u5bae\u4e4b\u539f\u5f18\u6643\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u677e\u5143\u4e00\u660e\u3001\u677e\u4e0b\u660c\u98a8 <\/td>\n \u30c7\u30a3\u30b9\u30af\u62e1\u6563\u6cd5\u3092\u7528\u3044\u305f3-\u30a2\u30df\u30ce\u30d5\u30a7\u30cb\u30eb\u30dc\u30ed\u30f3\u9178\uff08APBA\uff09\u3001\u30b8\u30d4\u30b3\u30ea\u30f3\u9178\uff08DPA\uff09\u3001cloxacillin\u306b\u3088\u308b\u30ab\u30eb\u30d0\u30da\u30cd\u30de\u30fc\u30bc\u7523\u751f\u83cc\u306e\u89e3\u6790 <\/td>\n \u7b2c60\u56de\u65e5\u672c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a <\/td>\n<\/tr>\n
\u4e0b\u5802\u8597\u6a29\u6d0b <\/td>\n“\u300e\u30c7\u30fc\u30bf\u306e2\u6b21\u5229\u7528\u306b\u3088\u308b\u696d\u52d9\u6539\u5584\u300f
\n \u75c5\u533b\u85ac\u5264\u90e8\u306b\u304a\u3051\u308b\u533b\u7642\u60c5\u5831\u30c7\u30fc\u30bf\u306e\u4e8c\u6b21\u5229\u7528” <\/td>\n		 \u7b2c15\u56de\u65e5\u672c\u533b\u7642\u60c5\u5831\u5b66\u4f1a\u6625\u5b63\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6a2a\u5c71\u96c4\u592a\u3001\u677e\u5143\u4e00\u660e\u3001\u5c71\u672c\u88d5\u4e4b\u3001\u4e95\u7554\u80fd\u6587\u3001\u4e95\u672c\u6d69\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u77f3\u7530\u5fd7\u6717\u3001\u5ca1\u91ce\u5584\u90ce\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f\u3001\u5c71\u7530\u52dd\u58eb <\/td>\n \u5fc3\u81d3\u8840\u7ba1\u624b\u8853\u60a3\u8005\u306e\u814e\u6a5f\u80fd\u306b\u5fdc\u3058\u305fampicillin\/sulbactam\u81f3\u9069\u6295\u4e0e\u6cd5\u306e\u78ba\u7acb <\/td>\n \u7b2c28\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5357\u8b19\u592a\u6717\u3001\u53e4\u5ddd\u9f8d\u5f66\u3001\u5c71\u672c\u96c5\u9054\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u5c0f\u677e\u6b63\u6cbb\u3001\u7530\u7551\u7965\u3001\u79cb\u5c71\u4f38\u4e00 <\/td>\n CNT1\u3068RRM1\u306e\u767a\u73fe\u5909\u5316\u304cGemcitabine\u8010\u6027\u81b5\u764c\u7d30\u80de\u682a\u306e\u8010\u6027\u3092\u62c5\u3063\u3066\u3044\u308b <\/td>\n \u7b2c15\u56de \u65e5\u672c\u304c\u3093\u5206\u5b50\u6a19\u7684\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5ddd\u6751\u82f1\u6a39\u3001\u677e\u5143\u4e00\u660e\u3001\u8302\u898b\u831c\u91cc\u3001\u5fb3\u7530\u6d69\u4e00\u3001\u897f\u9806\u4e00\u90ce <\/td>\n \u6574\u5f62\u5916\u79d1\u9818\u57df\u6e05\u6f54\u624b\u8853\u306b\u304a\u3051\u308b\u30bb\u30d5\u30a1\u30be\u30ea\u30f3\u3092\u4f7f\u7528\u3057\u305f\u8853\u5f8c\u611f\u67d3\u4e88\u9632\u30d7\u30ed\u30c8\u30b3\u30fc\u30eb\u52b9\u679c\u306e\u691c\u8a0e <\/td>\n \u7b2c59\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6a2a\u5c71\u96c4\u592a\u3001\u677e\u5143\u4e00\u660e\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u8302\u898b\u831c\u91cc\u3001\u6b66\u7530\u6cf0\u751f\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u5bae\u4e4b\u539f\u5f18\u6643\u3001\u6298\u7530\u7f8e\u5343\u4ee3\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u897f\u9806\u4e00\u90ce\u3001\u5c71\u7530\u52dd\u58eb <\/td>\n \u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662\u306b\u304a\u3051\u308b\u904e\u53bb5\u5e74\u9593\u306eMRSA\u306b\u5bfe\u3059\u308b\u5404\u7a2e\u6297\u83cc\u85ac\u306eMIC\u63a8\u79fb <\/td>\n \u7b2c59\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8302\u898b\u831c\u91cc\u3001\u677e\u5143\u4e00\u660e\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u5c4b\u5730\u6176\u5b50\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f\u3001\u5c71\u7530\u52dd\u58eb <\/td>\n \u30ac\u30f3\u30b7\u30af\u30ed\u30d3\u30eb\u6ce8\u5c04\u85ac\u306e\u6709\u52b9\u6027\u304a\u3088\u3073\u5fcd\u5bb9\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n \u7b2c59\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cbShiori Saito, Junko Arima, Yoshihiro Shimodozono, Yasuo Takeda, Katsushi Yamada <\/td>\n Pharmacist contribute to decrease the loss of pharmaceutical costs in the operating room <\/td>\n 71st International Congress of FIP (World Congress of Pharmacy and Pharmaceutical Sciences 2011) <\/td>\n<\/tr>\n
\u677e\u5143\u4e00\u660e <\/td>\n \u30b0\u30e9\u30e0\u9670\u6027\u83cc\u306b\u5bfe\u3059\u308b\u6297\u83cc\u85ac\u3068\u6cbb\u7642\u6cd5 <\/td>\n \u7b2c21\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5927\u5834\u5ef6\u6d69\u3001\u6298\u4e95\u5b5d\u7537\u3001\u666f\u5c71\u8302\u3001\u5317\u6751\u6b63\u6a39\u3001\u4e45\u4fdd\u7530\u6f54\u3001\u53e4\u9591\u6643\u3001\u4f50\u85e4\u55e3\u9053\u3001\u690e\u540d\u6075\u7f8e\u5b50\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u677e\u4e95\u7814\u4e00\u3001\u516b\u91cd\u3086\u304b\u308a\u3001\u5c71\u53e3\u62d3\u6d0b <\/td>\n \u30b9\u30bf\u30c1\u30f3\u7cfb\u85ac\u5264\u306b\u95a2\u3059\u308b\u85ac\u5264\u75ab\u5b66\u7814\u7a76\uff08\uff2a\uff33\uff33\uff09\uff1a\u30b1\u30fc\u30b9\u306e\u8a55\u4fa1\u65b9\u6cd5 <\/td>\n \u7b2c21\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6a2a\u5c71\u96c4\u592a\u3001\u677e\u5143\u4e00\u660e\u3001\u5c71\u672c\u88d5\u4e4b\u3001\u4e95\u7554\u80fd\u6587\u3001\u4e95\u672c\u6d69\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u77f3\u7530\u5fd7\u6717\u3001\u5ca1\u91ce\u5584\u90ce\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f\u3001\u5c71\u7530\u52dd\u58eb <\/td>\n \u5fc3\u81d3\u8840\u7ba1\u624b\u8853\u60a3\u8005\u306e\u4eba\u5de5\u5fc3\u80ba\u4f7f\u7528\u4e0b\u306b\u304a\u3051\u308bampicillin\/sulbactam\u81f3\u9069\u6295\u4e0e\u6cd5 <\/td>\n \u7b2c21\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u91d1\u6fa4\u76f4\u5b50\u3001\u677e\u5143\u4e00\u660e\u3001\u8302\u898b\u831c\u91cc\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u5bae\u4e4b\u539f\u5f18\u6643\u3001\u5ddd\u6751\u82f1\u6a39\u3001\u6298\u7530\u7f8e\u5343\u4ee3\u3001\u897f\u9806\u4e00\u90ce\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f\u3001\u5c71\u7530\u52dd\u58eb <\/td>\n Clostridium difficile\u30c8\u30ad\u30b7\u30f3\u967d\u6027\u60a3\u8005\u306e\u6cbb\u7642\u304a\u3088\u3073\u518d\u767a\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u56e0\u5b50\u306e\u691c\u8a0e <\/td>\n \u7b2c21\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5357\u8b19\u592a\u6717\u3001\u53e4\u5ddd\u9f8d\u5f66\u3001\u5c71\u672c\u96c5\u9054\u3001\u897f\u6fa4\u7531\u7d00\u5f66\u3001\u7530\u7551\u7965\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u5c0f\u677e\u6b63\u6cbb\u3001\u79cb\u5c71\u4f38\u4e00 <\/td>\n Gemcitabine\u8010\u6027\u81b5\u764c\u7d30\u80de\u306eCNT1\u3068RRM1\u306e\u8010\u6027\u6a5f\u69cb\u3078\u306e\u95a2\u4e0e <\/td>\n \u7b2c70\u56de \u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u25cb\u897f\u6fa4\u7531\u7d00\u5f66\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u677e\u4e0b\u8302\u4eba\u3001\u7530\u7551 \u7965\u3001\u5c71\u672c\u96c5\u9054\u3001\u5357 \u8b19\u592a\u6717\u3001\u5c71\u53e3\u8fb0\u54c9\u3001\u79cb\u5c71\u4f38\u4e00\u3001\u53e4\u5ddd\u9f8d\u5f66 <\/td>\n \u764c\u7d30\u80de\u3067\u306e5-FU\u4f9d\u5b58\u7684early growth response protein-1 \u304a\u3088\u3073thrombospondin-1 \u767a\u73fe\u4ea2\u9032\u306b\u304a\u3051\u308bthymidine phosphorylase \u306e\u5f79\u5272 <\/td>\n \u7b2c70\u56de \u65e5\u672c\u764c\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u4e0b\u5802\u8597\u6a29\u6d0b <\/td>\n \u300c\u30c1\u30fc\u30e0\u533b\u7642\u63a8\u9032\u306b\u5411\u3051\u3066\u300d \u75c5\u9662\u85ac\u5264\u5e2b\u306e\u7acb\u5834\u304b\u3089 <\/td>\n“\u7b2c6\u56de \u4e5d\u5dde\u653e\u5c04\u7dda\u533b\u7642\u6280\u8853\u5b66\u8853\u5927\u4f1a
\n \u7b2c60\u56de\uff08\u793e\uff09\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u4e5d\u5dde\u90e8\u4f1a\u5b66\u8853 \u5927\u4f1a
\n \u7b2c57\u56de\u4e5d\u5dde\u653e\u5c04\u7dda\u6280\u5e2b\u5b66\u8853\u5927\u4f1a” <\/td>\n<\/tr>\n
\u25cb\u5927\u5834\u5ef6\u6d69\u3001\u6298\u4e95\u5b5d\u7537\u3001\u666f\u5c71\u8302\u3001\u5317\u6751\u6b63\u6a39\u3001\u4e45\u4fdd\u7530\u6f54\u3001\u8535\u7530\u82f1\u660e\u3001\u53e4\u9591\u6643\u3001\u4f50\u85e4\u55e3\u9053\u3001\u690e\u540d\u6075\u7f8e\u5b50\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u677e\u4e95\u7814\u4e00\u3001\u516b\u91cd\u3086\u304b\u308a\u3001\u5c71\u53e3\u62d3\u6d0b\u3001\u5409\u7530\u535a <\/td>\n \u30b9\u30bf\u30c1\u30f3\u7cfb\u85ac\u5264\u306b\u95a2\u3059\u308b\u85ac\u5264\u75ab\u5b66\u7814\u7a76\uff08\uff2a\uff33\uff33\uff09\uff1a\u7c97\u767a\u751f\u7387\u3068\u7c97\u7387\u6bd4\u306e\u63a8\u5b9a <\/td>\n \u7b2c17\u56de\u65e5\u672c\u85ac\u5264\u75ab\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a <\/td>\n<\/tr>\n
\u4e0b\u5802\u8597\u6a29\u6d0b <\/td>\n \u300c\u9577\u671f\u5b9f\u52d9\u5b9f\u7fd2\u300d \u75c5\u9662\u5b9f\u7fd2\u306b\u304a\u3051\u308b\u554f\u984c\u3078\u306e\u6539\u5584\u306b\u5411\u3051\u3066 <\/td>\n \u7b2c73\u56de\u4e5d\u5dde\u5c71\u53e3\u85ac\u5b66\u5927\u4f1a <\/td>\n<\/tr>\n
\u4e0b\u5802\u8597\u6a29\u6d0b <\/td>\n“\u96fb\u5b50\u30ab\u30eb\u30c6\u6642\u4ee3\u306b\u6c42\u3081\u3089\u308c\u308b\u770b\u8b77\u8a18\u9332\u3068\u306f\uff1f
\n \uff5e\u85ac\u5264\u5e2b\u306e\u7acb\u5834\u304b\u3089\uff5e” <\/td>\n		 \u7b2c31\u56de \u533b\u7642\u60c5\u5831\u5b66\u9023\u5408\u5927\u4f1a \uff08\u7b2c12\u56de \u65e5\u672c\u533b\u7642\u60c5\u5831\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff09 <\/td>\n<\/tr>\n
\u677e\u5143\u4e00\u660e <\/td>\n \u81e8\u5e8a\u73fe\u5834\u3067\u6d3b\u8e8d\u3059\u308b\u5148\u8f29\u85ac\u5264\u5e2b\u304b\u3089\u5f8c\u8f29\u3078\u306e\u30e1\u30c3\u30bb\u30fc\u30b8 <\/td>\n \u7b2c28\u56de\u65e5\u672c\u85ac\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6a2a\u5c71\u96c4\u592a\u3001\u677e\u5143\u4e00\u660e\u3001\u5c71\u672c\u88d5\u4e4b\u3001\u4e95\u7554\u80fd\u6587\u3001\u4e95\u672c\u6d69\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u5c71\u7530\u52dd\u58eb\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n Ampicillin\/sulbactam\u306e\u900f\u6790\u60a3\u8005\u306b\u304a\u3051\u308b\u624b\u8853\u611f\u67d3\u4e88\u9632\u6295\u4e0e\u6cd5\u306e\u9069\u6b63\u5316 <\/td>\n \u7b2c28\u56de\u65e5\u672c\u85ac\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6e21\u8fba\u82f1\u91cc\u9999\u3001\u677e\u5143\u4e00\u660e\u3001\u6a2a\u5c71\u96c4\u592a\u3001\u91d1\u6fa4\u76f4\u5b50\u3001\u6df1\u6c34\u77e5\u82f1\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u90e1\u5c71\u8c4a\u6cf0\u3001\u5bae\u4e4b\u539f\u5f18\u6643\u3001\u732a\u5ddd\u548c\u6717\u3001\u68ee\u5ddd\u5247\u6587\u3001\u5c71\u7530\u52dd\u58eb\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30c6\u30a4\u30b3\u30d7\u30e9\u30cb\u30f3\u6295\u4e0e\u60a3\u8005\u306e\u81e8\u5e8a\u8a55\u4fa1 \uff0dPK-PD\u7406\u8ad6\u306b\u57fa\u3065\u304f\u691c\u8a0e\uff0d <\/td>\n \u7b2c28\u56de\u65e5\u672c\u85ac\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u5927\u4f1a <\/td>\n<\/tr>\n
\u25cb\u725b\u5c71\u7f8e\u5948\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u5bae\u8107\u662d\u5f66\u3001\u7530\u5be6\u88d5\u4ecb\u3001\u897f\u6fa4\u7531\u7d00\u5f66\u3001\u5c71\u53e3\u8fb0\u54c9\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u4e2d\u6751\u5178\u53f2\u3001\u5c71\u7530\u52dd\u58eb\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u6297\u304c\u3093\u5264\u611f\u53d7\u6027\u8a66\u9a13\u306b\u57fa\u3065\u304f\u79d1\u5b66\u7684\u304c\u3093\u85ac\u7269\u7642\u6cd5\u306b\u95a2\u3059\u308b\u53d6\u308a\u7d44\u307f <\/td>\n \u533b\u7642\u85ac\u5b66\u30d5\u30a9\u30fc\u30e9\u30e02011 \/ \u7b2c19\u56de\u30af\u30ea\u30cb\u30ab\u30eb\u30d5\u30a1\u30fc\u30de\u30b7\u30fc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u7530\u5be6\u88d5\u4ecb\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u7530\u7551 \u7965\u3001\u897f\u6fa4\u7531\u7d00\u5f66\u3001\u5c71\u53e3\u8fb0\u54c9\u3001\u725b\u5c71\u7f8e\u5948\u3001\u5c71\u672c\u96c5\u9054\u3001\u53e4\u5ddd\u9f8d\u5f66\u3001\u79cb\u5c71\u4f38\u4e00\u3001\u5c71\u7530\u52dd\u58eb\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u9ad8\u6d78\u900f\u5727\u306b\u3088\u308b major vault protein (MVP) \u767a\u73fe\u5236\u5fa1\u306b\u304a\u3051\u308b Sp1 \u306e\u5f79\u5272 <\/td>\n \u7b2c64\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u897f\u5357\u90e8\u4f1a <\/td>\n<\/tr>\n
\u25cb\u897f\u6fa4\u7531\u7d00\u5f66\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u7530\u7551 \u7965\u3001\u7530\u5be6\u88d5\u4ecb\u3001\u4fe3\u6728\u535a\u5fb3\u3001\u53e4\u5ddd\u9f8d\u5f66\u3001\u725b\u5c71\u7f8e\u5948\u3001\u5c71\u53e3\u8fb0\u54c9\u3001\u5c71\u672c\u96c5\u9054\u3001\u677e\u4e0b\u8302\u4eba\u3001\u79cb\u5c71\u4f38\u4e00\u3001\u5c71\u7530\u52dd\u58eb\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n“\u30c1\u30df\u30b8\u30f3\u30db\u30b9\u30db\u30ea\u30e9\u30fc\u30bc\u767a\u73fe\u816b\u760d\u3067\u306e 5-fluorouracil (5-FU) \u306b\u3088\u308b thrombospondin-1
\n (TSP-1) \u767a\u73fe\u8a98\u5c0e” <\/td>\n		 \u7b2c64\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u897f\u5357\u90e8\u4f1a <\/td>\n<\/tr>\n
\u25cb\u5357\u8b19\u592a\u6717\u3001\u5c71\u672c\u96c5\u9054\u3001\u5c0f\u677e\u6b63\u6cbb\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u7530\u7551 \u7965\u3001\u79cb\u5c71\u4f38\u4e00\u3001\u5c71\u7530\u52dd\u58eb\u3001\u6b66\u7530\u6cf0\u751f\u3001\u53e4\u5ddd\u9f8d\u5f66 <\/td>\n CNT1\u3068RRM1\u306e\u767a\u73fe\u5909\u5316\u304cGemcitabine\u8010\u6027\u81b5\u764c\u7d30\u80deMGEM6\u306e\u8010\u6027\u3092\u62c5\u3063\u3066\u3044\u308b <\/td>\n \u7b2c64\u56de\u65e5\u672c\u85ac\u7406\u5b66\u4f1a\u897f\u5357\u90e8\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6709\u99ac\u7531\u4f73\u3001\u6709\u99ac\u7d14\u5b50\u3001\u5c4b\u5730\u6176\u5b50\u3001\u4e0a\u7247\u5e73\u6075\u3001\u53e4\u7530\u8cb4\u5fd7\u3001\u897f\u516b\u91cd\u4e43\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u6ce8\u5c04\u85ac\u8abf\u5264\u624b\u9806\u306a\u3089\u3073\u306b\u8abf\u5264\u74b0\u5883\u306e\u518d\u691c\u8a0e\u306b\u3088\u308b\u8abf\u5264\u30a4\u30f3\u30b7\u30c7\u30f3\u30c8\u6e1b\u5c11\u3078\u306e\u53d6\u308a\u7d44\u307f\uff0d\u30d2\u30e5\u30fc\u30de\u30f3\u30a8\u30e9\u30fc\u30bc\u30ed\u3092\u76ee\u6307\u3057\u3066\uff0d <\/td>\n \u7b2c21\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
“\u25cb\u725b\u4e4b\u6ff5\u98a8\u898b\u3001\u4e8c\u5ddd\u4fca\u9686\u3001\u76ca\u7530\u5c06\u543e\u3001\u5927\u5ead\u771f\u7406\u5b50\u3001\u725b\u5c71\u7f8e\u5948\u3001\u6709\u99ac\u7d14\u5b50\u3001\u6c60\u7530\u9f8d\u4e8c\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001
\n \u5c71\u53e3\u8fb0\u54c9\u3001\u6b66\u7530\u6cf0\u751f” <\/td>\n		 \u982d\u9838\u90e8\u764c\u306b\u5bfe\u3059\u308bDocetaxel, Cisplatin, 5-FU\u4f75\u7528\u5316\u5b66\u7642\u6cd5\uff08TPF\u7642\u6cd5\uff09\u306e\u8840\u6db2\u6bd2\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e <\/td>\n \u7b2c21\u56de\u65e5\u672c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cbKazami Ushinohama, Toshitaka Futagawa, Mariko Oba, Shogo Masuda, Mina Ushiyama, Junko Arima, Ryuji Ikeda, Tatsuya Yamaguchi, Yasuo Takeda <\/td>\n Hematologic toxicity of chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with head and neck cancer <\/td>\n The Forbidden City International Pharmacist Forum <\/td>\n<\/tr>\n
\u25cbMariko Oba, Megumi Kamikatahira, Yuko Fujisaki, Yoshihiro Shimodouzono, Yasuo Takeda <\/td>\n Analgesics usage for radiation therapy-induced mucositis pain in patients with head and neck cancer. <\/td>\n The Forbidden City International Pharmacist Forum <\/td>\n<\/tr>\n
\u25cb\u85e4\u5d0e\u88d5\u5b50\u3001\u6b66\u4e9c\u5e0c\u5b50\u3001\u5bae\u8597\u5e78\u6c5f\u3001\u7af9\u5143\u660e\u5b50\u3001\u9577\u30f6\u539f\u771f\u5948\u7f8e\u3001\u524d\u7530\u73b2\u5b50\u3001\u5c71\u5185\u662d\u535a\u3001\u5bae\u539f\u9ebb\u7531\u7f8e\u3001\u677e\u4e0b\u8302\u4eba <\/td>\n \u9e7f\u5150\u5cf6\u5927\u5b66\u75c5\u9662\u8925\u7621\u5bfe\u7b56\u30c1\u30fc\u30e0\u306b\u304a\u3051\u308b\u85ac\u5264\u5e2b\u306e\u53c2\u753b\u2015\u8925\u7621\u6cbb\u7642\u5916\u7528\u5264\u306b\u95a2\u3059\u308b\u60c5\u5831\u63d0\u4f9b\u2015 <\/td>\n \u7b2c13\u56de\u65e5\u672c\u8925\u7621\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a <\/td>\n<\/tr>\n
\u25cb\u83c5\u539f\u82f1\u8f1d\u3001\u65e5\u9ad8\u4f38\u4e4b\u4ecb\u3001\u5927\u5ddd\u5185\u5bff\u6c5f\u3001\u897f\u516b\u91cd\u4e43\u3001\u5c0f\u7389\u54f2\u53f2\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u30a4\u30db\u30b9\u30d5\u30a1\u30df\u30c9\u6295\u4e0e\u306b\u304a\u3051\u308b\u4e2d\u67a2\u795e\u7d4c\u969c\u5bb3\u306e\u767a\u75c7\u7387\u3068\u5371\u967a\u56e0\u5b50\u306b\u3064\u3044\u3066\u306e\u89e3\u6790 <\/td>\n \u7b2c5\u56de\u65e5\u672c\u7de9\u548c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
\u25cb\u6c60\u7530\u9f8d\u4e8c\u3001\u6b66\u7530\u6cf0\u751f\u3001\u5c71\u7530\u52dd\u58eb <\/td>\n \u6297\u304c\u3093\u5264\u8010\u6027\u6a5f\u5e8f\u306e\u89e3\u660e\u306b\u5411\u3051\u3066 <\/td>\n \u7b2c5\u56de\u65e5\u672c\u7de9\u548c\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a <\/td>\n<\/tr>\n
Hideki Kawamura, Kazuaki Matsumoto, Toyoyasu Koriyama, Akari Shigemi, Hiroaki Miyanohara, Michiyo Orita, Koichi Tokuda, Naoya Kawabata, Setsuro Komiya, Junichiro Nishi <\/td>\n The effect of cefazolin-based antimicrobial prophylaxis protocol on the isolation of bacteria from a surgical wound after clean orthopaedic surgery <\/td>\n 49th Annual Meeting of the Infectious Diseases Society of America <\/td>\n<\/tr>\n
Ryuji Ikeda, Yusuke Tajitsu, Yukihiko Nishizawa, Sho Tabata, Mina Ushiyama, Tatsuhiko Furukawa, Shin-ichi Akiyama, Katsushi Yamada, Yasuo Takeda <\/td>\n Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cells <\/td>\n \u7b2c5\u56de\u6b21\u4e16\u4ee3\u3092\u62c5\u3046\u82e5\u624b\u533b\u7642\u85ac\u79d1\u5b66\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 <\/td>\n<\/tr>\n
\u25cb\u67f4\u7530\u7531\u9999\u91cc\u3001\u6df1\u6c34\u77e5\u82f1\u3001\u5927\u8107\u54f2\u6d0b\u3001\u51fa\u53e3\u5c1a\u5bff\u3001\u52a0\u6cbb\u5efa\u3001\u4f50\u85e4\u9999\u5948\u5b50\u3001\u798f\u7530\u3086\u304b\u308a\u3001\u7530\u4e2d\u7766\u7f8e\u3001\u9ad8\u677e\u82f1\u592b <\/td>\n \u4e0b\u75e2\u75c7\u4f8b\u306b\u5bfe\u3059\u308b\uff2e\uff33\uff34\u306e\u4ecb\u5165 <\/td>\n \u7b2c27\u56de\u65e5\u672c\u9759\u8108\u7d4c\u8178\u6804\u990a\u5b66\u4f1a <\/td>\n<\/tr>\n
\u25cb\u8fd1\u85e4\u667a\u5b50\u3001\u677e\u5143\u4e00\u660e\u3001\u5357\u679d\u91cc\u3001\u4e0a\u91ce\u548c\u7f8e\u3001\u4e0b\u5802\u8597\u6a29\u6d0b\u3001\u5c71\u53e3\u8fb0\u54c9,\u3001\u6b66\u7530\u6cf0\u751f <\/td>\n \u7cd6\u5c3f\u75c5\u85ac\u7269\u6cbb\u7642\u306b\u95a2\u3059\u308b\u770b\u8b77\u5e2b\u3078\u306e\u6559\u80b2\u52b9\u679c\u3068\u6709\u7528\u6027\u306e\u691c\u8a0e <\/td>\n \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c132\u56de\u5e74\u4f1a <\/td>\n<\/tr>\n<\/table><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

 2024\u5e74\u696d\u7e3e \u8ad6\u6587\uff08\u7dcf\u8aac\uff09 \u8ad6\u6587\u533a\u5206 \u8457\u8005\u533a\u5206 \u8457\u8005\u540d \u8ad6\u6587\u540d \u96d1\u8a8c\u540d\u7b49 \u5dfb\u6570\uff1a\u521d\u9801\uff0d\u7d42\u9801 \u767a\u884c\u5e74\uff08\u897f\u66a6\uff09\u6708\u65e5 \u548c\u6587\u7dcf\u8aac \u5358\u8457 \u83c5\u539f\u3000\u82f1\u8f1d \u6211\u304c\u56fd\u306e\u6709\u5bb3\u4e8b\u8c61\u81ea\u767a\u5831\u544a\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u3092\u7528\u3044\u305f\u304c\u3093\u30fb\u7de9\u548c\u85ac\u7269\u7642\u6cd5\u306b\u95a2 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-103","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hosp.kagoshima-u.ac.jp\/pharm\/wp-json\/wp\/v2\/pages\/103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hosp.kagoshima-u.ac.jp\/pharm\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.hosp.kagoshima-u.ac.jp\/pharm\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.hosp.kagoshima-u.ac.jp\/pharm\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hosp.kagoshima-u.ac.jp\/pharm\/wp-json\/wp\/v2\/comments?post=103"}],"version-history":[{"count":17,"href":"https:\/\/www.hosp.kagoshima-u.ac.jp\/pharm\/wp-json\/wp\/v2\/pages\/103\/revisions"}],"predecessor-version":[{"id":214,"href":"https:\/\/www.hosp.kagoshima-u.ac.jp\/pharm\/wp-json\/wp\/v2\/pages\/103\/revisions\/214"}],"wp:attachment":[{"href":"https:\/\/www.hosp.kagoshima-u.ac.jp\/pharm\/wp-json\/wp\/v2\/media?parent=103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}